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STRUCTURAL AND MOLECULAR CORRELATES OF INDIVIDUAL 
DIFFERENCES IN ANXIETY BEHAVIOR AND THE STRESS RESPONSE 
Melinda Miller, PhD. 
The Rockefeller University 2010 
 
Although many people are exposed to stressful experiences during their 
lifetime, only 5-35% will be diagnosed with Post-Traumatic Stress Disorder 
(PTSD). While most animal models of stress are effective at producing 
behavioral changes in an entire group of animals, they fail to account for 
individual differences in the human stress response or for the variability in 
baseline anxiety.  
Animal models of acute and chronic stress increase anxiety behavior and 
induce structural and neurochemical changes in brain regions necessary for 
learning, memory, fear responses, and executive function; the hippocampus, 
amygdala and medial prefrontal cortex (mPFC). In the following experiments, we 
measured basal anxiety levels and compared anxiety behavior before and after 
stress.  Individuals were grouped based on basal anxiety profiles (either “Calm” 
or “Anxious”) or by whether they developed changes in behavior after stress 
(stress vulnerable, or “PTSD-like” and stress resilient, or “Resilient”). 
Results showed that molecular and morphological differences were 
already apparent prior to stress.  Anxious Sprague Dawley and Lewis rats had 
shorter apical dendrites in pyramidal neurons of mPFC and anxiety correlated 
negatively with dendritic arbor size.  Densitometry analysis found individual 
  
differences in mRNA expression of the neuropeptide Cocaine-Amphetamine–
Regulated-Transcript (CART). CART expression was higher in the hippocampus 
and medial amygdala of “Calm” individuals, and expression in the hippocampus, 
central amygdala, mPFC, and orbitofrontal cortex correlated with anxiety 
behavior.  CART expression also differed in individuals in the PTSD-like and 
Resilient profiles. CART mRNA and protein levels were higher in the 
hippocampus and lower in several nuclei of the amygdala in stress-resilient 
animals; while CART levels in the PTSD-like group was lower in the Infralimbic 
mPFC.  
These results emphasize the importance of individual differences in 
behavior, and show that there are significant structural and molecular differences 
between adult male rats. They also illustrate the need for experiments that 
produce both stress-vulnerable and resilient individuals, as resilience may be an 
active process involving changes to many brain regions.  Finally, these results 
present a novel role for the neuropeptide CART in establishing or predicting 
individual differences in anxiety, and suggest that CART may be involved in both 
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Chapter 1: Introduction 
What is stress? 
Practically everyone has an understanding of what stress is, at least in terms 
of the modern world; however, this term can be somewhat hard to define. Stress 
can be thought of as the organism’s response to threatening stimuli in the 
environment, either real or perceived, that increases production of hormones such 
as cortisol and adrenaline, and activates many other neurochemical systems in the 
brain.  These produce a cascade of changes that initiate the “fight or flight” 
response, essentially the immediate upregulation of the sympathetic nervous 
system and the temporary inhibition of parasympathetic function (de Kloet et al. 
2005).   In the short term, this helps the organism to adapt, accommodate to, or 
escape from the stressor and bring the body back into balance. This process is also 
called “allostasis”, meaning establishing stability through change (McEwen 2004).  
The release of the stress hormones CRH, ACTH, and cortisol, as well as the 
neurotransmitters epinephrine, norepinephrine, and serotonin during a stressful 
event can help the body to produce enough energy to quickly escape from aversive 
stimuli (Sandi et al. 1992) or predators (Adamec et al. 1998).  Acutely, these 
neurochemicals have also been shown to boost the immune system, increase 
attention and even enhance memory (McEwen 2004). However, during chronic 
stress these same systems work overtime, which causes wear and tear on the body 
and results in  increased “allostatic load” or “overload” (McEwen et al. 1993). In 
contrast with acute stress, chronic stress can reduce energy, disrupt mood, weaken 
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the immune system, and impair attention and memory processes (McEwen 2003, 
2006).    
Post-Traumatic Stress Disorder 
Occasionally, a single stressor can be so severe and traumatic, or the body 
can adapt so poorly, that it can create long-term imbalance in the systems involved 
in allostasis. Post Traumatic Stress Disorder (PTSD) is a condition contingent upon 
a physical or psychosocial stressor that is remembered or re-experienced with such 
emotional strength, that people continue to have intensely fearful, anxious, and 
dysphoric responses well after the threat is gone (Bonne et al. 2004).  In the United 
States, there is a 6.8% lifetime prevalence for developing PTSD (Kessler et al. 
2005).  Yehuda and LeDoux (2007) have classified the common symptoms of PTSD 
into three types: 1. reexperiencing symptoms; the uncontrollable intrusions of 
memories for the traumatic event that coincide with the same physiological 
responses associated with the original trauma, such as flashbacks and nightmares; 
2. avoidance symptoms, intentional avoidance of reminders of the traumatic event, 
and may include general avoidance of social and emotional situations; and 3. 
hyperarousal symptoms, physiological responses on par with stress-state arousal 
when no stressors are present.  These include hypervigilance, increased startle 
response and a general state of fearfulness. Treatment options for PTSD symptoms 
include exposure therapy, psychotherapy, as well drugs to treat other forms of 
anxiety and typical and atypical antidepressants; however, most treatments have 
less than ideal response rate (Seidler et al. 2006; Hofmann et al. 2008; Donovan et 
al. 2009). 
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 Animal models have commonly been used to elucidate the biological 
mechanisms of neurological diseases and disorders.  Using animals to study PTSD 
is particularly challenging because many of the psychological symptoms that 
characterize the disorder, such as flashbacks, nightmares, and anxiety towards 
complex stimuli, are difficult to reproduce outside of the human species. 
Nonetheless, the major structures thought to be involved in processing fearful 
stimuli, producing a stress response, and encoding emotional memory are shared 
across mammalian species.  
          The major structures involved in the stress response - the amygdala, 
hippocampus and prefrontal cortex - have an intricate connectivity that controls and 
modulates the behavioral stress response. These generate a series of checks and 
balances via excitatory connections and inhibitory feedback loops. Likewise, anxiety 
behaviors have been identified that are shared across species, including hyper-
vigilance to novel stimuli (Mikics et al. 2008; Grillon et al. 2009), and enhanced 
acoustical startle reflex (Garrick et al. 2001; Cohen et al. 2004), and social 
withdrawal (Morilak et al. 2005; Adamec et al. 2007).  Although non-invasive 
neuroimaging techniques have begun to develop the resolution to examine 
connectivity between areas involved in the processing of emotionally arousing 
events, animal research is still the cornerstone to understanding the anatomical, 
functional, and molecular pathways through which these brain structures 
communicate.  
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Fear in the Brain - The amygdala 
 Several decades of research has helped to validate the role of the amygdala 
as the locus of fear processing and fear learning in the brain (Fanselow et al. 1999).  
Bilateral lesions or pharmacological inactivation of the amygdala before training 
eliminate the fear conditioning response (LeDoux et al. 1988; Muller et al. 1997), 
and temporary inactivation after fear conditioning can prevent consolidation of a fear 
memory, impairing subsequent memory recall (Sacchetti et al. 1999).  Further, 
bilateral amygdala lesions many days after fear conditioning can completely abolish 
the memory, demonstrating that the amygdala is also a site of fear memory storage 
(Maren et al. 1996).  Although less pronounced in humans, bilateral loss of the 
amygdala limits the production of an appropriate autonomic fear response during 
conditioning, and also impairs the comprehension of social cues, such as the 
recognition of fearful and angry facial expressions (Adolphs et al. 1994; LaBar et al. 
1995; Adolphs et al. 1998).    
 The amygdala is divided into several nuclei that are involved in input of 
sensory information, fear processing and coincidence detection, and output of fear 
behavior (Pitkanen et al. 1997). The lateral nucleus of the amygdala (LA) is the 
region that receives the heaviest sensory input, mainly from thalamic nuclei. LA 
projects to almost all other subnuclear regions within the amygdala. It is thought that 
most of the processing and consolidation of fear learning occurs here, as lesions 
specific to LA, or the slightly larger lateral/basolateral amygdala (LA/BLA) complex, 
prevent the consolidation of fear conditioning (Nader et al. 2001).  Projections from 
LA form separate fiber tracts that innervate the Basal, Accessory Basal, Medial 
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(ME) and Central (CE) subnuclei of the amygdala.  Processing of information 
received from LA occurs in parallel within each of the other subnuclei, and then 
converges into the major output region, CE. Neurons in CE project to the brainstem, 
hypothalamus and higher cortical areas, signaling the production of stress 
hormones and a behavioral response (Bohus et al. 1996; Salome et al. 2001). CE is 
required for the elicitation of a learned fear response, and CE specific lesions 
prevent animals from producing conditioned behavior (Nader et al. 2001).  
 LA and the other subnuclei also receive projections from hippocampal and 
parahippocampal structures, the thalamus, and discrete regions of the prefrontal 
cortex that can modulate amygdalar activity (Ino et al. 1990; Szinyei et al. 2000; 
Furtak et al. 2007).  Additionally, there are interneurons that send feedback to and 
from the subnuclei as during stimulus processing (Washburn et al. 1992; Royer et 
al. 2002).  Together these connections for a complex network responsible for 
producing appropriate and highly specific behavioral responses to changes in the 
environment. 
Amygdala Modulation of the Hippocampus 
While hippocampal projections to the amygdala may modulate early stimulus 
processing (Maren et al. 1995), the influence of amygdalar activity on hippocampal 
function and hippocampal-dependent memory is more extensive. The ability to 
induce long term potentiation (LTP) in the brain has been utilized as a measure of 
neuroplasticity and learning. Conditioning a rat to respond to a neutral stimulus, 
such as a tone, when it is paired with an innately aversive footshock, induces LTP in 
LA , which coincides with the learning of the new fear contingencies (Rogan et al. 
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1997). An increase in amygdala activity can increase activity in the hippocampus, 
specifically enhancing LTP in the dentate gyrus, and lesions in the amygdala impair 
LTP induction (Ikegaya et al. 1995; McGaugh 2002).   
Behaviorally, amygdala modulation of the hippocampus is even more 
evident.  In animals, amygdala activity has been demonstrated to both enhance and 
impair memory for spatial tasks, inhibitory avoidance, context conditioning, 
appetitive conditioning and reward learning (Izquierdo et al. 1997; McGaugh 2002; 
Hayes et al. 2004; Richter-Levin 2004).  Studies employing pharmacological 
excitation of the amygdala using amphetamines and glucocorticoids injected before 
and after training have shown increases in accuracy in the Morris water maze and 
inhibitory avoidance tasks (Packard et al. 1998; Roozendaal 2000).  The pairing of 
acute stressors shown to temporarily increase amygdala activity, such as footshock 
and restraint stress with the Morris water maze, have demonstrated both positive 
and negative effects on performance (Luine et al. 1996; de Quervain et al. 1998; 
Kim et al. 2001; Shors 2001). Lesions to the amygdala or temporary inhibition of 
amygdala activity prevent these stress-induced alterations in memory performance 
and often cause impairment (Kim et al. 2001; Kim et al. 2005), demonstrating that 
stress is a complex stimuli that activates much more than the amygdala.   
In humans, amygdala activity also has been confirmed to enhance 
hippocampal dependent memory. Memory for arousing words and events is 
generally better than for emotionally neutral ones (Phelps et al. 1997), and pairing 
neutral words or stories with emotionally arousing ones enhances recollection for 
the neutral stimuli (Maratos et al. 2001). Although people with amygdala damage 
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can remember arousing and non-arousing stimuli as well as control subjects, they 
do not show the recall enhancement for the emotionally arousing stimuli (Anderson 
et al. 2001). Functional Magnetic Resonance Imaging (fMRI) evidence suggests 
that an image is more likely to be remembered if there is greater amygdala 
activation, and if amygdala activity correlates with hippocampal activity during the 
original encoding (Dolcos et al. 2004). However, people with PTSD have 
exaggerated amygdala activation for trauma-associated stimuli that does not 
habituate even after many presentations (Protopopescu et al. 2005). While further 
research is needed, it is possible that amygdala-hippocampal interactions during 
encoding and consolidation of a traumatic event may be a major factor in the vivid 
recollection and enduring properties of PTSD related memories.  
Bidirectional modulation of the amygdala and the prefrontal cortex 
Major projections from the prefrontal cortex (PFC) innervate the amygdala.  
These connections are largely inhibitory, or GABAergic, with the bulk of the 
projections converging on inhibitory interneurons in the  LA/BLA and CE (McDougall 
et al. 2004; Vertes 2004).  Fiber tracts originate from several areas, including the 
anterior cingulate (ACg), prelimbic (PL) and infralimbic (IL) region. By inhibiting 
activity in LA/BLA, these projections inhibit aversive conditioning and the elicitation 
of fear responses in the presence of previously conditioned stimuli.  This effect is 
called extinction, and it is a gradually learned process thought to be governed by 
the more medial areas of PFC (mPFC) in rodents (Maren et al. 2004). Lesions in 
mPFC and ACg prevent extinction learning (Morgan et al. 1993) and 
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electrophysiological studies show that LTP in mPFC is necessary to maintain 
extinction (Herry et al. 2002). 
  Extinction is a two-way street.  When a neutral stimulus does not continue to 
predict an aversive outcome, the memory trace detecting this “coincidence” in the 
amygdala ceases to be reinforced with electrophysiological and molecular activity.  
As a result, mPFC, which receives inhibitory input from many areas including the 
hippocampus and amygdala, becomes more active as the these  regions become 
less active (Quirk et al. 2003).  This allows for stronger inhibitory input from mPFC 
to the amygdala.  
This feedback loop has been confirmed in human extinction learning. Using 
fMRI, a similar negative correlation has been found between amygdala and 
prefrontal activation during extinction learning in healthy subjects (Phelps et al. 
2004). This suggests that the neural correlates of fear learning and extinction are 
preserved across species.  It has been suggested that people with anxiety disorders 
may have an enhanced amygdala response to threatening stimuli due to poor 
inhibitory tone from a less active PFC.  This may lead to reduced inhibition of the 
amygdala during memory encoding, which could give  heightened emotional 
significance to neutral environmental stimuli, and cause symptoms of anxiety 
disorders (Protopopescu et al. 2005). This would also impair future memory 
extinction, possibly preventing these fear-associated memories from being properly 
extinguished once the threat is gone (Quirk et al. 2003). Irregularities in both 
encoding and extinction may be possible in PTSD. 
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Acute and Chronic Stress Models 
 The amygdala, hippocampus and PFC, supplemented by other connected 
brain structures are responsible for creating fear-related adaptive responses to the 
environment. By examining simple models of animal stress, we can better 
understand how physical and behavioral symptoms develop after a traumatic 
episode and determine ways to reverse a maladaptive stress response. Acute and 
chronic stressors have been extensively studied in the rodent.  The most common 
stress methods are the use of restraint or immobilization, social interaction and 
defeat, and predator or predator odor presentation. In addition, electrical shocks to 
the feet or tail are employed in acute stress studies, and even fear conditioning can 
be thought of as an acute stressor.   
The hippocampus is one of the few areas of known adult neurogenesis. 
Newly proliferating neurons in the dentate gyrus seem particularly vulnerable to the 
effects of stress, making the hippocampus one of the most variable regions in the 
brain.  Chronic restraint stress has been shown to inhibit neurogenesis in the 
granule cell layer and decrease cell survival by almost 50 percent after six weeks of 
stress (Pham et al. 2003).  In the surviving neurons and neurons from surrounding 
regions, chronic stress results in considerable dendritic remodeling. Repeated 
restraint, social subordination, and predator exposure all produce apical dendritic 
remodeling in hippocampal CA3,  resulting in fewer branch points, shorter mean 
dendritic length and reduced spine density (Magarinos et al. 1996; McEwen 1999; 
Diamond et al. 2000; Vyas et al. 2002).  The hippocampus has a major role in the 
consolidation of memory (Morris et al. 1990; Izquierdo et al. 2000; Holscher 2003). 
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As would be predicted by the structural and electrophysiological data, chronic stress 
produces deficits in spatial memory and impairments in other hippocampal-
dependent learning paradigms, including inhibitory avoidance and context 
conditioning (Izquierdo et al. 1997; de Quervain et al. 1998; McEwen 1999).  
Fortunately, once the stress has ceased, most of these effects are reversible over 
time (McEwen 1999), which gives hope to reversing the effects caused by long-term 
stress related disorders in humans. 
In the PFC, chronic stress results in similar dendritic remodeling. Repeated 
restraint stress produces a reduction in apical dendritic length and loss of spine 
density on pyramidal neurons in ACg, PL and IL regions of the mPFC (Radley et al. 
2004; Liston et al. 2006; Radley et al. 2006; Goldwater et al. 2009) .  However, the 
chronic stress induced dendritic atrophy is reversible if the animals are given 
several weeks to recover (Radley et al. 2005); but, there is some evidence that the 
original dendritic morphology is permanently altered (Goldwater et al. 2009). In a 
test of working memory, chronic stress induced memory impairments, and poor task 
performance correlated with shorter apical dendrites in mPFC (Liston et al. 2006).  
In contrast, dendritic hypertrophy is found in the amygdala following chronic 
stress.  A 10-day immobilization stress paradigm produced an increase in dendritic 
length and total number of branch points on apical dendrites of BLA pyramidal-like 
neurons (Vyas et al. 2002), as well as increased spine density along the apical 
dendrite (Mitra et al. 2005).  An increase in anxiety behavior was also found in the 
same animals.  A significant aspect of the dendritic hypertrophy in BLA is that it 
does not appear to be readily reversible once the stress has ceased, at least not 
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after the same amount of recovery time sufficient to reverse CA3 and mPFC stress-
induced atrophy (Vyas et al. 2004).  The potential failure of amygdala neurons to 
return to a pre-stress state may be a key reason why the symptoms of PTSD and 
other stress disorders often diminish very slowly and sometimes not at all 
Although the effects are smaller and more discrete, a single acute stress also 
appears to differentially affect dendritic morphology in several brain regions. Acute 
stress-induced changes in the hippocampus have been previously examined in both 
male and female rats (Shors et al. 2001).  In males, apical dendritic spine density in 
CA1 pyramidal neurons increased 24 hours after acute tailshock, whereas spine 
density decreased in the apical dendrites of diestrus females. Regardless of the sex 
differences, this suggests that the hippocampus can rapidly adapt to stress through 
structural modifications.  Long-enduring structural changes after acute stress have 
also been demonstrated in the hippocampus. Three weeks after a brief social defeat 
stress, a reduction in apical dendritic length of CA3 pyramidal neurons was still 
evident (Kole et al. 2004).  
In the amygdala, a single two-hour immobilization stress  was shown to 
increase spine density on primary branches of the apical dendrite 10 days after 
stress, but not just 24 hours post-stress (Mitra et al. 2005). This correlated with a 
delayed enhancement in anxiety behavior in the same animals.  There are no 
published studies examining the effect of acute stressors on mPFC dendritic 
morphology, although a 10-minute restraint stress repeated for one week was 
sufficient to reduce the length of proximal branches on the apical dendrites of 
pyramidal neurons (Brown et al. 2005). 
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Models of predator stress 
In a more naturalistic model of stress exposure, rodents have been subjected 
to their natural predators, namely cats, foxes and ferrets, and examined for long 
term behavioral and neurochemical changes.  Adamec and Shallow (1993) reported 
a long-lasting increase in anxiety-like behavior and a decrease in risk assessment in 
the elevated plus maze (EPM) following a single 5-minute direct exposure of a rat to 
a cat.  These effects could be seen 30 minutes to 1 hour after predator exposure 
and persisted for at least 3 weeks in hooded rats.  Likewise, acute predator stress 
increased acoustic startle response and decreased entries into the light box of the 
light-dark box paradigm (Blundell et al. 2005) and potentiated neural transmission 
both to and from the amygdala 10 days post-stress (Adamec et al. 2005).  Chronic 
indirect predator exposure also produces long lasting changes in anxiety and 
defensive behaviors.  While the CORT response to chronic restraint stress tends to 
habituate over time (Magarinos et al. 1995), there was an increase in basal 
corticosterone levels that did not appear to habituate up to 20 days after the start of 
daily predator stress (Blanchard et al. 1998).  Further, chronically exposed animals 
demonstrated a blunted corticosterone response to a novel restraint stress. 
Rodents, even those that have been bred and raised in a laboratory, show an 
innate and immediate stress response to odors produced in the urine, hair, and 
scent glands of their predators. Cat odors alone, using odorants coming from a 
used collar worn by a cat (Dielenberg and McGregor, 1999), a ball of cat fur 
(Vazdarjanova et al., 2001), or used cat litter (Cohen, et al., 2004) have also been 
shown to cause both immediate and long-term changes to behavior commensurate 
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with those seen after actual predator exposure. These behavioral changes are 
dependent on many brain regions that are involved in other forms of stress.  
Lesions or temporary inactivation of BLA have been shown to prevent the 
expression of anxiety and avoidance during cat odor exposure (Vazdarjanova et al. 
2001). Lesions to the medial amygdala, ventral hippocampus, and dorsal 
premammilary nucleus inhibit predator and predator odor induced defensive 
behaviors during exposure (Blanchard et al. 2005).  Systemic (Blundell et al. 2005) 
and amygdala specific (Adamec et al. 2005) injections of NMDA receptor 
antagonists administered before predator exposure block the stress-induced 
increase in anxiety.  Post-stress systemic administration of beta-adrenergic receptor 
antagonists, mineralcorticoid receptor antagonists (Adamec et al. 2007), a serotonin 
receptor 2 (5-HT2) selective antagonist (Adamec et al. 2004), and the SSRI 
sertraline (Matar et al. 2006) have all demonstrated therapeutic effects on later 
anxiety behavior, although the extent of their benefits are not consistent in the 
literature.  Future studies may have to target specific regions of the brain in order to 
understand the mechanism causing these long lasting behavioral changes.  
Individual differences in anxiety and the stress response 
As mentioned previously, approximately 6.8% of adults in the United States 
are diagnosed with PTSD in their lifetime (Kessler et al. 2005).  Yet, most surveys 
estimate that as much as 75% of the population reports experiencing at least one 
traumatic life event; and of those who experience trauma, only 5 to 35% actually 
develop PTSD and other types of anxiety disorders (Breslau et al. 1998; Breslau 
2001; Sledjeski et al. 2008).  This is in stark contrast to the way that most animal 
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models are designed – with a control group and an “experimental” group, and the 
expectation that the majority of animals will develop anxiety symptoms.  This has 
recently become an important topic of debate in translational research of anxiety 
and mood disorders (Yehuda et al. 2006; Yehuda et al. 2007), and has raised 
important questions about investigating individual differences in the stress 
response. 
One way to concentrate the likelihood of obtaining affected individuals is by 
choosing strains of rats known to have higher baseline anxiety than others.  Lewis 
rats are an inbred strain developed from the Sprague-Dawley.  The Lewis rat strain 
has been implicated as a model for PTSD, as they exhibit greater baseline anxiety 
behaviors and greater stress-induced increases in anxiety than other strains. 
Furthermore, Lewis rats have been characterized by their abnormal HPA stress 
response (Cohen et al. 2006). Lewis rats have normal basal blood corticosterone 
levels, as compared to their Sprague-Dawley cousins, but have a hypoactive 
response to stress.  
According to studies using Lewis rats by Cohen, et al. (2004; 2006), one 
week after a cat odor exposure paradigm the majority of animals demonstrated 
“extreme behavioral responses,” such as never entering the open arms of the EPM, 
and heightened acoustic startle that did not habituate. Administration of CORT prior 
to stress brought CORT levels to those found in other strains, and reduced anxiety 
behavior.  Similar effects have been found in humans. An enhanced acoustical 
startle response is also common in patients with PTSD (Grillon et al. 2009). There is 
also some evidence that people who produce lower than average levels of cortisol 
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after a traumatic event may have a higher probability of later developing PTSD 
(Yehuda et al. 1994; Yehuda et al. 1998; Delahanty et al. 2000; Yehuda 2002). In 
addition, people with PTSD symptoms have lower than average basal cortisol levels 
(Yehuda et al. 1994; Heim et al. 2000). 
Individual differences can also be examined by dividing animals into groups 
based on behavior.  This can either be accomplished by collecting basal levels of 
locomotor, anxiety and depressive behaviors and separating animals into groups 
prior to experimental procedure, or dividing them after the experimental 
manipulation based on stress-induced individual behavioral responses.  Studies of 
the former have shown that behavior varies greatly between individuals.  In 
Sprague-Dawley rats, different measures of anxiety behavior including open field 
locomotion and inhibitory avoidance were correlated within individuals across many 
days of monitoring (Cure et al. 1992).   In a longevity study, fear of novelty in infant 
rats predicted later CORT responses to novelty in adulthood and correlated with 
shorter lifespan (Cavigelli et al. 2003). 
In Wistar rats grouped by the amount of rearing behavior elicited in the open 
field, high and low rearers were associated with a number of behavioral differences 
as well as brain differences. High rearers moved around more, but spent less time 
in the open arms of the EPM and had poorer retention for both passive and active 
memory tests (Borta et al. 2005). However, they were also quicker at obtaining food 
reward and resistant to weight loss (Gorisch et al. 2006).  This would indicate that 
some of the traits that would point towards high anxiety may be beneficial for 
survival in the wild. During novelty exposure, high responders had increased 
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extracellular dopamine levels compared to low responders in the nucleus 
accumbens (Saigusa et al. 1999) suggesting that these two groups of animals have 
differences in their reward-learning pathways.  Additionally, high and low 
responders were differentially affected by the administration of agonists and 
antagonists to alpha and beta adrenergic receptors suggesting that receptor 
concentration in the nucleus accumbens correlates with behavioral differences 
(Tuinstra et al. 2000). 
Experiments where individuals are divided into groups based on their stress 
response provide information about what brain regions mediate stress vulnerability 
and stress resilience.  While there are very few of these types of studies in the 
literature, there is both structural and molecular evidence of differences between the 
stress vulnerable and stress resilient.  Two weeks after a predator stress, animals 
that showed low post-stress anxiety had shorter, more compact dendritic branching 
in the pyramidal neurons of BLA, whereas highly anxious animals looked no 
different from unstressed controls (Mitra et al. 2009). This would suggest that stress 
resilience may be an active process. In another study, after predator stress, animals 
that were found to be affected by stress had decreased levels of brain-derived-
neurotrophic-factor (BDNF) in the cornu Ammonis region 1 (CA1) of the 
hippocampus (Kozlovsky et al. 2007). Additionally, only the animals with the highest 
post-stress anxiety showed decreases in plasma dehydroepiandrosterone (DHEA) 
levels (Cohen et al. 2007).  In stress resilient animals, mRNA expression of the 
neuropeptide galanin was higher in CA1, while galanin levels were reduced in both 
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CA1 and PFC of the stress vulnerable.  Injection of galanin prior to stress was also 
able to abolish stress-induced anxiety one week later (Kozlovsky et al. 2009).  
In another model of stress resilience, rats that had undergone a chronic mild 
stress paradigm were divided by whether or not the stressor had produced 
anhedonia in a sucrose preference test (Bergstrom et al. 2008). Rats that were 
vulnerable to stress-induced anhedonia had reduced mRNA expression of the 
neurotrophic factor vascular endothelial growth factor (VEGF) in region CA3 of the 
hippocampus, while the anhedonia resistant individuals had upregulated expression 
of BDNF in CA3 (Bergstrom et al. 2008). In another model that investigated 
individual differences in extinction learning, animals were divided into two groups 
based on their ability to recall previous extinction learning of a fear-conditioned 
stimulus. Electrophysiological recordings of cells in the IL region of mPFC revealed 
that individuals with better extinction recall had more activity in IL during recall, and 
that activity in IL was dependent on NMDA receptor activity (Burgos-Robles et al. 
2007). There is evidence that neuropeptide Y (NPY) plays a role in stress resilience 
in both animals and humans, which will be discussed further below. As a whole, 
these results substantiate the recent trend to examine individual differences in the 
stress response, and provide evidence that changes in brain and behavior are 
closely correlated. 
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Modulators of the stress response 
Glucocorticoids 
Glucocorticoid imbalance has been implicated in a number of disorders. 
While chronic elevation of cortisol is a common symptom of major depression and 
Cushing’s disease (McEwen 2005); there is evidence that people with lower than 
average basal cortisol levels are more likely to develop PTSD (Yehuda et al. 1998). 
Some clinical trials have found success administering cortisol in the hospital to 
patients undergoing cardiovascular surgery or treatment for septic shock in reducing 
later occurrences of PTSD (Briegel et al. 1999; Schelling et al. 1999; Schelling et al. 
2001; Pitman et al. 2005). It has also been reported that 10mg/day cortisol 
treatment, considered to be a low dose, can reduce symptoms of chronic PTSD 
(Aerni et al. 2004).   However, even in these studies, only a small number of people 
reported feeling better, while many others reported no difference (Yehuda 2002).   
In rats, low glucocorticoid levels also correlate with likelihood to develop 
anxiety after stress (Cohen et al. 2006). Injection of corticosterone (CORT) prior to 
stress prevents stress induced anxiety and reduces the acoustic startle reflex 
(Cohen et al. 2006). Moreover, glucocorticoid administration has been shown to 
prevent retrieval of previously created fear memories in rats and in humans (de 
Quervain et al. 2000; Roozendaal et al. 2004).  
However, studies of chronic CORT treatment in rodents show stress-like 
effects of increased generalized anxiety, enhancement of fear and contextual 
conditioning (Korte 2001), and impairment of spatial learning in the Morris water 
maze (Roozendaal 2000). Chronic high-dose glucocorticoid administration in 
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rodents produces effects on hippocampal dendritic remodeling and memory 
identical to those seen from chronic stress (Woolley et al. 1990; Wellman 2001; 
McEwen 2005). Likewise in the BLA, chronic CORT administration induces the 
same hypertrophy found during stress (Mitra et al. 2008), thus implicating 
glucocorticoids and their receptors in the mechanism behind stress-induced 
structural plasticity and anxiety behavior  
  It is important to note that these effects are sometimes produced by doses 
that provide higher than physiological hormone levels and that the usual method of 
systemic injection is inherently aversive and stressful.  In contrast to invasive 
injection studies, there is evidence that noninvasive administration of low doses of 
corticosterone (CORT) in the drinking water can prevent restraint stress-induced 
remodeling of dendrites in the CA3 region of the hippocampus (Magarinos et al. 
1998).  However, either stress or CORT administration alone produced dendritic 
hypertrophy.  In addition, depressive-like behaviors in rats are increased not only by 
the absence of glucocorticoids though adrenalectomy (Edwards et al. 1990; King et 
al. 2001) but also by higher than average CORT levels (Kademian et al. 2005).  
The variability of these results suggests a non-linear adaptive response to 
glucocorticoids (Roozendaal 2000), and supports an inverted U-shaped dose-
response theory for hormones, stress, and their effect on brain and behavior 
(McEwen 2001). At very low and very high levels of circulating glucocorticoids, we 
may speculate that stress is more likely to alter neural plasticity and memory in a 
negative way, resulting in increased amygdala activity, dendritic remodeling, and 
non-fear related memory impairment.    
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Since it appears that glucocorticoids are important molecular modulators of 
many of the physiological stress effects found in the brain, then it is possible that by 
controlling glucocorticoid levels, one could control an organism’s behavioral stress 
response and prevent the long-term effects on behavior. Unfortunately, there is no 
straightforward answer whether to increase or decrease glucocorticoid levels on 
order to prevent maladaptive stress responses.  In order for this research to 
translate into clinical applications, basal glucocorticoid levels and the hormonal 
stress response of each patient would have to be well understood in order to make 
a diagnosis for each individual. 
Catecholamines 
Along with glucocorticoids, the role of the norepinephrine system in the study 
of stress has become a very popular topic.  While beta-adrenergic receptors do not 
appear to necessary for fear conditioning (Lee et al. 2001; Debiec et al. 2004), there 
is evidence that these receptors are involved in the consolidation of hippocampal-
dependent fear memories in both animals and humans. Beta-blockers, such as 
propranolol, administered prior to contextual conditioning impair learning and 
subsequent recall of the conditioned response to context (Ji et al. 2003; Grillon et al. 
2004; Roozendaal et al. 2004).  Based on electrophysiological evidence, blockade 
of beta-adrenergic receptors in the amygdala is sufficient to inhibit LTP in the 
hippocampus (Ikegaya et al. 1997), suggesting that the site of beta-adrenergic 
influence is in the amygdala and not directly on the hippocampus. It is not fully 
understood how these receptors are modulating the stress response, but activation 
of the beta-adrenergic receptors may turn on downstream molecular pathways that 
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along with circulating glucocorticoids, enhance neural plasticity in the hippocampus.  
Beta receptor blockade prevents glucocorticoid-induced impairment of contextual 
conditioning and inhibitory avoidance memory (Quirarte et al. 1997; Roozendaal et 
al. 2004).  This evidence further supports the importance of the amygdala in 
controlling how other brain regions respond to stress, and helps to emphasize the 
involvement of multiple modulatory neurochemicals systems in different aspects of 
fear learning. 
An important finding regarding propranolol is that it appears to be effective in 
preventing stress-related hippocampal-dependent memory if administered after 
stress.  Results from early clinical trials although small in number, appeared 
promising (Pitman et al. 2005), however, recent studies have not found beneficial 
effects (Stein et al. 2007; McGhee et al. 2009).  Another exciting application of this 
drug may not be in the prevention of PTSD, but in the treatment of already 
established symptoms. People who experience a traumatic event often are not able 
or willing to seek immediate help, and it is only after symptoms develop that they 
seek treatment.  There is evidence that long-term fear memories can be abolished 
during a secondary consolidation, or reconsolidation, after a reminder cue (Sara 
2000). In rats, systemic administration of propranolol immediately after re-exposure 
to a previously conditioned stimulus can block the reconsolidation of the fear 
memory, thus impairing recall of  the conditioned response 24 hours later (Debiec et 
al. 2004).   
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Serotonin 
Research examining the role of serotonin and serotonin receptors in the 
stress response has shown potential for PTSD treatment. Several antidepressants, 
including selective serotonin reuptake inhibitors (SSRIs), have been somewhat 
successful in modulating the effects of acute and chronic stress in rats.  Although 
SSRIs are often prescribed to patients with PTSD (Friedman 2004), they have 
produced an interesting paradox in animal models.  The SSRI Fluoxetine has been 
shown to mitigate stress-induced anxiety and weight-loss (Berton et al. 1999) and 
reverse the stress effects on sucrose preference and glial cell death in the PFC 
(Banasr et al. 2007). However, the SSRI, citalopram, has been shown to reduce 
fear conditioning responses only if administered chronically before conditioning, and 
it may actually enhance conditioning when acutely administered (Burghardt et al. 
2004). Other SSRIs, such as paroxetine and sertraline have shown to be more 
valuable for stress related depression than for stress related anxiety (Ramanathan 
et al. 2003)  
A potential candidate for PTSD treatment is tianeptine, which enhances 
serotonin uptake, but has a mechanism of action different from SSRIs (McEwen et 
al. 2005). Tianeptine administration after an acute stress prevents the stress-
induced inhibition of LTP in the hippocampus without causing abnormal levels of 
LTP when administered to unstressed controls (Shakesby et al. 2002).  Chronically, 
tianeptine prevents hippocampal dendritic atrophy when given concurrently with 
chronic stress, and is able reverse previous stress-induced atrophy when given 
daily after chronic stress (Magarinos et al. 1999). In contrast, fluoxetine had no 
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effect on dendritic remodeling, but enhanced neurogenesis in the dentate gyrus 
(Duman et al. 2001).  In the amygdala, tianeptine studies also indicate that it can 
prevent stress-induced enhancement of anxiety and growth of BLA neurons 
(McEwen et al. 2004).  
There have been only a few clinical trials using tianeptine for PTSD. In one 
small trial, although patients reported a decrease in symptoms after daily tianeptine 
administration, this was not significantly different than patients given fluoxetine 
(Onder et al. 2005).  Still, results cited above suggest that tianeptine may be more 
beneficial at the structural level than SSRIs (McEwen et al. 2005).   
Glutamate 
 There is much evidence that the universal excitatory neurotransmitter 
glutamate and its receptors are involved in the stress response. The ionotropic 
glutamate receptor N-methyl D-aspartate (NMDA) has been heavily investigated for 
its role in memory consolidation, including fear memories. NMDA receptors are both 
voltage-gated and ion-gated, thus requiring depolarization of both the presynaptic 
and postynaptic cell before they are able to open. This often referred to as 
coincidence detection, and NMDA receptors are responsible for long term 
potentiation of activity between multiple cells in a circuit , which is often though of as 
the hallmark of neural plasticity (Morris et al. 1990; Shors et al. 1997).  NMDA 
receptor activity is necessary for both fear conditioning acting through the BLA  
(Maren et al. 1996) and fear extinction acting through the mPFC (Burgos-Robles et 
al. 2007).  Injection of NMDA receptor antagonist into CE or dorsal hippocampus 
have also been shown to prevent stress-induced anxiety behavior (Adamec 1997; 
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Padovan et al. 2000).  Since modulating NMDA receptors can both impair fear 
conditioning and enhance extinction learning, this has made NMDA receptor 
agonists and antagonists a potential therapeutic target for PTSD and anxiety 
disorders (Heresco-Levy et al. 2002; Ducrocq et al. 2005; Lehner et al. 2009),  
The role of small neuropeptides 
NPY and its receptors 
Neuropeptide Y (NPY)  is a small (36 amino acids) peptide that is part of the 
pancreatic polypeptide family, and the only one found in both the brain and 
periphery (Berglund et al. 2003). NPY is released only from neurons, and the 
highest levels are found in the paraventricular nucleus, and arcuate of the 
hypothalamus, hippocampus and amygdala (Allen et al. 1983; de Quidt et al. 1986). 
It is often a co-transmitter with norepinephrine (Sheikh et al. 1988; Niu et al. 1996) 
and it has shown to be involved in many behavioral functions, including feeding, 
reward, and anxiety.  Injection of NPY or NPY receptor agonists in the 
hypothalamus increase food intake and receptor antagonists decrease food intake 
(Morley et al. 1987). NPY also has the ability to modulate leptin levels (Wang et al. 
1997), while both leptin and insulin production inhibit NPY expression (Sato et al. 
2005).  There is also evidence that NPY may be neuroprotective. Under control 
conditions, NPY receptor agonists are anti-epileptic and protect against 
excitotoxicity in the hippocampus (Xapelli et al. 2006). 
 Glucocorticoids have been shown to modulate the actions of NPY. An 
adrenalectomy can prevent NPY administration from causing obesity (Sainsbury et 
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al. 1997) that glucocorticoids, NPY and the metabolic hormones are all closely 
linked. Chronic administration of dexamethasone increases NPY expression in the 
arcuate nucleus (Konno et al. 2008). NPY can also modulate anxiety behavior. 
Injection of NPY systemically, into the ventricles, or directly into CE has anxiolytic 
effects (Heilig et al. 1993; Zhang et al. 2009). Stress appears to have a differential 
effect on NPY expression depending on the length and timing. Acute stress 
increases NPY in the BLA and hippocampus, whereas chronic stress reduces NPY 
expression in these regions (Conrad et al. 2000; Sweerts et al. 2001; Sergeyev et 
al. 2005). 
Interestingly, NPY has been implicated in the study of stress resilience and 
increased NPY levels may enhance resilience from maladaptive behavioral 
responses. There is evidence that war veterans have higher levels of plasma NPY 
compared to non-veterans. Additionally, NPY levels predicted the extent of current 
PTSD symptoms, where those with recently reduced PTSD symptoms had the 
highest levels of plasma NPY (Yehuda et al. 2006).  Special forces personnel 
trained in torture resistance tactics have also been shown to have higher NPY 
levels than other military (Morgan et al. 2000). In rats, NPY administration into the 
ventricles or amygdala prevents stress-induced behaviors such as fear potentiated 
startle and enhanced anxiety behavior after chronic stress (Gutman et al. 2008; Luo 
et al. 2008; Fendt et al. 2009; Zhang et al. 2009). In a study specifically aimed at 
investigating resilience, Sajdyk and colleagues (2008) found that pre-treatment with 
five days of infusion of NPY into the BLA prevented acute restraint stress induced 
changes in a social interaction test. 
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In the brain, there are four known g-protein coupled receptors for the 
pancreatic polypeptides including NPY: Y1, Y2, Y4 and Y5, and all of them have 
been implicated in the expression of anxiety-like behavior or the modulation of the 
response to stress (Thorsell et al. 2002; Painsipp et al. 2008).  Activation of Y1 
receptor through intraventricular injection of an agonist has shown to be anxiolytic 
(Heilig et al. 1993), and Y1 receptor activation can modulate glucocorticoid release 
(Dimitrov et al. 2007).  In contrast activation of Y2 receptors produces anxiogenic 
effects, and blocking Y2 receptors reduces anxiety (Heilig 2004). The Y5 receptor is 
not as heavily expressed in the brain, and is always expressed in neurons that are 
also positive for Y1 receptors (Parker et al. 1999).  However there are relatively high 
amounts of Y5 in the hippocampus, a region where all the known NPY receptors are 
expressed (Parker et al. 1998).  Systemic administration of a Y5 antagonist reduced 
anxiety in a model of chronic unpredictable stress, and reduced depressive-like 
symptoms in a depression-sensitive rat strain (Walker et al. 2009).  
 The ability of NPY and its receptors to modulate anxiety behavior and its 
established role in stress resilience in both human and animal studies makes it a 
prime candidate for continued investigation into its function in encoding individual 
differences in anxiety behavior, stress vulnerability and resilience. 
CART Neuropeptide 
Another recent molecule of interest in the study of stress has been Cocaine-
Amphetamine-regulated-transcript (CART). Although CART received its name from 
early research in reward learning, CART appears to have a role in the stress 
pathway, and manipulation of CART expression can alter anxiety behavior.  CART 
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is an endogenous neuropeptide with no known receptor, although recent evidence 
suggests that it may have a g-protein coupled receptor that exerts an inhibitory 
effect (Lakatos et al. 2005).  The rat CART gene is translated into an inactive pro-
CART precursor that is cleaved into two biologically active small peptides (89 and 
102 amino acids long), CART 66-102 and CART 55-102 (Dominguez 2006; Stein et 
al. 2006).  CART 55-102 antibodies are commercially available, and this was the 
form that was analyzed in the studies below.  Like NPY, CART is most likely a co-
transmitter. It has been shown to be located in vesicles of GABAergic cells in the 
nucleus accumbens, hypothalamus and ventral midbrain (Smith et al. 1997; 
Dallvechia-Adams et al. 2002; Moragues et al. 2003). As with NPY, much of the 
research on CART has examined its role in appetitive and reward seeking behavior.  
CART is involved in food intake, and is modulated by leptin (Lambert et al. 1998; 
Parent et al. 2000; Hunter et al. 2004). It can be an appetite suppressant when 
injected (Kristensen et al. 1998), and decreased expression of CART has been 
found in the hypothalamus with anorexia behavior and increased expression in 
obesity (Johansen et al. 2000; Rohner-Jeanrenaud et al. 2002). CART works in 
opposition to NPY in relation to food intake; intraventricular injections of NPY 
increase food intake, while the additional administration of CART peptide, reduces 
levels back to normal (Vrang et al. 1999)  
In pathways of reward learning, both cocaine and dopamine can modulate 
CART expression in the Nucleus Accumbens; while CART, in turn, can modulate 
the production of dopamine in the ventral tegmental region (Jaworski et al. 2006). 
CART administration into the Nucleus Accumbens directly effects behavior.  An 
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infusion of CART into this region reduced both food and cocaine self-administration 
and inhibited cocaine induced locomotion (Jaworski et al. 2003; Jaworski et al. 
2008). 
 More recently, CART has been shown to be involved in fear modulated 
pathways in the brain and can affect the expression of anxiety behavior.  CART 
expression in the hippocampus is regulated by glucocorticoids. Adrenalectomy 
decreases CART mRNA expression in the dentate gyrus of the hippocampus, and 
chronic corticosterone replacement returns CART expression to control levels 
(Hunter et al. 2007). In contrast with NPY, CART produces anxiogenic effects on 
EPM behavior when injected into the ventricles (Chaki et al. 2003) and also 
increased anxiety behavior when injected directly into the amygdala (Dandekar et 
al. 2008; Dandekar et al. 2009).  Stress induced CART mRNA expression has been 
shown in several regions, and this appears to be dependent on the duration of the 
stressor (whether acute or chronic) and the area examined. Hunter and colleagues 
(2007) found increased mRNA expression in the CE immediately after a two-hour 
acute restraint stress but no difference between controls after a 21-day chronic 
restraint stress.  In contrast, there was increased CART expression in DG after the 
chronic restraint stress but no effect was seen at the 2-hour timepoint.  
 These results suggest that CART may play a modulatory role in the stress 
response and encode for stress timing, modality or other aspects such as salience 
of the stress. As CART can directly enhance anxiety, this makes it a good candidate 
for continued investigation into its function in encoding individual differences in 
anxiety behavior and stress vulnerability. 
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Current Aims 
 The purpose of this research was to determine how stress hormones and 
neuropeptides modulate the cell-signaling pathways that regulate the stress-
induced morphological changes in the brain. Based on the individual differences in 
emotionality and anxiety found in both experimental and control animals, the goals 
of this thesis were reshaped to investigate whether these structural and molecular 
changes correlate with individual differences in general anxiety and the stress 
response, particularly in an animal model of PTSD. The following studies have been 
broken down in to chapters that attempt to address these aims. 
 
Chapter 3: Small neuropeptides present different profiles based on stressor 
timing and modality.  Here, our objective was to investigate how the brain 
encodes for and responds to stressors of varying length and different modalities.  
Using animals that were exposed to stressors that differed in duration, stressor 
type, and timing of exposures,  we examined mRNA expression of the candidate 
peptides CART, NPY and the Y5 receptor in regions responsible for memory, 
including fear memories and fear extinction, and reward learning. 
 
Chapter 4: The structural and molecular correlates of individual differences in 
control anxiety profiles. Humans produce a wide range of anxiety behaviors 
based on genetic makeup and a lifetime of experience. Similarly, rats elicit anxiety 
behaviors that also vary greatly. Our objective was to find differences already 
present by adulthood in the brains of animals that vary in their general anxiety 
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response.  We did this by creating selection criteria to consistently choose animals 
on the far ends of the spectrum of rat anxiety behavior. We then  investigated the 
influence of these individual differences on the neuronal structure of cells in mPFC 
and on mRNA expression of the candidate peptides, CART, NPY and Y5 receptor in 
regions known to be involved in plasticity, learning and memory, and previously 
shown to be affected by stress. 
 
Chapter 5: Individual differences in an animal model of Post-Traumatic Stress 
Disorder.  As only a small percentage of humans exposed to traumatic events 
develop PTSD, we created a stress model where some, but not all animals develop 
anxiety symptoms after stress. Using the multimodal stress model, we then 
designed criteria to detect those animals that actually change in their anxiety 
behavior due to the stress experience and those that do not appear affected by the 
stressor.  Our objective was to investigate how individual differences in the stress 
response (stress vulnerable compared to stress resilient) changed mRNA 
expression of the candidate peptides, CART, NPY and Y5 receptor, as well as 
CART protein levels. The different molecular profiles found between the PTSD-like 
and Resilient groups validate the multimodal stress model of PTSD and our 
selection criteria for separating out these groups. 
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Chapter 6: Mechanisms for stress resilience and prevention of PTSD. In this 
chapter our objective was to find pharmacological manipulations that would tip the 
balance of post-stress behavior toward a more resilient phenotype.  We examined 
the efficacy of several proteins and hormones of interest, Corticosterone, NMDA 
receptors, and Y5 receptors in enhancing stress resilience in our model of PTSD 
and in a more robust chronic stressor 
 
Chapter 7:   General Discussion and Implications for Stress Research.  Here 
we discuss the key findings of the previous chapters, and propose several ways that 
the peptide CART maybe acting in the brain to reduce anxiety and prevent post-
stress PTSD-like symptoms.  Future directions for investing CART as a possible 







Chapter 2: Materials and Methods 
Animals Three strains of adult male rats were used in the following experiments 
as noted: Lewis, Fischer (F344), and Sprague-Dawley.  All rats were obtained from 
Charles River Labs (Wilmington, MA) and were approximately two months old 
(weighing 175-250g) at the start of the studies. Upon arrival, rats were housed in 
either groups of two or three for all experiments and were given one to two weeks to 
habituate to the animal facility prior to the start of the experiment. Animals were kept 
on a 12 hour/12 hour light/dark cycle and had unlimited access to chow and water 
except during experimental manipulations. Experiments occurred during the lights-
on period, except as noted. All animals used in this study were treated in 
accordance with the National Institutes of Health Guide for the Care and Use of 
Laboratory animals and protocols were approved by the Institutional Animal Care 
and Use Committee at The Rockefeller University (protocols #04073 and #07092). 
  
Stress.  Three types of stressors were used in the following studies: 
Restraint Stress. For the restraint stress procedure, a rat was placed in a flexible 
wire mesh tube with the diameter of about the animal's body size.  The ends of the 
tube were closed off and the restrainer with the rat was returned to the home cage.  
Animals remained in the restrainers for six hours during the light period, after which 
they were released into their home cages. This procedure was used only in the 
chronic stress experiments and was repeated once a day for 21 consecutive days 
(chronic restraint stress or CRS).  
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Immobilization Stress. For the immobilization stress procedure, rats were placed 
in flexible plastic cone-shaped bags typically used for blood draws or decapitation 
(Decapicones; Braintree Scientific, Braintree, MA). Cones were custom made for 
animals weighing less than 300g. Once the rat entered, the back opening of the 
cone was taped closed, while the front end of the cone was left open so that the 
animal had a source of fresh air.  The immobilized rats were then returned to their 
home cage and remained for two hours during the light period, after which they 
were released back into their home cage.  This procedure was used both as an 
acute and chronic stressor.  In the acute immobilization stress experiments, rats 
were restrained once using this method, followed by ten days of rest in their home 
cage (Acute Immobilization Stress plus 10 days rest – AIS+10d). In the chronic 
immobilization stress experiments, this procedure was repeated once a day for 10 
consecutive days (10-day Chronic Immobilization Stress – CIS) 
 
Cat Odor Exposure Stress. For the cat odor exposure procedure, two sources 
of cat odor (fur and urine) were collected and presented together. Cat fur was 
collected from outside sources (healthy indoor female cats, with up-to-date shots 
and regular veterinary visits) and stored in airtight plastic containers.  Used organic 
cat litter was filtered for fecal matter, stored in airtight containers and refrigerated for 
up to 48 hours. Without the presence of fecal matter, the risk of the rats developing 
toxoplasmosis was negligible. For animals in the stress group, used cat litter was 
spread over the bottom of a clean plastic rat cage and a small ball (approximately 
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4cm in diameter) of cat fur was placed in one corner of the cage. For animals in the 
control group, unused cat litter was scattered over the bottom of a clean rat cage 
and a similar size ball of synthetic nylon fur was placed in one corner.  Rats were 
individually placed in the prepared cages for 10 minutes.  Behavior was recorded 
using video cameras.  All cat products were sealed in air tight containers and further 
sealed in plastic bags before entry into the animal facility.  Cat products were kept in 
the fume hood before use and were disposed as biohazard materials, and all used 
cages and equipment were disinfected with a bleach solution before removal to 
cage wash facility. All cat odor experiments were performed at or near the hoods or 
backdraft tables to reduce the spread of odorant throughout the rodent rooms.  
Stress and control exposures were conducted in two different testing rooms, and all 
personal protective equipment (gloves, coats, booties) were changed before 
entering each room in order to prevent transfer of odor into the control rooms. In 
one experiment, rats were acutely exposed to the cat odor followed by 10 days of 
rest in the home cage (cat odor stress plus 10 days of rest – COS + 10d). 
 
Multimodal Stress. For the multimodal stress procedure, rats were subjected to a 
40-minute acute stressor that combined the 10-minute cat odor exposure 
immediately followed by 30 minutes of immobilization stress, both as described 
above. Rats in the control group were exposed to the control cages for 10 minutes 
and then were returned to their home cages, which remained in the testing room for 
30 minutes before returning to the housing room. Rats in these experiments were 
allowed to rest in their home cages for seven days before further testing or sacrifice. 
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Blood collection 
Tail blood collection. In some instances during immobilization stress, tail blood 
was obtained from immobilized animals.  The tail was cleaned with ethanol, and 
then a fresh single-edge razor was used to nick the tip of the tail.  Blood was 
collected in heparin-coated 1.5ml tubes and immediately placed on ice. For 
repeated tail blood collection, the resulting scab was nicked again. Three to five 
drops of blood (approximately 100-250μl) were collected each time, for a maximum 
of three times. Blood was centrifuged at 1500g for 15 minutes, and the plasma 
collected and stored at -20°C for steroid hormone analysis. 
 
Trunk blood collection. After rapid decapitation, trunk blood was collected in 
7ml EDTA coated tubes using a fresh plastic funnel, and immediately placed on ice. 
Tubes were spun in a centrifuge at 1500g for 15 minutes, and the plasma collected 
and stored at -20°C for steroid hormone analysis.  
 
Corticosterone Assay. Plasma was thawed and samples were processed in 
duplicate using a radioimmunoassay kit (RIA) for rat corticosterone.  When large 
samples of plasma where available ( > 100μl), the Coat-a-Count RIA kit was used 
(Siemens Medical Solutions Diagnostics,  Los Angeles, CA).  When tail blood or 
only smaller samples were available, the ImmuChem Double Anitbody RIA kit was 
used (MP Biomedical, Orangeburg, NY). 
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Behavioral testing. Either before, during, or after completing the 
stress/experimental procedures, behavior was video-taped and analyzed as 
described below: 
 
Open Field. Rats were placed in a plexiglass square box (80 cm x 80 cm) with 20 
cm sides and allowed to explore freely for five minutes.  Movement, including 
distance traveled, mean velocity, time spent immobile, and time and distance in the 
center versus perimeter was recorded and analyzed by Ethovision XT tracking 
software (Noldus Information Technology, Leesburg, VA). 
  
Elevated plus maze (EPM). Rats were placed in an apparatus consisting of two 
open arms (40 cm x 10 cm with a 0.5 cm border) and two closed arms (40 cm x 10 
cm with a 20 cm opaque wall around them).  These arms met in the middle to form 
the shape of a “plus” sign.  Rats were placed in a closed arm of the maze and 
allowed to freely explore for five minutes.  Movement including distance traveled, 
time spent immobile, time spent in the open and closed arms, and number of times 
animals reached the end of the platform were recorded and analyzed by Ethovision 
XT tracking software.  
 
Cat odor exposure behavior.  During the 10 minute exposure to either the cat-
odor cages or the matched control cages, behavior inside the cages was video-
taped. Behaviors were quantified and analyzed, including total movement, time 
spent immobile, and number of approaches toward the ball of fur. 
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Home cage behavior and social interaction:  After stress or control exposure, 
rats were returned to their home cage. Rats were marked in some experiments, 
using non-toxic permanent markers.  The cages were then videotaped for 1-2 
hours.  Video was analyzed for instances of individual behaviors, including eating, 
drinking, self-grooming and sleeping; and social behaviors, including grooming 
others, group sleeping, and aggressive behaviors such as chasing, boxing, pinning 
and biting. 
 
Sucrose preference: Animals (housed 3 per cage) were deprived of food and 
water for 6 hours during the light period of their light cycle. Then two bottles were be 
returned to the home cage, one with regular tap water and one with tap water 
containing 1% (w/v) sucrose. Animals were exposed to the bottles for 18 hours, 
locations of the bottles switched at the 9 hour time point.  Total volume based on 
weight of the water bottles was recorded at the 0, 9 hour and 18 hour time point.  
 
Decapitation: A rodent guillotine was used for sacrifice by decapitation.  Brains 
were removed from the skull and flash frozen on dry ice.  
 
Perfusion: An i.p injection of Sodium Pentobarbital (at an overdose of 150mg/kg 
in saline) was used for anesthesia prior to perfusion. For brain 
immunohistochemistry, rats were transcardially perfused first with saline containing 
sodium heparin (10U/L) and then with 0.1M Phosphate buffered saline containing 
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4% paraformaldehyde. Brains were then post-fixed in the same solution overnight 
and processed as described below. For cell-loading, rats were transcardially 
perfused first with 0.1M Phosphate buffered saline (PBS) containing 1% 
paraformaldehyde and then 0.1M PBS containing 4% paraformaldehyde and 
0.125% glutaraldehyde. Brains were then post-fixed for 4-6 hours in the same 
solution and then transferred to 0.1M PBS prior to sectioning. 
 
Cell-loading: Tissue used for cell-loading was sectioned at 200-250μm in 0.1M 
cold PBS using a vibratome (Leica, Bannockburn, IL ). The iontophoretic cell 
loading procedure performed as described by Radley et al. (2006).  Briefly, neurons 
in layer II/III of the Prelimblic (PL) and Infralimbic (IL) region of the medial prefrontal 
cortex (mPFC) were iontophoretically injected with of 5% Lucifer Yellow (Molecular 
Probes, Eugene, OR) in 0.01M PBS. Sections were chosen from both right and left 
hemisphere and PL and IL regions were identified based on atlas landmarks in an 
area spanning +3.3 to +2.8mm relative to bregma (Paxinos and Watson, 1998).  
After loading, sections were coverslipped using PermaFluor mounting medium 
(Thermo Scientific, Watham, MA). 
 
Cell tracing and analysis: Filled cells were identified and reconstructed in 
three-dimensions using Neurolucida software (MicroBrightField, Williston, VT).  
Cells were chosen based on the following criteria: cells must be pyramidal in 
morphology and located in layer II/III of the PL or IL with the apical dendrite 
projecting towards the medial line of the mPFC; dendritic arbors must completely 
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filled as evidenced by well-defined endings at or near the pial surface; cells will be 
considered reasonably intact as long as all tertiary branches appear to be complete. 
Basal branches were traced and considered reasonably intact when at least one 
tertiary branch was present. 
 Cells were analyzed for total dendritic material, number of branch points and 
number of endings for both apical and basal dendrites using Neurolucida Explorer.  
A Sholl analysis was also performed on the apical dendrite in the Explorer program.  
Briefly, in Sholl analysis, a series of concentric spheres (30μm apart) are placed 
from the cell body outward.  Dendritic material that falls within each distance range 
(0-30μm, 30-60μm, etc…) is quantified and number of branch points analyzed.  Six 
to nine cells were analyzed for each animal for PL. As the IL is smaller, four to six 
cells were analyzed for each animal.  For total dendritic material, branch points, and 
endings, an average was determined for each animal for the apical dendrite. For 
basal dendrites, the average of all basal dendrites was taken for each cell before 
further analysis. A student’s t-test was used to the compare means of different 
groups. For Sholl analysis, a mean was determined for dendritic material at each 
distance for each animal, and a repeated measures ANOVA with post hoc analysis 
(Bonferroni corrected) was used. 
 
Immunohistochemistry: Paraformaldehyde perfused brains were placed in 
30% sucrose in buffer and allowed to sink overnight.  Sucrose brains were flash 
frozen in dry ice and stored at -80° C before sectioning at 40µm via microtome. 
Sections were stored at -20° in cryoprotectant [30% sucrose, 30% ethylene glycol in 
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0.1M sodium phosphate buffered saline (PBS)]. Immunohistochemical analysis was 
performed on matched sections containing the hippocampus, amygdala and 
prefrontal cortex using the CART (55-102) anti-rat antibody (1:50,000, Phoenix 
Pharmaceuticals) by the avidin:biotinylated complex - nickel 3,3'-Diaminobenzidine 
(ABC-NiDAB) immunohistochemical method described by Hoffman and colleagues  
(2008). An antibody titration (1:100-1:300,000) was first set-up to find the optimum 
concentration for the primary antibody.  Briefly, chosen sections were removed and 
rinsed 6 x 10 minutes in 0.05M potassium-phosphate buffered saline (KPBS) at RT. 
Sections were then incubated in 1% hydrogen peroxide in 0.05M KPBS to remove 
residual peroxidases, and then rinsed several times in 0.05M KPBS. Sections were 
then incubated in primary antibody (1:50,000) in 0.05M KPBS containing 0.4% 
Triton X-100, for 1 hr at RT, then for 48 hr at 4°C. After 48 hrs, sections were rinsed 
10x 6mins in 0.05M KPBS and then incubated for 1 hr with biotinylated anti-rabbit 
secondary antibody (1:600, Vector, Burlingham, CA) in 0.05M KPBS containing 
0.4% Triton X-100. Sections were then rinsed 5x 10mins and then incubated for one 
hour in ABC solution (Vectastain Elite ABC kit).  Sections were then rinsed 3x 5 
mins in 0.1M sodium acetate and then incubated for exactly 20 minutes in 0.1M 
sodium acetate containing 2.5% Nickel-sulfate and 0.01% DAB. Sections were 
immediately rinsed in 0.1M sodium acetate and then rinsed 3x 5mins in fresh 
sodium acetate solution.  Sections were then transferred to 0.1M sodium phosphate 
buffer, mounted on electrostatically charged slides (Plus slides, Fisher Scientific) 
and allowed to dry overnight. Slides were then washed in progressively higher 
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concentrations of ethanol, transferred to 100% xylenes and then coverslipped using 
DPX (Sigma) mounting medium.     
 
In situ hybridization: Frozen sections used for In situ hybridization were cut at 
20 µm on a cryostat and placed on Fisher Biotech ProbeOn Plus slides (Fisher, 
Pittsburgh, PA). Oligonucleotide probes were purchased from Integrated DNA 
Technologies (Coralville, IA).  Oligonucleotide probe sequences were determined 
from those used in the literature.  For each probe, the complement was also 
purchased tested on several slides as a control. Probes sequences are as follows: 
 
Cocaine-amphetamine-regulated-transcript (CART):  The CART oligonucleotide 
probe used in the following experiments was determined previously in our lab 
(Hunter et al. 2007), and the sequence used was complementary to nucleotides 
223-270 of the rat  
CART gene: 5′-ATC GGA ATG CGT TTA CTC TTG AGC TTC TTC AGG-3′. 
 
Neuropeptide Y (NPY): The sequence for NPY was obtained from the literature 
(Conrad et al. 2000). In order to enhance sensitivity, two probe sequences were 
used for NPY as a 1:1 cocktail. The first sequence was complementary to 
nucleotides 1355–1386 of the rat NPY gene: 5’-TGC CCG GAC CTG GCC CCT 
CTG CTC CGC CCC AT -3’.  The second sequence was complementary to 
nucleotides 1629–1669 of the rat NPY gene: 5’- GCT GGC GCG TCC TCG CCC 
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GGA TTG TCC GGC TTG GAG GGG TA-3’ Both sense and antisense probes were 
generated and tested through the in situ hybridization procedure. 
 
NPY, Y5 receptor (Y5):  The sequence for the Y5 receptor was obtained from the 
literature (Durkin et al. 2000).  The following sequence complementary to 
nucleotides 1086-1130 of the rat NPY Y5 gene was used: 5’-AGA CAC AGG CCG 
TCT TCT TGC TGT ACC TCC TTC TGT GCT TTC TGA-3’.  Both sense and 
antisense probes were generated and tested through the in situ hybridization 
procedure. 
 
Following the guidelines listed in the terminal deoxynucleotidyl transferase 
instruction booklet (Promega Corp, Madison, WI) oligonucleotide sequences were 
incubated with the enclosed buffer,  [33P]dATP (Perkin Elmer Inc., Waltham, MA) 
and the terminal transferase enzyme in water for 1hr at 37°C.  The probe was then 
purified using the QIAquick nucleotide removal kit (QIAGEN, Valencia, CA) and 
tested in a Liquid Scintillation Analyzer (Packard Instrument Co., Meriden, CT) to 
determine efficacy of the tailing reaction.  The in situ hybridization procedure was 
adapted from Romeo, et al., (Romeo et al. 2007) Briefly, sections mounted on slides 
were fixed in 3.7% formaldehyde 5 minutes, then rinsed in phosphate-buffered 
saline (PBS), followed by triethanolamine-HCl (TEA) with 0.5% acetic anhydride in 
water. Slides were then rinsed in 2X sodium chloride citrate (SCC) and dehydrated 
in progressively higher concentrations of ethanol, (70, 95 and 100%), delipidated in 
chloroform, and rinsed in 100% alcohol. Slides were exposed to pre-hybridization 
 43 
buffer without probe (150 µl/slide), covered with parafilm and placed in a humidity 
chamber and incubated at 42°C for 1 h. Slides were then washed in 2× SCC and 
then 70% and 95% ethanol, and allowed to dry. Slides were then exposed to 
hybridization buffer (150 µl/slide) with the 33P-labeled probes (approximately 5 × 105 
cpm/slide), covered with parafilm, and placed in a humidity chamber  at 42°C 
overnight. The following day, parafilm was removed and slides were washed in 1X 
SCC buffer at 55°C, 3x for 15 minutes each.  Slides were then transferred to a final 
1X SSC wash, and allowed to cool to RT. Slides were then washed in 50% and 
90% ethanol containing ammonium acetate, followed by 100% ethanol. Slides were 
air dried for 1 h and then exposed to Kodak BioMax MR film for 2-4 weeks to 
generate autoradiographs. 
  
Densitometry analysis:  Densitometry analysis was conducted on both 
autoradiographs in the case of the in situ hybridization studies and on NiDAB 
mounted sections for immunohistochemical studies.  Films or slides were placed on 
a light box with a camera mounted above it.  Relative optical density (ROD) 
measurements were obtained of regions of interest using the program MCID 5.0 
(Imaging Research, St. Catharine's, OT, Canada) by comparing the density of the 
regions of interest subtracted by a background measurement for the same animal. 
When available, regions of interest on both right and left hemispheres were 
analyzed and averaged.  Regions of interest were identified based on landmarks 
delineated in The Rat Brain in Stereotaxic Coordinates, fourth edition (Paxinos et al. 
1998). Further explanation of the regions of interest examined for densitometry can 
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be found in Appendix 1. Depending on the number of variable being compared, 
either a student’s t-test or a one or two-way ANOVA was used to the compare 
means of different groups. Post-hoc analyses (Tukey-Kramer or Bonferroni) were 
also conducted. 
 
Corticosterone modulation of stress resilience: In this experiment, the 
drinking water was supplemented with 400µg/ml of corticosterone (CORT) in 2.4% 
ethanol in water.  Animals received either the corticosterone supplement or 2.4% 
ethanol only (vehicle) in their normal water bottles for the 12 hours (overnight) prior 
to acute multimodal stress. Adult male Lewis rats were divided into four groups: 
control/vehicle, control/CORT, stress/vehicle, and stress/CORT.   
 
NMDA-receptor modulation of stress resilience:  In this experiment, the 
drug CGP43487, an antagonist for N-methyl-D-aspartic acid receptors (NMDAR 
Ant), was injected 1 hour prior to the acute multimodal stress or control exposure. 
Adult male Lewis rats were divided into 6 groups: control/no injection, 
control/vehicle, control/NMDAR Ant, stress/no injection, stress/vehicle, stress 
NMDAR Ant.  Animals in the injection groups were either injected (s.c in the scruff 
of the neck) with 5mg/kg CGP43487 (dissolved in ≤ 200μl saline) or with 200μl 
saline (vehicle).  All animals were subjected to a handling procedure that mimicked 
the injection process (without needle prick) for 5 days prior to actual injection in 
order to habituate them to the procedure and reduce the stress response from the 
injection.   
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Neuropeptide Y, Y5 receptor experiment: In this experiment, the diet was 
supplemented with a Y5 receptor antagonist (Y5 Ant) before and during 21-day 
CRS.  Adult male SD rats were divided into four groups: control/normal chow, 
control/ Y5Ant,  stress/normal chow, stress/ Y5 Ant.  For animals receiving the Y5 
Ant, the NPY, Y5 Receptor Antagonist Lu AA33810 [N-[[trans-4-[(4,5-
Dihydro[1]benzothiepino[5,4-d]thiazol-2-yl)amino]cyclohexyl]methyl]-
methanesulfonamide] was synthesized at Lundbeck Research USA (Paramus, NJ), 
and mixed in with Research Diets lab chow to the equivalent of approximately 30 
mg/kg/day. Y5Ant chow administration began four days prior to the start of the 
stress experiment and continued throughout the duration of the experiment. Animals 
in the normal chow group received the same Research Diets chow without drug 
beginning four days prior to the start of the stress experiment. All food was available 
ad libitum.  During CRS, control animals were handled at least twice a week.  
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Chapter 3: Small neuropeptides present different profiles 
based on stressor timing and modality 
Many different stimuli and paradigms have been used in literature to elicit a 
stress response from the rat. Restraint and immobilization stress, predator exposure 
and predator odor, as well as footshock, social defeat and many other stressors 
produce short term increases in stress hormones and long term increases in anxiety 
and depressive-like behaviors (McEwen et al. 1999; Miller et al. 2006).   Although 
often the hormonal and behavioral output is the same, it is possible that the brain is 
in some way encoding for the different properties of the stressor. With this in mind, 
the goals of this experiment were to confirm previous findings in the literature for 
acute and chronic restraint stress using different types of acute and chronic 
stressors, and to determine whether the mRNA expression profile of the candidate 
neuropeptides or receptors changed with any of the properties of the stressor. 
Expression of the two peptides examined, CART and NPY, have previously been 
shown to be affected by stress (Conrad et al. 2000; Sweerts et al. 2001; Balkan et 
al. 2006; Hunter et al. 2007).   Here, we examine properties of the stressors that 
including timing (acute or chronic) or type of stressor (immobilization of predator 
odor), as well as timing after cessation of stress (immediately after stress or 10 days 





Brain sections from adult male SD rats were used in the following four experimental 
paradigms.  For a detailed description, please refer to the Methods section: 
 
CIS – Chronic Immobilization Stress. Restraint in flexible plastic bag for 2 hours for 
10 consecutive days (n=6 per group, Stress and Control) 
AIS + 10 days – Acute Immobilization Stress. Restraint in flexible plastic bag once 
for 2 hours followed by a 10 day rest period (n=9 per group, Stress and Control) 
COS + 2 hrs – Cat Odor Stress. Placement in a cage containing both fur and urine 
from a cat for 10 mins followed by 2 hrs of rest (n=9 per group, Stress and Control) 
COS +10 days - Placement in a cage containing both fur and urine from a cat for 10 
mins followed by 10 days of rest (n=6 per group, Stress and Control) 
 
Prior to sacrifice, all animals except for the COS+2h group were placed in the EPM 
for five minutes, and percent time spent in the open arms and total open arm entries 
recorded. Slides containing the following areas were examined; dorsal 
hippocampus, nucleus accumbens, central and medial amygdala, medial prefrontal 
cortex, orbital frontal cortex. One slide per animal was processed through the in situ 
hybridization procedure described in the Methods section for both the CART, NPY, 
and Y5 oligonucleotide probe. Autoradiographs of mRNA expression were 
examined on the light box and relative optical density measured for each region of 
interest as compared to background. Densitometry measurements for each region 




For all experiments, there was no difference between Stress and Controls for 
percent time spent in the open arms (Figure 1, p > 0.05 for all groups) or number of 
open arm entries (p > 0.05 for all groups). 
CART neuropeptide  
CART mRNA expression differed by both stress timing and modality.  All 
optical density calculations were normalized to matched controls from the same 
experiment. Optical density measurements for experimental groups are shown as a 
percent of control (optical density measurements for controls = 1, or 100%). In layer 
II/III of the prelimbic region of the mPFC (Figure 2A), stress decreased mRNA 
expression for the CIS group, t(8) = 2.33, p = 0.0481, and there was a trend for 
stress to reduce CART expression in the AIS + 10d group, t(13) = 1.87, p = 0.0836. 
No difference was found between stress and control in the COS + 10d or COS +2h 
groups (p > 0.10).  No differences were found in the OFC (Figure 2B); however, 
there was a strong trend towards an increase in expression in the COS + 2h group, 
t(16) = 2.10, p = 0.0521. 
In the dentate gyrus of the dorsal hippocampus, CART mRNA expression 
was calculated for the granule cell layer of both upper and lower blades. As 
normalized expression levels did not differ between upper and lower blades, the 
mean of the two regions was calculated and plotted in Figure 2C.  A significant 
increase in expression was found in the COS + 10d group, t(10) = 2.91, p = 0.0157, 
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and trend towards an increase for the CIS group t(9) = 2.05, p = 0.0707. No 
differences were found in the dentate gyrus for either the AIS + 10d or COS +2h 
group (p > 0.10). 
CART expression in the medial nucleus of the amygdala produced a similar 
pattern of expression as the hippocampus; CIS caused a significant increase in 
CART expression, t(9) = 3.29, p = 0.0093, while there was a trend for and COS + 
10d to also increase expression, t(10) = 1.83, p =  0.0966 (Figure 2D). No 
differences were again found in the AIS + 10d or COS +2h group (p > 0.10).  In the 
central nucleus of the amygdala, no clear differences were seen between stress 
and control groups (p > 0.05), however there was a trend towards a decrease in 
expression for AIS + 10d, t(14) = 1.85, p = 0.0853 (Figure 2E). 
The shell and core regions of the nucleus accumbens were also analyzed 
(Figure 2 F and G, respectively).  There were no significant differences found in 
either area (p > 0.05). However, there was a strong trend towards an increase in 
CART expression in the shell region after CIS, t(10) = 2.10, p = 0.0620, and a trend 









Figure 1. Post-stress elevated plus maze behavior. Stress did not alter behavior 
in the EPM as measured by time spent in the open arm (A) or in the number of 
open arm entries (B) in any of the groups (p > 0.05). The groups analyzed were: 
Chronic Immobil. (10 days of immobilization stress), Immobil. 10d (acute 
immobilization stress followed by 10 days of rest), Cat Odor 10d (cat odor 
exposure followed by 10 days of rest), Cat Odor 2hr (cat odor exposure followed 
by 2 hours rest).    EPM behavior was not analyzed in the cat odor stress with 2hr 








Figure 2.  CART mRNA expression changes with stressor timing and 
modality. CART mRNA expression was analyzed in four different stress groups: 
Chronic Immobil. (10 days of immobilization stress), Immobil. 10d (acute 
immobilization stress followed by 10 days of rest), Cat Odor 10d (cat odor 
exposure followed by 10 days of rest), Cat Odor 2hr (cat odor exposure followed 
by 2 hours rest).  CART mRNA expression was normalized to controls from the 
same experiment. Significance is illustrated; *, where p < 0.05, and ¥, when 0.10 > 




Neuropeptide Y (NPY) 
NPY mRNA expression differed by both stress timing and modality.  All 
optical density calculations were normalized to matched controls from the same 
experiment. Optical density measurements for experimental groups are shown as a 
percent of control (optical density measurements for controls = 1, or 100%). In layer 
II/III of the prelimbic region of the mPFC (Figure 3A), stress increased expression in 
the COS + 2h group, t(16) = 2.33, p = 0.0331.  This was the only group to show 
differences in expression pattern in the mPFC (all other groups, p > 0.10). 
All other analysis of NPY mRNA expression occurred in the dorsal 
hippocampus, as this region displayed the highest levels of mRNA expression in the 
autoradiographs.  In the granule cell layer of the dentate gyrus, upper and lower 
blades were analyzed separately.  Again, as there was no difference in pattern of 
expression, the mean of both blades was calculated and analyzed (Figure 3B).  
NPY expression was found to increase in the COS + 2h group, t(16) = 2.19, p = 
0.0436.  There was a trend towards a decrease in expression in the AIS + 10d 
group, t(14) = 1.79, p = 0.0950.  No differences were found in the CIS and COS + 
10d groups (p >0.10).    
The pyramidal layer of the Cornu Ammonis (CA) of the hippocampus was 
divided into five regions that were calculated separately (see Appendix 1).  As there 
was very low expression of NPY in CA3c, this region was left out of the analysis. In 
CA1, no stress related differences were found in any of the groups (Figure 3C, p > 
0.10).  This also may have been due to the low levels of expression in this region.  
In CA2 (Figure 3D), CIS caused a significant increase in NPY expression, t(9) = 
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3.06, p = 0.0135.  In contrast, there was a significant decrease in expression in the 
AIS + 10d group, t(14) = 2.55, p = 0.0232.  There was also a trend for stress to 
induce an increase in expression levels in the COS + 2h group, t(16) = 1.88, p = 
0.0782.  No differences were found in the COS + 10d group (p > 0.1). NPY 
expression patterns were very similar in CA3a (Figure 3E) and CA3b (Figure 3F).  
In CA3a, CIS again increased expression, t(9) = 2.51, p = 0.0334, while there was 
only trend for CIS to increase expression in CA3b, t(9) = 1.87, p = 0.0919.  For the 
AIS + 10d group, stress significantly decreased NPY mRNA levels in CA3a, t(14) = 
2.40, p = 0.0307, and in CA3b, t(14) = 2.33, p = 0.0356.  Although not significant, 
there was a trend for stress to increase expression in the CA3b for the COS + 2h 
group, t(16) = 1.80, p = 0.090. No differences were found in either of these regions 
for the COS + 10d group (p > 0.1). 
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Figure 3. NPY mRNA expression changes with stressor timing and modality. 
NPY mRNA expression was analyzed in four different stress groups: Chronic 
Restraint (10 days of immobilization stress), Restraint 10d (acute immobilization 
stress followed by 10 days of rest), Cat Odor 10d (cat odor exposure followed by 
10 days of rest), Cat Odor 2hr (cat odor exposure followed by 2 hours rest).  NPY 
mRNA expression was normalized to controls from the same experiment. 









Neuropeptide Y receptor Y5  
 The Y5 receptor oligonucleotide has been shown previous to be effective 
(Durkin et al. 2000), and Y5 mRNA expression was present in the pyramidal layer of 
the Cornu Ammonis and in the granule cell layer of the dentate gyrus.  All optical 
density calculations were normalized to matched controls from the same 
experiment. Optical density measurements for experimental groups are shown as a 
percent of control (optical density measurements for controls = 1, or 100%).  In all 
areas examined, no stress-induced changes to Y5 mRNA expression were found 
















Figure 4. Y5 mRNA expression does not change with stress.  Y5 mRNA 
expression was analyzed in four different stress groups: Chronic Restraint (10 
days of immobilization stress), Restraint 10d (acute immobilization stress followed 
by 10 days of rest), Cat Odor 10d (cat odor exposure followed by 10 days of rest), 
Cat Odor 2hr (cat odor exposure followed by 2 hours rest).  Y5 mRNA expression 
was normalized to controls from the same experiment. For all graphs, the symbol * 
is used when p < 0.05 and ¥ when 0.10 > p > 0.05). No stress induced differences 






The results of these experiments show that there are different molecular 
profiles in response to stressors that vary by the timing and time course and by the 
modality, or type of stress.  Further, stress appears to cause molecular changes to 
areas involved in learning and memory and emotional regulation, whether or not 
there are significant changes to behavior.  These results suggest that the brain 
encodes a stressful experience differently depending on the sensory systems 
involved and the stressor length and severity, and that the molecular changes are 
less sensitive to the factors that contribute to the variability in behavior. 
The changes found in CART expression were largely in the CIS group.  As 
this was the only chronic stressor that was used in this series, and therefore more 
severe, it would be expected that this group would have the most significant 
changes.  After CIS, an increase in CART expression was found in the DG, ME and 
shell of the nucleus accumbens. These results generally agree with the literature.  
Hunter and colleagues (Hunter et al. 2007) found an increase in CART expression 
the dentate gyrus after a 21-day chronic restraint stress.   
Additionally, injection of CART peptide into the central nucleus of the 
amygdala has been show to be anxiogenic (Dandekar et al. 2008), but also has 
some anti-depressant properties (Dandekar et al. 2009).  Here we find a stress-
related increase in the medial amygdala, which has not been studied but sends 
strong input to many of the same regions that the central nucleus innervates, 
including the bed nucleus stria terminalis, parahippocampal areas, hypothalamus, 
and midbrain regions involved in stress-induced behaviors (Canteras et al. 1995).  
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In the nucleus accumbens, increases in CART have been shown to inhibit 
dopamine-induced locomotive behavior (Jaworski et al. 2008) suggesting the CART 
is acting on cells with dopamine receptors. However, there is also evidence that 
CART may been inhibiting GABAergic activity in this region (Shirayama et al. 2006).  
Most of the GABAergic neurons are spiny neurons that project to the globus pallidus 
and aid in refining reward learning behaviors. Although not studied, it is possible 
that the stress-related increase in CART expression alters the reward learning 
pathways through this circuit. 
In contrast to other regions, a decrease in CART expression was found in the 
mPFC.   The cortico-limbic pathways linking the mPFC, hippocampus and 
amygdala have been well studied, particularly in the fear conditioning and extinction 
circuit in rodents (Quirk et al. 2008) and in human patients with PTSD (Shin et al. 
2006).  These studies would suggest opposing activity in the mPFC and amygdala, 
in which the activity of each region can inhibit the other and differentially affect 
behavior. Extinction learning requires a strengthening of the inhibitory inputs from 
mPFC to amygdala, and both animals and humans that have an mPFC activity that 
is out of balance with the amygdala have heightened fear responses. 
Chronic stress also changed NPY mRNA expression in the hippocampus.  
As with CART mRNA expression, NPY expression increased after CIS. There is 
some conflicting evidence of NPY levels changing with the timing of stress; stress 
has been shown to increase expression in the medial nucleus of the amygdala and 
hippocampus over the first few days of stress (Sweerts et al. 2001), whereas 
chronic stress for an extended period (3 weeks) has been shown to decrease NPY 
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expression in the hippocampus (Sergeyev et al. 2005).  There is evidence that 
CART positive neurons are juxtaposed to NPY positive axon terminals in both the 
hypothalamus and medial amygdala (Broberger 1999), suggesting that changes to 
NPY expression may directly affect CART expression.  As CART and NPY 
administration appear to have opposite effects on anxiety behavior (Heilig et al. 
2002; Chaki et al. 2003), NPY may play a role in inhibiting the release of CART thus 
reducing anxiety. 
The profile of the acute stressors was quite difference than both chronic 
stress and varied by stress modality.  Ten days after restraint stress (AIS + 10d) 
there was an overall trend toward a decrease in CART expression in the mPFC and 
central nucleus of the amygdala.  There was also a decrease in NPY expression in 
the hippocampus, which was the opposite found for chronic stress at the same 
timepoint.  There are several possible explanations for this. As mentioned above, 
there is evidence that NPY mRNA expression changes over the time course of 
stress (Sweerts et al. 2001), and that this is strain dependent. Behaviorally, 
although neither stress group differed from controls, the animals in the AIS+10d 
group appear to be slightly less nervous than both the CIS or COS + 10d group.  
One possibility may be that a single acute restraint stress that is not strong enough 
to induce anxiety has taught the animal something else, such as resilience.  This 
possibility is considered further in the general discussion. 
The other acute stressor, the COS + 10d group, had a completely different 
profile from AIS + 10d.  There was a stronger effect of COS + 10d on CART 
expression than NPY expression, and the changes in CART expression appear to 
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be consistent although not entirely overlapping with chronic stress.  Similar behavior 
was also seen in the COS + 10d and CIS group.  Interestingly, there was a large 
increase in CART expression in the dentate gyrus and core of the nucleus 
accumbens. The core of the nucleus accumbens is involved in associating stimuli 
with valence and motivational value (Bassareo et al. 2002; Shirayama et al. 2006).  
It may be that a more environmentally relevant stressor, such as cat odor, had a 
stronger effect on this region. The failure of COS + 10d to change NPY expression 
further distinguished this stressor from acute or chronic restraint stress. Although it 
is not clear why there are no changes to NPY expression, this is further support for 
the idea that both neuropeptides are involved in encoding the complexity of this 
stimulus. 
The COS + 2h group was the only group that illustrated the immediate 
changes that occur in mRNA expression for CART and NPY neuropeptides.  CART 
expression appeared to be less affected acutely by cat odor stress than it was in the 
long term. COS induced an increase in CART expression only in the orbitofronal 
cortex. However, there was a consistent increase in NPY expression in the mPFC 
and hippocampus.  This was further evidence that the change in NPY expression is 
more immediate and the changes in CART are farther downstream; it may be 
necessary to have longer stress experience or time for consolidation of learning 
before CART expression changes 
Surprisingly, no changes to Y5 receptor mRNA expression were found in any 
stress manipulation.  This would suggest that although there are changes to NPY, 
this is not affecting the expression Y5 receptor, at least in regions where NPY is 
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altered by stress. As other NPY receptors, such as Y1, and Y2, are more prevalent 
in these regions of learning and memory (Parker et al. 1998), it is possible that the 
changes in NPY levels are acting on these receptors.   
In summary, mRNA expression of the neuropeptides CART and NPY are 
differentially affected by both stress timing and modality.  Chronic stress had the 
greatest effect on CART expression, inducing increases in the hippocampus, 
amygdala and nucleus accumbens.  NPY mRNA expression was more responsive 
in the immediate aftermath of an acute stress, increasing in the dentate gyrus and 
CA3 region of the hippocampus as well as the mPFC. As molecular profiles 
changed in response to stress without changes in behavior, we next wanted to 
examine the variability and range of behavior in the open field and EPM measures 
of anxiety.  In the following chapter, we examined individual differences in 
behavioral in response to stress and how that corresponds to the molecular profile 







 Chapter 4: The structural and molecular correlates of 
individual differences in control anxiety profiles 
Individual differences in the behavior of control rats in inbred and outbred 
strains have been widely reported but few studies have examined structural and 
molecular changes associated with these differences. The variety of anxiety 
behavior found in control animals is represented in the wide range of results found 
in the literature for the open field and EPM.  Here, in part because of the variability 
of behavior described in Chapter 3, we examine the individual differences in control 
anxiety behavior in two strains of rats, the outbred and commonly used Sprague-
Dawley, and an inbred strain know for high anxiety, the Lewis strain. From the 
results presented in the first part of this chapter, that apical dendritic length of 
pyramidal neurons in the mPFC correlate with anxiety behavior regardless of stress, 
and that apical dendritic size in  this region has correlated previously with chronic 
stress-induced deficits in behavior (Liston et al. 2006),  individuals from both strains 
that fell on the extreme ends of the anxiety behavior spectrum were chosen for 
morphological analysis of pyramidal neurons within the medial prefrontal cortex. 
Additionally, we examined brain tissue from control individuals selected for 
repeatedly demonstrating high or low anxiety behavior.  Brains were screened for 
mRNA expression of two neuropeptides previously shown to be altered by stress in 
Chapter 3 and the literature, CART (Hunter et al. 2007), NPY (Thorsell et al. 1998) 
and the Y5 receptor (Kakui et al. 2007). We expected that extremely anxious control 
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individuals would show similar patterns of dendritic remodeling and mRNA 
expression to that found in stressed animals. 
Experimental Paradigm 
 In the following experiments, unstressed, control animals were divided based 
on anxiety profile as measured by the open field and EPM. The first task was to 
establish a consistent way of dividing animals based on their range of anxiety 
behavior.  Then individuals were selected that fit the criteria of “calm” or “anxious,” 
and their brains examined for both structural and molecular differences  
To provide rationale for examining individual differences in the structure of 
neurons in mPFC, an acute stress experiment was first conducted to determine if a 
single stress experience could induce changes in dendritic morphology in pyramidal 
neurons of layer II/III of the PL region. Based on the correlation found between 
dendritic length and anxiety behavior regardless of stress, individual differences 
were further investigated. In two separate experiments, 72 Lewis and 60 Sprague-
Dawley (SD) used for other experiments (a cohort from the multimodal stress with 
NMDA receptor antagonist and the chronic restraint stress with Y5 antagonist, 
respectively; see Chapter 6) were handled for several days prior to behavioral 
testing and then placed in the open field for five minutes.  Time spent in the center 
and distance traveled in the center of the open field were recorded for each animal.  
Individuals were selected for the Anxious and Calm groups from an entire 
population of at least 60 animals, in order to have at least six animals per group that 
were above and below one standard deviation from the mean.  This approximately 
corresponded to the top 15% and bottom 15% of animals based on time spent and 
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distance traveled in the center. Six animals (selected from the top and bottom 11 
out of 72 for the Lewis rats and top and bottom 9 out of 60 for the SD rats.) were 
selected from the top 15% and placed in the Calm group and bottom 15% and 
placed in the Anxious group.  Great care was taken to prevent the re-housing of the 
remaining animals that were used in other experiments. These animals were used 
for the cell-loading and neuron reconstruction experiment, as described below. 
For the molecular profile analysis of anxiety extremes, brain tissue from 
behaviorally screened control animals sacrificed during previous experiments was 
used. Lewis rats who served as controls for three separate cat odor stress 
experiments (multimodal stress as described in Chapter 5, multimodal stress with 
NMDA receptor antagonist and multimodal stress with CORT in the drinking water, 
both as described in Chapter 6) were used, as all were exposed to identical and 
fairly noninvasive experiments.  Sectioned frozen brain tissue from these groups 
that repeatedly fell within the top (Calm) and bottom (Anxious) 20% in two 
measures of anxiety behavior, the open field and EPM, along with three matched 
controls per experiment with behaviors that fell near the mean (Average), were 
processed for in situ hybridization. 
Experiment 1: Analysis of dendritic arborization of pyramidal neurons 
in layers II/III of the medial prefrontal cortex after a single acute restraint 
stress and in control animals with behavioral extremes.  
 In first part of the experiment, a group of 12 male SD rats (6 controls and 6 
stress) underwent two hours of acute immobilization stress followed by 10 days of 
rest (AIS + 10d).  On the tenth day, animals were placed in the EPM and then 
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immediately sacrificed by perfusion.  Sections from the prelimbic region of the 
medial prefrontal cortex were iontophoretically injected with Lucifer yellow dye as 
described in the Methods, above.  Six to eight neurons from each animal were 
reconstructed and analyzed. 
 In the second experiment, 12 SD and 12 Lewis rats were removed from a 
larger populations based on their open field behavior.  Individuals whose behavior 
fell into the top or bottom 15% were divided into Calm and Anxious groups (6 
animals each, based on criteria as described above) and were sacrificed by 
perfusion. Sections from the prelimbic region of the medial prefrontal cortex were 
iontophoretically injected with Lucifer yellow dye as described in the Methods, 
above.  Six to ten neurons from each animal were reconstructed and analyzed. 
Experiment 2: Analysis of mRNA expression of small peptides in 
control animals with behavioral extremes. 
Tissue from control animals was selected based upon behavioral extremes 
(calm, anxious) along with controls that fell near the median control behavior 
(average) in the EPM (9 animals per group, resulting in 3 groups: Calm, Anxious, 
Average).  Slides containing the following areas were examined; dorsal 
hippocampus, central and medial amygdala, medial prefrontal cortex and orbital 
frontal cortex. One slide per animal containing matched regions of interest was 
processed through the in situ hybridization procedure described in the Methods 
section for the CART, NPY, and Y5 oligonucleotide probe. Autoradiographs of 
mRNA expression were examined on a light box and relative optical density 
measured for each region of interest as compared to background. Densitometry 
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measurements for each region of interest were compared using a one-way ANOVA.  
A Pearson’s correlation analysis was also performed to compare EPM behavior to 
densitometry results to examine individual differences. 
Results 
Time spent in the center of the open field was plotted in a frequency 
histogram for both the Lewis and SD group (Figure 5A and B).  Neither the 
frequency distribution histogram for the Lewis rats nor SD rats met the requirements 
for a Gaussian distribution based on the D’Agostino & Pearson omnibus normality 
test (K2 = 16.82, p = 0.0002, and K2 = 6.87 p = 0.0453, respectively).  Animals 
selected from the top 15% were placed into the Calm group and animals selected 
from the bottom 15% were placed into the Anxious group. 
 Lewis strain controls were analyzed in the open field and seven days later in 
the EPM.  Percent time spent in the center of the open field was plotted against 
percent time spent in the open arms of the EPM (Figure 5C).  A Pearson’s analysis 
found that these behaviors correlated with each other (r = 0.377, n = 36, p = 
0.0233).  Individuals that fell within the top third of the range in both behaviors were 
placed in the Calm group, while individuals that fell within the bottom third of the 
range in both behaviors were placed in the Anxious group.  Individuals in the 
Average group were taken from the center of the range. 
Experiment 1 
 Behavior in the EPM was measured 10 days after AIS treatment.  An 
unpaired student’s t-test found no difference in the percent time spent in the open 
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arms between stress and controls (p > 0.05, Figure 6A).  Mean apical dendritic 
length was measured in pyramidal neurons from layers II/III of the mPFC in both 
groups.  An unpaired student’s t-test found no differences in apical dendritic 
material between stress and controls (p > 0.05, Figure 6B).  However, when total 
apical material was plotted against EPM behavior for each individual, regardless of 
stress, a correlation appeared (Figure 6C). Time spent in the open arms of the EPM 
correlated positively with total apical dendritic length in pyramidal neurons of the 
prelimbic area of the mPFC (Pearson correlation, r2 = 0.520, p = 0.0123).  This data 
was used to support the hypothesis that control individuals selected for high anxiety 
(Anxious) and low anxiety (Calm) would have morphological differences in 














Figure 5. Factors for separating groups based on anxiety behavior. 
Frequency histograms are shown for time spent in the center of the open field for 
both (A) Sprague-Dawley (SD) and (B) Lewis rat strains.  Blue lines indicated the 
mean, while dashed lines indicate each standard deviation (SD) away from the 
mean. Data represented by the bars highlighted in the red boxes approximate the 
animals chosen from the top 15% (Calm) and bottom 15% (Anxious) for each 
group (n = 60 rats for SD and n = 72 rats for Lewis).  (C) A sample behavior 
scatterplot is shown for control group individuals used in the densitometry analysis.  
Anxiety behavior correlates on two behavioral experiments, measured seven days 
apart (p < 0.05).  Data represented by the symbols highlighted in the red boxes 
approximate animals selected that fall within the top 20% (Calm) and bottom 20% 








Figure 6. Individual behavior in the elevated plus maze correlated with mPFC 
dendritic length regardless of stress.  (A) No difference was found in behavior 
between stress and controls 10 days after a two-hour acute immobilization stress 
(p > 0.05). (B) Likewise, no difference was found in total apical dendritic material 
from pyramidal neurons in layer II/III of the prelimbic region of the mPFC.  
However, regardless of stress, there was a positive correlation between apical 
dendritic material and anxiety behavior in the EPM (R2 = 0.520, p = 0.0123, red 








 Pyramidal neurons from the prelimbic region of the mPFC were chosen from 
animals that represent the top and bottom 15% of behavior based on time spent in 
the center of the open field (Figure 5C).  As such, an unpaired student’s t-test found 
the animals in the Calm group spent significantly more time in the center of the 
open field than animals in the Anxious group, in both strains of rats, t(10) = 8.65, p < 
0.0001 for SD, t(10) = 5.65, p  = 0.0002, for Lewis. A two-way ANOVA comparing 
the time spent in the center of the open field for both Lewis and SD rats in both 
behavioral groups revealed a main effect of behavior, F(1,20) = 108, p > 0.0001, as 
well as a main effect of strain, F(1,20) = 19.8, p = 0.0002, and a strain by behavior 
interaction, F(1,20) = 16.6, p = 0.0006, confirming that Sprague-Dawley rats are 
generally less anxious in the open field than the Lewis strain (Figure 7). 
 In the Sprague-Dawley strain, a student’s t-test found a larger amount of total 
apical dendritic material in the prelimbic pyramidal neurons of the calm group as 
compared to the anxious group, t(10) = 2.58, p = 0.0273 (Figure 8A); however there 
was no difference in the number of branch points on the apical dendrite (p > 0.05, 
Figure 8B).  Similarly, in the Lewis rat strain, a student’s t-test found a larger 
amount of total apical dendritic material, t(10) = 3.36, p = 0.0072 (Figure 8C) as well 
as an increase in the number of branch points in the calm group, t(10) = 2.77, p = 
0.198 (Figure 8D).  No effect was found on the basal dendrites (p > 0.05 for both 
strains). 
 In order to further analyze the differences in dendritic material along the 
length of the apical arbor, a Sholl analysis was plotted for each behavioral group for 
both the Sprague-Dawley (Figure 9A) Lewis (Figure 9B) strain.  Dendritic material 
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was calculated into 30 μm bins along the length of the apical dendrite. A two-way 
repeated measures ANOVA of the Sholl histograms revealed a significant difference 
in the distribution of apical dendritic material in the prelimbic neurons of Calm and 
Anxious animals.  In the Sprague-Dawley group, this analysis found the expected 
main effect of distance, demonstrating that the majority of dendritic material can be 
found within 90-150 μm from the soma, F(10,100) = 234, p < 0.0001.  Additionally, 
there was an effect of anxiety behavior, F(1,100) = 7.22, p = 0.0249, and a behavior 
by distance interaction, F(10,100)  = 3.83, p = 0.0002.  Post-hoc comparisons found 
a significant difference between calm and anxious groups only at the 180μm point 
from the cell body (p < 0.05, Bonferroni corrected). In the Lewis group, the two-way 
ANOVA with repeated measures also found the expected main effect of distance, 
F(10,100) = 238, p < 0.0001.  While there was a main effect of anxiety behavior, 
F(1,100) = 5.83, p = 0.0364, there was no behavior by distance interaction, nor any 
differences at any distance from the cell body (p > 0.05 for all comparisons). 
 Additionally, dendritic length was compared to anxiety behavior for each 
individual. A Pearson’s analysis of dendritic length by anxiety behavior found a 
significant correlation in the Sprague-Dawley strain, (r = 0.606, n = 12, p = 0.0366, 
Figure 10A) and in the Lewis strain, (r = 0.622, n = 12, p = 0.0309, Figure 10B).  In 
order to better compare dendritic measurements between strains, the weight of 
each animal was used as a normalizing factor to compare the relative sizes of the 
dendritic arbors.  As male Lewis rats generally weigh less than the Sprague-Dawley 
strain at adulthood (see Charles River Laboratories, Inc. pricing and literature guide 
for animal models), it could be hypothesized that they would also have smaller 
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brains.  This normalizing factor should take into account dendritic length differences 
based on the size of the brain. A two-way ANOVA of weight-normalized dendritic 
length scores (calculated by dividing the mean dendritic length by body weight in 
grams), found a main effect of anxiety behavior, F(1,20) = 16.4, p = 0.0006, and a 






















Figure 7. Confirmation of selection criteria for Calm and Anxious groups for both 
Lewis and Sprague-Dawley (SD) rat strains.  In both strains, animals in the Calm 
groups spend significantly more time in the center of the open field (OF) as compared 
to those in the Anxious groups (p < 0.05).  Additionally, there was a main effect of 
strain, which was driven by the Calm group behavioral data. This suggests that SD rats 
are generally less anxious than Lewis in the OF, and display a wider range of anxiety 




Figure 8. The size of the apical dendritic arbors differ between Calm and 
Anxious extremes in the prelimbic area of the mPFC in two strains of rats. 
Sprague-Dawley rats in the Calm group displayed (A) significantly longer apical 
dendrites than Anxious group, but no difference was found in (B) the number of 
branch points on the apical dendrite. Lewis rats in the Calm group had both (A) 
larger apical dendrites and (B) more branch points on the apical dendrite. 
Significance is illustrated above; *, where p < 0.05, and **, where p < 0.01. 
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Figure 9. Sholl Analysis reveals overall differences in the distribution of 
dendritic material along the apical dendrite of pyramidal neurons of the 
prelimbic area of the mPFC. In (A) the Sprague-Dawley strain, there is a 
significant effect of behavior    (p <0.05) and a significant anxiety behavior by 
distance interaction (p < 0.01), revealing a shift in the concentration of dendritic 
material in the anxious group. In (B) the Lewis strain, although there is a 
significant effect of behavior (p < 0.05), there is no interaction, suggesting that the 
increase in apical dendritic material in the Calm group is evenly distributed across 






Figure 10. Other factors that contribute to the anxiety behavior and dendritic 
length differences found in both strains of rats. As individuals were selected 
based on their anxiety behavior, a significant correlation between dendritic material 
and open field behavior was present in both (A) the Sprague-Dawley strain, and 
(B) the Lewis strain (p < 0.05 for both analyses).  An analysis of body weight as it 
compares to dendritic length (C) revealed a significant effect of behavior, an also 
an effect of strain (p < 0.05); showing that for their size, the Lewis rats have larger 
apical dendrites on the pyramidal neurons in mPFC as compared to the Sprague-










As CART and NPY mRNA expression was shown to be differentially 
expressed during stress based on timing and modality in Chapter 3, expression of 
the candidate neuropeptides was further analyzed in the control animals divided into 
groups based on individual differences in anxiety.  CART mRNA expression in 
regions of interest were compared across the three groups of controls as 
determined by individual anxiety levels; Average, Calm, and Anxious.  All optical 
density calculations were normalized to matched controls from the Average group 
from the same experiment. Optical density measurements for Anxious and Calm 
groups are shown as a percent of Average control (optical density measurements 
for controls = 1, or 100%). In the dorsal hippocampus, both the upper and lower 
blades of the dentate gyrus (DG) were analyzed separately.  In the upper blade of 
the DG (Figure 11A), a one-way ANOVA showed a significant difference between 
the three control groups, F(2, 18) = 3.89,  p =0.0383.  Post-hoc comparisons found 
that individuals in the Calm group had increased optical density compared to 
Anxious controls (p < 0.05, Bonferroni corrected).  A one-way ANOVA of the lower 
blade of the DG (Figure 11B) showed a trend towards a significant difference 
between the three groups, F(1,18) = 3.15 p = 0.0669.  In the central amygdala 
(Figure 11C), no differences were found between anxiety groups (p > 0.05), 
however a significant difference was found in the medial amygdala (Figure 11D).  
There was a significant group effect, F(2,13) = 5.84, p = 0.0155, as well as a 
significant difference between the Average and Calm control groups (p < 0.05, 
Bonferroni corrected).  
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 CART mRNA expression was also examined in the prefrontal cortex.  A one-
way ANOVA comparing control groups found no difference in CART levels in the 
prelimbic regions of the mPFC (Figure 12A, p > 0.05).  In the orbitofrontal cortex 
(Figure 12B) there was a significant group effect, F(1,18) = 3.93, p = 0.0384.  
Although there was a trend for the Anxious group to have lower CART expression 
than both the Calm and Average groups, it was not significant in post-hoc analysis 
(p > 0.05, Bonferroni corrected). 
 A Pearson’s correlation analysis comparing behavior in the EPM to CART 
mRNA expression in the chosen regions of interested was conducted for all 
individuals.  As all animals in the three anxiety behavior groups were controls, all 
individuals were grouped into one analysis in order to examine the entire spectrum 
of control behavior.  A positive correlation between CART expression and behavior 
was found in the dentate gyrus (Figure 13A, r = 0.456, n = 22, p = 0.033), while a 
negative correlation was found between EPM behavior and CART mRNA 
expression in the central nucleus of the amygdala (Figure 13B, r = -0.458,n = 23, p 
= 0.0279).  However, no correlation was found between CART mRNA expression 
and behavior in the medial nucleus of the amygdala (Figure 13C, r = -0.0245, n = 
21, p > 0.1).  Although not significant, there was a trend towards a positive 
correlation in the orbitofrontal cortex (Figure 13D, r = 0.363, n =21, p = 0.106).  In 
the prelimbic region of the mPFC, CART mRNA expression correlated negatively 
with CART expression (Figure 13E, r = -0.514, n = 18, p = 0.029). 
 Densitometry for NPY mRNA expression was conducted in the dentate 
gyrus, upper and lower blade, and CA2, CA3a, CA3b, CA3c as well as the 
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infralimbic and prelimbic regions of the prefrontal cortex. A one-way ANOVA was 
conducted between PTSD-like, Resilient and control groups for all regions listed.  
No differences between groups were found in any region examined.  Additionally, a 
Pearson’s analysis was conducted in the same regions, and no correlations 
between NPY mRNA expression and anxiety behavior were determined (p > 0.05 
for all groups, data not shown). 
 Densitometry for Y5 receptor mRNA expression was conducted in the 
dentate gyrus, upper and lower blade, and CA1, CA2, CA3a, CA3b, CA3c as well 
as the infralimbic and prelimbic regions of the prefrontal cortex. A one-way ANOVA 
was conducted between PTSD-like, Resilient and control groups for all regions 
listed.  No differences between groups were found in any region examined (p > 0.05 













Figure 11. Control groups divided by anxiety behavior differ in CART mRNA 
expression in the hippocampus and amygdala. There was a significant 
difference between groups in (A) the upper blade of the dentate gyrus (DG, p < 
0.05) and, a trend towards a group effect was found in  (B) the lower blade of the 
dentate gyrus (DG, p < 0.1). Post-hoc analysis showed the calm group had 
significantly higher CART expression than the Anxious group in the upper blade (p 
< 0.05, Bonferroni corrected). There was no difference in CART expression levels 
in (C) the central amygdala.  In (D) the medial amygdala a one-way ANOVA found 
difference between groups (p < 0.05). Post-hoc analysis showed the calm group 
had significantly higher CART expression than the Average group (p < 0.05, 







Figure 12. Control groups divided by anxiety behavior differ in CART mRNA 
expression in the prefrontal cortex. While there is no difference between 
behavioral groups in (A) the prelimbic region of the medial prefrontal cortex ( mPFC, 
p > 0.05), there is a significant group effect (p < 0.05) in the orbitofrontal cortex 
(OFC). 
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Figure 13. CART mRNA expression correlates with individual anxiety 
behavior in the elevated plus maze. Probability values can be found under each 
scatterplot for each region of interest analyzed.  A Pearson’s correlation analysis 
found the following; (A) a significant positive correlation in the dentate gyrus of the 
hippocampus; (B) a significant negative correlation in the central nucleus of the 
amygdala; (C) no correlation was found in the medial nucleus of the amygdala; (D) 
a trend towards a positive correlation in the orbitofrontal cortex; and, (E) a 
significant negative correlation in prelimbic region of the mPFC.  For all analyses, 






 The results of this chapter clearly demonstrate that anxiety behavior varies 
significantly across individuals that, for all intents and purposes, have identical 
upbringing, environments, and life experiences, are often siblings and have very 
similar genetic makeup.  This variability in behavior appears to correlate with 
molecular and structural changes in brain regions known to be highly plastic and 
involved in learning and memory.   
 When divided into groups that contained individuals from both ends of the 
anxiety behavior spectrum, these groups differed from each other in both dendritic 
arborization in layer II/III of the prelimbic region of the mPFC and in CART mRNA 
expression profile.  Individuals in the low anxiety (Calm) group had significantly 
longer apical dendrites than the anxious individuals.  Although this effect was more 
robust in the Lewis strain, it was also present in the Sprague-Dawley rats.  These 
effects mirror the same trends seen in mPFC neurons of stressed animals.  Three 
weeks of chronic restraint causes dendritic retraction and an anxious behavioral 
profile (Cook et al. 2004; Radley et al. 2004; Brown et al. 2005). 
Additionally, the Sholl analysis revealed a difference in the distribution of 
dendritic material between the Lewis and Sprague-Dawley strains.  Calm Sprague-
Dawley individuals showed a typical distribution of dendritic material across the 
dendrite, the largest concentration of branches was located around 90-120μm from 
the cell body, and gradually tapered off farther away from the soma.  Anxious 
animals, while having smaller branches in general also had a shift in where the 
dendritic material was located, with a peak around 90μm from the soma and less 
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material spread out farther away from the cell body as compared to the calm 
individuals.  This difference in distribution may indicate that cells in the prelimbic 
region of anxious animals are receiving stronger inputs from a different population 
of neurons, and suggests that there is an overall difference in connectivity in the 
prefrontal cortex of calm and anxious individuals.  Lewis rats in both the Calm and 
Anxious groups had similar Sholl profiles, suggesting that the increase in dendritic 
length found in the calm animals was spread across the entire dendritic arbor. 
Another interesting result of this research was that Lewis rats have larger 
apical dendrites compared to body mass on the neurons of layer II/III of the 
prelimbic cortex when compared to the Sprague-Dawley strain (Figure 10C).  This 
would be in contrast to what would be predicted based on their behavior, since even 
the calmest Lewis rats spend little time in the open arms of the EPM (Figure 7), 
which would indicate anxiety. While there is not much published research on strain 
differences in the prefrontal cortex, Lewis rats appear to have lower c-fos 
expression after stress (Trneckova et al. 2006). 
 The differences found in prefrontal cortical dendritic structure between Calm 
and Anxious controls may account for much of the variability (differences of as 
much as 15-25% of apical dendrite size) seen in experimental groups after stress. 
This may be one reason why we have had great difficulty getting a stress effect on 
behavior and in the brain when subjecting animals to mild and acute stressors, such 
as those in Chapter 3. The stress-induced changes that are occurring may not be 
large enough to compensate for the differences that are already present in an adult 
animal before an experiment has even taken place.  
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 There are many explanations for why there is such a large range of anxiety 
behavior in control animals that are essentially similar in their genetics and life 
experiences. The differences that we can’t control for include individual genetic 
variation, which can have a large impact on gene expression (Alfonso et al. 2002),  
and previous and ongoing social interactions, which includes both maternal care 
and behavior (Clinton et al. 2007) and social hierarchy in cages in adulthood 
(Blanchard et al. 1993). Finally, an often disregarded factor that can cause large 
differences in anxiety behavior is the impact of husbandry procedures or 
experimenter experiences (Burn et al. 2008). This will be further examined in the 
main discussion.  
Nevertheless, anxiety behavior appears to be consistent across time and 
across behavioral measures in unstressed animals.  This was demonstrated in the 
correlation found between open field and EPM anxiety measures (Figure 5C).  
Although not always evident in smaller groups of animals, this trend has been 
consistent in groups of control animals greater than 24 individuals and in a meta-
analysis of all of the previous Lewis controls run in the multimodal stress 
experiments, normalized by experiment. 
 CART mRNA expression also differed between Calm and Anxious groups.  
There was an increase in CART expression in the upper blade dentate gyrus of the 
calm individuals as compared to the Anxious group.  There was also increased 
expression in the medial amygdala of calm animals as compared to average 
animals. In the Anxious group, there was a trend towards a decrease in expression 
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in the orbitofrontal cortex, as evidence by the significant difference between the 
three control groups in a one-way ANOVA.   
          These differences are further explored in the correlation analyses (Figure 13).  
Notably, CART mRNA expression significantly correlated with behavior in several 
regions, and not always in the same direction.  These correlations with behavior 
would suggest that if CART mRNA expression is correlated with protein expression 
in these regions, then CART is either directly influencing the anxiety behavior of the 
animal, or that a pathway further upstream is acting upon both the CART system 
and other neurochemical systems to change behavior. Evidence for the former is 
that injection of CART peptide into the lateral ventricles or central amygdala 
(Dandekar et al. 2008) can directly enhance anxiety behavior.  As we found that 
increased CART expression correlates with reduced anxiety behavior in another 
region adjacent to the lateral ventricles, the dentate gyrus of the hippocampus, this 
would suggest that CART may have opposing effects in different regions. A CART 
increase in the central amygdala, particularly at higher than physiological levels, 
may trump the anxiolytic effect that high levels of CART appear to have in the 
hippocampus.  These results indicate that a complex interaction is going on 
upstream of CART gene expression and behavioral change.    
One way to better understand what aspects of the CART expression profile 
may be induced by stressors that occurred prior to the start of an experiment 
compared to those that may have more of a genetic component, would be to 
examine CART expression in stressed animals with different behavioral profiles. 
From the results in this chapter, it is evident that CART expression varies with 
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anxiety behavior and disposition before any experimental manipulation has 
occurred, and it was important that we take that into account.  One way to 
accomplish this is by measuring pre-stress baseline anxiety behavior. We could 
then select the animals that changed over time (those that develop anxiety due to 
the experimental manipulations), the PTSD-like, and those who do not change, the 
stress resilient.  In the following chapter, we designed a stress paradigm that 






















Chapter 5: Individual differences in an animal model of 
Post-Traumatic Stress Disorder 
As we demonstrated in Chapter 4 that basal levels of anxiety correlate with 
both structural and molecular differences in the unstressed brain, we next wanted to 
confirm that any stressor used to induce anxiety behavior actually caused a change 
from basal anxiety levels in each individual.  Here we adapted and enhanced a 
published model of Post Traumatic Stress Disorder (PTSD) that used a presentation 
of cat odor (Cohen et al. 2004). By combining it with another type of stressor, 
restraint, we were able to increase the number of animals that showed stress-
induced behavioral changes. We also added a neutral auditory cue to the stress 
episode to determine whether presentation of the cue after stress would further 
enhance anxiety.  Similar to human behavior, not every individual showed increased 
anxiety after stress, some appeared resilient.  We then selected for individuals who 
appeared most affected by the stressor and those whose behavior remained the 
same, the PTSD-like and the Resilient.  Brains from these animals and controls 
were screened for mRNA and protein expression of two neuropeptides previously 
shown to be altered by stress in the previous chapters and the literature; CART 
(Hunter et al. 2007), NPY (Thorsell et al. 1998) and the Y5 receptor (Kakui et al. 
2007). We expected that stress-resilient individuals would show similar patterns of 
mRNA expression to that found in the control animals in the Calm group. 
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Experimental Paradigm 
Following an animal model of Post-Traumatic Stress Disorder (PTSD) 
previously established in the literature (Cohen et al. 2004), a cat odor stress was 
implemented that consisted of a 10-minute cat odor exposure using both urine and 
fur, followed by a seven-day rest period.  As no effect on behavior in the EPM was 
found in either Sprague-Dawley rats ten days after stress (see Chapter 3, Figure 1) 
or in Lewis rats seven days after stress (data not shown), the multimodal stress 
paradigm was created in order to develop a longer-lasting stress episode with more 
contextual cues.  For comparison, both Fischer (F344) and Lewis rat strains were 
tested on the multimodal stressor, which consisted of a 10-minute cat odor or 
control exposure followed by 30 minutes of immobilization stress. Tail blood was 
drawn from the stressed rats immediately after cat odor exposure and again 20 
minutes after the start of the immobilization stress (30 minutes into stress period) for 
corticosterone analysis.  Blood was not drawn from control animals as this would 
have created a stressful experience. Seven days after stress or control episodes, 
anxiety behavior was measured in the EPM. For all other experiments in this 
chapter, the multimodal stress model was used. 
Using the multimodal stress episode with a conditioned cue as a model 
of PTSD. 
 In the next experiment 72 Lewis rats underwent the multimodal stress 
paradigm with the addition of a novel audio cue followed by seven days of rest.  
Behavior in the open field was measured prior to placing animals in experimental 
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groups.  During the stress or control exposure, animals in half of the groups heard a 
novel, neutral audio stimulus; a looped two-minute audio track of “Songbirds of the 
British Wetlands” (British Library online Archival Sound Recordings).  The 
remainder of the animals heard no novel audio cues.  There were four exposure 
groups (18 animals per group, stress/song, stress/no song, control/song, control/no 
song). On the seventh day after stress or control exposure, animals were placed in 
the EPM for five minutes. During the five-minute episode, the same audio stimulus 
was playing in the background for some of the animals, while others heard no 
additional audio stimuli. All combinations of song exposure and stress were run, 
although more animals were run in groups where the song would be a relevant cue, 
played during both exposures [18 stress/song/song(cued), 6 stress/song/no song, 6 
stress/no song/song, 6 stress/no song/no song, 18 control/song/song(cued), 6 
control/song/no song, 6 control/no song/song, 6 control/no song/no song].  Five 
minutes after being removed from the EPM, most animals were sacrificed by rapid 
decapitation and blood collected for plasma corticosterone analysis, although one 
group (n = 24) was perfused for a different analysis. 
Separation of affected individuals by examining changes to anxiety 
behavior over time 
 The analysis of the study above was further broken down into behavioral 
profiles. Animals in the stress groups were divided based on anxiety behavior as 
measured by the open field and EPM. Difference scores were generated from 
normalized pre-stress scores subtracted from post-stress scores normalized to the 
mean of the controls. Stressed individuals with scores well below the control mean 
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were selected and separated into “PTSD-like” and those near or above the control 
mean were placed in the “Resilient” group for molecular analysis.  
Molecular analysis 
For the molecular profile analysis of the PTSD-like and Resilient groups, 
brain tissue from animals sacrificed during previous experiments were used. Lewis 
rats that underwent multimodal stress and average controls for three separate 
experiments (multimodal stress as described above, multimodal stress with NMDA 
receptor antagonist and multimodal stress with CORT in the drinking water, both as 
described in Chapter 6) were used. Animals were selected from groups with the 
fewest other experimental manipulations; however, it was necessary to choose from 
animals that had been exposed to bird song or 2.4% ethanol in the drinking water 
for one 12-hour period.  Nonetheless, unstressed controls were matched who 
shared these manipulations.  
Sectioned frozen brain tissue from these groups was selected using the 
criteria described below for PTSD-like and Resilient animals. Slides containing the 
following areas were examined; dorsal hippocampus, central and medial amygdala, 
medial prefrontal cortex and orbital frontal cortex. One slide per animal was 
processed through the in situ hybridization procedure described in the Methods 
section for the CART, NPY, and Y5 oligonucleotide probe. Autoradiographs of 
mRNA expression were examined on a light box and relative optical density 
measured for each region of interest as compared to background. Densitometry 
measurements for each region of interest were compared using a one-way ANOVA.  
For immunohistochemistry and analysis, animals that met the criteria for PTSD-like 
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and Resilient and matched controls were taken from the perfused sets of tissue 
collected for the multimodal stress with NMDA receptor antagonist (non-injected 
groups), described in Chapter 6.  Nickel-DAB immunohistochemistry using an 
antibody against CART (55-102) was conducted on matched brain sections for each 
individual, and analyzed by densitometry. The hippocampal formation and 
amygdala were subdivided into layers based on staining patterns and atlas 
landmarks, and sampled separately.  
Results 
The multimodal stressor: Lewis vs. Fischer rats 
 Plasma corticosterone (CORT) levels were calculated from tail blood taken 
10 minutes and 30 minutes after the start of the multimodal stressor (Figure 14A). A 
two-way ANOVA with repeated measures found a significant effect of time, F(1,13) 
= 38.6, p < 0.0001, but no effect of rat strain (p > 0.05).  Anxiety behavior was also 
compared between strains and stress groups in the EPM seven days after stress or 
control exposure (Figure 14B).  A two-way ANOVA revealed a significant effect of 
stress, F(1, 32) = 35.8, p < 0.0001, as well as a main effect of strain, F(1,32) = 16.4, 
p = 0.0003.  Post-hoc comparisons showed that both Lewis and F344 animals in the 
stress groups spent significantly less time in the open arms of the EPM (p < 0.05 for 







Figure 14. The multimodal stress episode is sufficient for producing a 
corticosterone response and behavioral changes seven days later. (A) Lewis 
and F344 rats have similar corticosterone responses to a multimodal stress 
episode, 10 minutes after the onset of cat odor exposure and 20 minutes after the 
onset of immobilization stress (30 minute timepoint). (B) Seven days after a single 
multimodal stress episode, both Lewis and F344 show significant reductions in time 
spent in the open arms of the EPM, although Lewis rats spend less time in the open 
arms in general compared to F344. Significance is illustrated; *, where p < 0.05. 
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Using the multimodal stress episode with a conditioned cue as a model 
of PTSD in Lewis rats 
 For the initial analysis, animals were grouped together by stress or control 
exposure. Overall, animals in the stress group spent less time in the open arms of 
the EPM (Figure 15A) and had a longer latency before entering the open arms 
(Figure 15B) than controls, t(70) = 2.2, p = 0.0316, and t(67)= 3.28, p = 0.0016, 
respectively.  Groups were further divided by those who were exposed to the audio 
stimulus.  Of these groups, song would be a relevant cue only when bird song was 
played during the multimodal stress or control exposure and during the EPM.  
Therefore, behavior for these animals was separated into a song cued group (either 
stress/song/song or control/song/song) and a nosong/uncued group (all other 
groups of audio stimulus exposure) divided by stress (Figure 15C). A two-way 
ANOVA between stress and controls in the song cued and no song/uncued groups 
found a main effect of stress on the percent time spent in the open arms of the 
EPM, F(1,67) = 4.58, p =0.0362, however, there was no significant effect of song 
cue on behavior in the EPM (p > 0.05). Analysis of latency to enter the open arms 
also showed a main effect of stress, F(1,67) = 10.5, p = 0.0018, but again, no effect 
of song cue (p > 0.05).  Post-hoc comparisons found that only the stressed animals 
in the No song/uncued group differed significantly from controls (p < 0.05, 
Bonferroni corrected).   
 Plasma corticosterone collected 10 minutes after entry into the EPM was 
also divided into song cued and no song/uncued groups (Figure 15E). A two-way 
ANOVA found a main effect of song on corticosterone levels, F(1,31) = 4.26, p = 
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0.0474, but no main effect of stress (p > 0.05).  Post-hoc comparisons were not 





























Figure 15. Playing a stress-associated audio cue during behavioral testing in 
the elevated plus maze does not further enhance the long-term effects of a 
multimodal stressor.  Overall, a multimodal stress episode decreased (A) percent 
time and increased (B) the latency to enter the open arms of the EPM seven days 
later. An audio cue played during the multimodal stress or control episode was 
again played in the EPM in the Song cued group. (C) While there was a main 
effect of stress on percent time and (D) latency to enter the open arms of the EPM, 
the presence of the audio cue had no further effect. (E) Corticosterone (CORT) 
levels 10 minutes after entry into the EPM were higher in the Song cued groups (p 
< 0.05); however, there was no difference between stress and control CORT 






Separating out the affected: PTSD-like vs. Resilient behavior 
 As previously shown, open field anxiety behavior was found to correlate with 
EPM anxiety behavior measured seven days later (Figure 16A).  Pre-stress open 
field anxiety behavior as measured by percent time spent in the center of the open 
field was again plotted against post-stress percent time spent in the open arms of 
the EPM for animals in the stress group (Figure 16B). A Pearson’s analysis found 
that pre-stress and post-stress behavior did not correlate in the stressed group (r = 
0.011, n = 36, p = 0.542). As the pre-stress open field test showed a wide range of 
anxiety levels, a comparison of anxiety behavior was accomplished by calculating z-
scores (calculated as percent of the population) for pre-experiment and post-
experiment behavior. The pre-experiment z-score was obtained by taking the 
individual data for time spent in the center of the open field, and subtracting the 
mean of the entire population.  Then this number was then divided by the standard 
deviation of the entire population, and adjusted to a z-score calculated percentile.  
The post-experiment z-score was obtained by taking the individual data for time 
spent in the open arms of the EPM, and subtracting the mean for the Control group, 
which represents an unchanged population.  This was then divided by the standard 
deviation of the same control group, and adjusted to a z-score percentile. In order to 
emphasize whether changes from pre-experiment behavior were in the positive 
(less anxiety) or negative (more anxiety) direction, z-score percentiles for post-
experiment behavior were subtracted from pre-experiment behavior to acquire a 
difference score (Figure 16C). From here, animals that fell above zero (meaning 
their behavior was unchanged from pre-stress levels) were placed in the Resilient 
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group, while animals that fell below one standard deviation below the average for 























Figure 16. Factors for separating groups based on anxiety behavior. A 
scatterplot illustrates the relationship between time spent in the center of the open 
field and time spent in the open arms of the EPM in the control and multimodal 
stress groups. (A) A Pearson’s analysis determined that anxiety behavior 
correlates between these two behavioral experiments, measured seven days apart 
in control animals (p < 0.05). (B) However, no correlation was found between 
anxiety behavior before and after stress (p > 0.05). (C) Difference scores were 
obtained from comparing individual pre-experiment and post-experiment anxiety 
measures in order to separate animals into those whose behavior had changed 
over time from those whose behavior remained the same. Data represented by the 
symbols highlighted in the red box were animals chosen for the PTSD-like group 
















CART Neuropeptide molecular profile in PTSD-like and Resilient 
animals 
CART mRNA expression analysis 
CART mRNA expression in regions of interest were compared between the 
PTSD-like and Resilient stress groups along with controls from the Average group 
(see Chapter 4).  All optical density calculations were normalized to matched 
controls from the Average group from the same experiment. Optical density 
measurements for PTSD-like and Resilient groups are shown as a percent of 
Average control (optical density measurements for controls = 1, or 100%).  A one-
way ANOVA was utilized for comparisons between the three groups, however, the 
PTSD-like and Resilient stress groups were also analyzed using a unpaired 
student’s t-tests. In the dorsal hippocampus, in both the upper blade (Figure 17A) 
and lower blade (Figure 17B) of the DG, a one-way ANOVA found an overall 
difference between groups, F(2,26) = 5.21, p = 0.0125, and F(2,26) = 4.82, p = 
0.0166. Further analysis revealed that the Resilient group had significantly higher 
CART expression than the PTSD-like group in both blades (p < 0.05). In the central 
nucleus of the amygdala (Figure 17C), a significant difference between groups was 
also discovered, F(2,27) = 3.41, p = 0.0471. A student’s t-test found that CART 
mRNA expression was significantly higher in the Resilient group (p < 0.05).  No 
differences were found in the medial amygdala (Figure 17D, p > 0.05).   
CART mRNA expression was also examined in the prefrontal cortex.  A one-
way ANOVA showed a significant group effect in the prelimbic region of the mPFC 
(Figure 18A), F(2,25) = 3.59, p = 0.0427. Further analysis found that animals in the 
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resilient group had significantly lower levels of expression than PTSD-like animals 


























Figure 17. Higher CART mRNA expression levels were found in the 
hippocampus and central nucleus of the amygdala in stress-resilient 
individuals. Animals in the Resilient group had higher CART mRNA expression in 
(A) the top and (B) the bottom blade of the dentate gyrus and (C) the central 
nucleus of the amygdala (p < 0.05).  No difference between groups was found in the 







Figure 18. Lower CART mRNA expression levels were found in the prelimbic 
region of the mPFC in stress-resilient individuals. Animals in the Resilient group 
had lower CART mRNA expression in (A) the prelimbic region of the mPFC than 
those in the PTSD-like group (p < 0.05).  No difference between was found in (B) 
the orbitofrontal cortex. Significance is illustrated; *, where p < 0.05. 
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CART peptide expression analysis 
 Densitometry for CART peptide expression was measured on matched 
sections in the hippocampal formation, amygdala and prefrontal cortex.  Nickel-DAB 
immunolabeling was present in both cell bodies and fiber tracts  Layers of the 
dentate gyrus that primarily contained immunopositive cell bodies were analyzed 
separately from layers that contained primarily fiber tracts.   Sub-regions including, 
the granule cell layer (GCL), Subgranular Zone (SGZ), and hilus of the dentate 
gyrus (DG) and the Cornu Ammonis region 3 (CA3) were sampled as shown in 
Figure 19A and B. . Nuclei of the amygdala, including the central (CE), medial (ME), 
lateral (LA), basolateral (BLA) nuclei along with the bed nucleus stria terminalis 
within the amygdalar region (BNST) were identified based on atlas landmarks and 
sampled separately for densitometry analysis as shown in Figure 19C. In the 
prefrontal cortex, the cell bodies of the orbitofrontal region were sampled as shown 
in Figure 19D and layer II/III of the prelimbic (PL) and infralimbic (IL) region of the 
medial prefrontal cortex (mPFC) were examined as shown in Figure 19E. 
  In the DG, the upper and lower blades were analyzed separately.  A one-way 
ANOVA showed a group difference in the GCL, in both the upper (Figure 20A) and 
lower (Figure 20B) blades, F(2,12) = 3.99, p = 0.047, and  F(2,12) = 4.30, p = 0.390, 
respectively. Post-hoc comparisons revealed higher CART expression in the 
Resilient group as compared to unstressed controls (p < 0.05 for both analyses, 
Bonferroni corrected).  An analysis of the SGZ found similar effects. There were 
group effects in the SGZ adjacent to both the upper (Figure 20C) and lower (Figure 
20D) blades of DG, F(2,12) = 4.68, p = 0.0314, and F(2,12) = 7.15,  p = 0.009, 
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respectively.  Post-hoc analyses revealed that there was higher expression in the 
Resilient group compared to controls in the upper blade and higher expression than 
both controls and PTSD-like individuals in the lower blade (p < 0.05, Bonferroni 
corrected). An analysis of the hilus (Figure 20E) also showed a significant difference 
between groups, F(2,12) = 5.64, p = 0.0187, and the same effects in the post-hoc 
comparisons (p < 0.05, Bonferroni corrected).  In the cornu Ammonis region of the 
hippocampus, clear labeling of fiber tracts was seen in CA3. A one-way ANOVA of 
the densitometry calculations revealed a trend towards a group effect in CA3a 
(Figure 20F), F (2,12) = 3.46,  p = 0.0653, However there was a difference between 
groups in CA3b (Figure 20G), F(2,12) = 5.37, p = 0.0216. Post-hoc analysis again 
found increased expression in the Resilient group a compared to unstressed 
controls (p < 0.05, Bonferroni corrected).  No differences were found in region CA3c 
(Figure 20H, p > 0.1). 
 An analysis of CART protein expression revealed contrasting effects in the 
amygdala. A one-way ANOVA of CE found no differences between groups (Figure 
21A, p > 0.05). However an analysis of ME (Figure 21B) found a significant group 
effect, F(2,14) = 4.37, p = 0.0334. Post-hoc comparisons revealed lower CART 
expression in the Resilient group as compared to unstressed controls (p < 0.05, 
Bonferroni corrected).  Similar results were found for LA (Figure 21C) and BLA 
(Figure 21D), F(2,14) = 4.05, p =0.0409, and F(2,14) = 4.02, p = 0.0418, 
respectively.  Post-hoc comparisons also found lower expression of CART protein in 
the Resilient group as compared to controls (p < 0.05, Bonferroni corrected). In the 
intraamygdaloid region of the bed nucleus stria terminalis, (BSTIA, Figure 21E) a 
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one-way ANOVA also showed differences between groups, F(2,14) = 6.34, p = 
0.011.  Resilient also displayed significantly lower CART expression than controls in 
this region (p < 0.05, Bonferroni corrected). 
 Immunolabeling for CART antibody was very light in the mPFC, as there very 
few CART-positive cell bodies or fiber tracts. In the prefrontal cortex, CART protein 
expression in both the prelimbic region and infralimbic region of the mPFC (Figure 
22A and B) was analyzed along with the orbitofrontal cortex (OFC Figure 22C).  No 
difference between groups was found in the PL region nor OFC (p > 0.05 for all 
analyses). However there was a significant effect in IL, F(2,13)=6.61, p = 0.0103. 
Post-hoc analysis found that there was a reduction in CART expression only in the 
PTSD-like group (p < 0.05, Bonferroni corrected).   
NPY and Y5 Receptor mRNA analysis 
 Densitometry for NPY mRNA expression was conducted in the dentate 
gyrus, upper and lower blade, and CA2, CA3a, CA3b, CA3c as well as the 
infralimbic and prelimbic regions of the prefrontal cortex. A one-way ANOVA was 
conducted between PTSD-like, Resilient and control groups for all regions listed.  
No differences between groups were found in any region examined (p > 0.05 for all 
groups, data not shown). 
 Densitometry for Y5 receptor mRNA expression was conducted in the 
dentate gyrus, upper and lower blade, and CA1, CA2, CA3a, CA3b, CA3c as well 
as the infralimbic and prelimbic regions of the prefrontal cortex. A one-way ANOVA 
was conducted between PTSD-like, Resilient and control groups for all regions 
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listed.  No differences between groups were found in any region examined (p > 0.05 























Figure 19. CART peptide expression in the hippocampal formation, 
amygdala and prefrontal cortex.  Photomicrographs of nickel-DAB 
immunolabeled sections using an antibody against CART neuropeptide display 
regions sampled for protein expression densitometry and analysis. Sampled 
regions of interest are labeled within the (A) hippocampal formation, including the 
CA3a, CA3b, and CA3c (B) the dentate gyrus in enlarged to show detail of layers 
of the dentate gyrus including the granule cell layer (GCL), subgranular zone 
(SGZ), and hilus (HIL). (C) Nuclei of the amygdala were sampled from the 
following regions, central (CE), medial (ME), lateral (LA), Basolateral (BLA), and 
the intraamygdaloid region of the bed nucleus stria terminalis (BNST). (D) In the 
prefrontal cortex, an anterior section was analyzed along layer II cell bodies in 
the orbitofrontal region (OFC). (E) Further posterior, layer II/III of the prelimbic 





Figure 20. Higher CART protein expression levels were found in the 
hippocampus in stress-resilient individuals. Animals in the Resilient group 
had higher CART protein expression as compared to unstressed controls in the 
granule cell layer (GCL) of (A) the top and (B) the bottom blade of the dentate 
gyrus, as well as in the regions of the subgranular zone adjacent to (C) the top 
and (D) the bottom blade of the dentate gyrus. There was also higher CART 
expression in the Resilient group as compared to the PTSD-like group in SGZ 
adjacent to the lower blade of the dentate gyrus. (p < 0.05 for all comparisons, 
Bonferroni corrected).   Higher CART expression in the Resilient group as 
compared to controls was also found in (E) the hilus and (G) region CA3b of the 
hippocampal formation. No significant differences were found between groups in 







Figure 21. Lower CART protein expression levels were found in the nuclei 
of the amygdala in stress-resilient individuals.  While no differences were 
found between groups in (A) the central nucleus of the amygdala (CE), animals 
in the Resilient group had lower CART protein expression as compared to 
unstressed controls in (B) the medial nucleus of the amygdala (ME); as well as in 
(C) the lateral nucleus (LA) and (D) basolateral nucleus of the amygdala (p < 
0.05 for all comparisons, Bonferroni corrected).   Lower CART expression in the 
Resilient group as compared to controls was also found in (E) the bed nucleus 
stria terminalis, intraamygdaloid region (BNSTIA, p < 0.05, Bonferroni corrected). 













Figure 22. Lower CART protein expression levels were found in the infralimbic 
region of mPFC in PTSD-like individuals.  While no differences were found 
between groups in (A) the prelimbic region (PL) of the mPFC, individuals in the 
PTSD-like group had lower CART protein expression as compared to unstressed 
controls in (B) the infralimbic region (IL) of the mPFC (p < 0.05, Bonferroni 
corrected). (C) No differences between groups were found in the orbitofrontal cortex 
(OFC).  Significance is illustrated; *, where p < 0.05. 
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Discussion 
 The results of this chapter validate our multimodal stress paradigm as an 
animal model of PTSD by showing that there is an overall increase in anxiety in 
stressed animals compared to controls.  Additionally, we find individuals that 
develop anxiety as a result of the stressor (the PTSD-like) and also individuals that 
appear behaviorally resistant to the effects of stress (the Resilient).  Using the 
criteria set above to separate the PTSD-like from the Resilient, we revealed 
differences in CART mRNA and protein expression in resilient individuals, a pattern 
that is in many ways similar to CART mRNA expression in the unstressed low-
anxiety individuals described in Chapter 4.   
 The multimodal stress episode produced a large plasma corticosterone 
(CORT) increase from baseline levels in both Lewis and F344 rat strains. In fact, 
rats of both strains produced elevated CORT levels immediately after a 10-minute 
psychogenic cat odor exposure that were almost as high as the response to 
immobilization and tail bleed. However, it was unexpected that the Lewis and F344 
lines would produce nearly identical CORT responses.  Historically, Lewis rats are 
thought to have basal CORT levels similar to those of other outbred strains, such as 
the Sprague-Dawley, but when challenged by a stressor, they produce a hypoactive 
response in all measures of the Hypothalamic-Pituitary-Adrenal (HPA) axis. F344 
rats on the other hand, are sometimes, although not always, found to have higher 
basal CORT levels and a much larger CORT response to stress (Griffin et al. 1991; 
Dhabhar et al. 1993; Gomez et al. 1996; Cohen et al. 2004; Cohen et al. 2006).  
The plasma CORT levels reported in this study are both particularly high in the 
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Lewis strain (typical range 100-200 ng/ml after stress) and particularly low for the 
F344 strain (typical range 400-600 ng/ml).  This poses an issue with the purity of the 
genetic line of the rats produced by the supplier.  Yet, there were still significant 
differences between the strains.  Lewis rats from Charles River Labs (Wilmington, 
MA) consistently weigh less than Sprague Dawley rats (data not shown).  Further, 
the anxiety behavior of the Lewis rats was consistently higher than both SD and 
F344 strains; control and stressed Lewis rats spend less time in the open arms of 
the EPM.   
 Yet the even the anxiety behavior produced was not in the same range as 
the published results that this experiment was modeled after. Cohen and colleagues 
found that unstressed Lewis rats spent about 4% of the time in the open arms of the 
EPM, which reduced to an average of about 1.4% with stress, and that F344 rats 
spent an average of 60% of their time in the open arms which reduced down to 
about 10% with stress (Cohen et al. 2006).  Additionally, they found that about 90% 
of stressed Lewis rats exhibited extreme behavioral responses, meaning they never 
entered the open arms of the EPM (Cohen et al. 2004).  In the above multimodal 
stress experiments, only about 10% of the stressed animals produced these 
extreme behavioral responses.   Pilot studies using only a 10-minute cat odor 
exposure (as per Cohen et al., 2004) were even less effective at eliciting a 
behavioral response (see Chapter 3).  It was for this reason that the multimodal 
stressor was chosen, in order to enhance the effects of the cat odor stress, but this 
paradigm still allows for a significant percent of the animals to remain resilient to the 
stressor (20-35%). 
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  There is some evidence that Lewis rats bred in different facilities may vary 
significantly in their CORT response and behavior (Stohr et al. 1999).  It is also 
possible that the behavioral facility, cat odor stress setup, and EPM conditions differ 
so greatly between laboratories that we find both a blunted response in the F344 
strain in both stress-induced CORT levels and in EPM behavior, and an enhanced 
response of both CORT and behavior in the Lewis strain; but this seems unlikely.  
The evidence leans towards a conclusion that there is a dilution of the inbred strains 
causing their hormone and behavioral responses to move towards the outbred SD 
profile. 
  Despite these problems, the multimodal stress was able to induce significant 
changes in anxiety behavior in the Lewis strain. Overall stressed rats spent less 
time in the open arms of the EPM and had a longer latency to first enter the open 
arms.  Unfortunately, it appeared that the bird song audio cue did not enhance 
anxiety when set as a conditioned stimulus for the traumatic experience and played 
as a reminder cue in the EPM. Several different scenarios could be happening to 
prevent cue –induced enhancement of anxiety. One suggestion would be that the 
bird song was not strongly associated with the traumatic experience or was not an 
effective reminder cue for the traumatic experience.  There is evidence against this 
possibility in that animals in the song cued groups had a higher CORT response 
after hearing the song than animals that either heard the song for the first time that 
day or did not hear the song at all that day. This would suggest that the cue was 
sufficient to induce an autonomic conditioned response but was not effective at 
reducing the time spent in the open arms of the EPM. 
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 While the song itself did not increase CORT levels when played in the EPM 
(as shown in the no song/song groups), regardless of stress, there was a main 
effect of song cue on anxiety behavior in those animals that heard the song on both 
stress/control exposure day and in the EPM. This would suggest that the song may 
have been consolidated as a slightly arousing stimulus for the control group, 
although this did not affect their EPM behavior. Another possible reason that the 
song cue was not effective in enhancing anxiety behavior is that the EPM may not 
an ideal environment to conduct a test of the recollection of a traumatic experience, 
or possibly the EPM measures are not sensitive enough to show a small 
enhancement of fear behavior which may look different than the types of anxiety 
behavior measured by this maze.   
 Even without the use of a cue to serve as reminder of the stressful 
experience, there was an overall effect of stress on anxiety behavior. The 
correlation between control open field and EPM behavior was lost in stressed 
animals, demonstrating that anxiety profiles may have changed after stress. 
However, from the graph (figure 16B), it was clear that there was a lot of variability; 
there were individuals whose behavior had that remained the same before and after 
stress and also those that had changed.  From the previous work in Chapter 4, we 
had also recognized that baseline anxiety levels could influence the dendritic 
morphology and molecular profile of the brain; therefore, we wanted to select for 
those animals that truly changed as a result of the multimodal stress experience.  
Equally as interesting were the animals that didn’t change after a stressful 
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experience, as these may provide insight into alterations in molecular profiles that 
produce a resilient individual in the face of stress. 
 CART mRNA expression and peptide were analyzed in individuals that 
present PTSD-like or resilient anxiety profiles after stress. While a plausible 
prediction would have been that since the PTSD-like group contained the 
individuals that had changed in their baseline stress levels we should find 
differences in their molecular profile, this was not case.  In nearly all regions 
examined, it was the resilient group that showed a change in expression, while the 
PTSD-like group tended to look more like controls.  CART mRNA expression 
increased in resilient animals in the dentate gyrus of the hippocampal formation, 
central nucleus of the amygdala, and decreased in the prelimbic region of the 
prefrontal cortex.  These results appeared consistent to what was found in the 
anxiety profiles of unstressed controls.  The calmer animals showed higher CART 
expression in the dentate gyrus and a correlation of lower expression with lower 
anxiety in the prefrontal cortex.  However, the resilient profile differed from the calm 
profile in the amygdala, where increased CART expression correlated with high 
anxiety.  The amygdala is highly involved in the fear response and the formations of 
fear memories, and it is possible that it serves a different purpose in response to 
stress. There is some evidence that the projections coming from the central nucleus 
of the amygdala that are involved in encoding a stressful experience are different 
than the ones that are involved in encoding for basal anxiety levels (Van Bockstaele 
et al. 1999).  While the role of CART in these two amygdala pathways are not clear, 
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in may be the combination of  activity in these pathways that determines total CART 
mRNA expression.  
 CART protein followed a similar profile to the mRNA expression with a few 
exceptions.  CART antibody allowed for better resolution, which allowed for 
visualization of immunolabeled cell bodies as well as areas and nuclei that 
contained a high concentration of CART-positive fiber tracts.  For this reason, the 
hippocampal formation was divided into several more regions to differentiate 
between areas containing primarily cell bodies (such as GCL) compared to those 
with mostly fiber tracts (SGZ, hilus, CA3).  This enhancement of resolution allowed 
us to also analyze immunolabeled fiber tracts in many nuclei of the amygdala that 
we were unable to visualize with mRNA expression, including the LA, BLA and 
BSTIA.   
 Similar to the mRNA profile, CART protein expression generally increased 
with resilience in the DG in most areas examined.  CART positive cell bodies in the 
GCL are most likely part of the mossy fiber pathway (Seress et al. 2004; Abraham 
et al. 2007), and may make up the bulk of the CART positive fiber tracts projecting 
into the hilus and into CA3, both regions where we also see increases in expression 
with resilience.  In the amygdala, the effects were opposite; CART protein 
expression was generally reduced in resilient individuals, particularly in areas that 
contained mostly immunolabeled fiber tracts.  This results is supported in the 
literature, as CART peptide injected into the amygdala has been shown to be 
anxiogenic on several behavioral measures (Dandekar et al. 2008; 2009), and 
CART mRNA expression has been found to increase with stress in the CE but not 
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ME (Hunter et al. 2007). The central amygdala appears to be an interesting area, as 
we see varying effects in this region depending on whether we measure mRNA or 
protein, and whether we are looking at behavior after stress or just basal anxiety. 
While all other amygdala nuclei examined show a reduction in CART protein 
expression with stress, only becoming significant in the behaviorally resilient 
animals, CART levels in CE do not appear to change. While many explanations are 
possible, the connectivity between the other nuclei of the amygdala and CE are 
quite different.  While LA/BLA, and ME receive and integrate input from lower order 
and higher order sensory processing areas, CE mainly receives both excitatory and 
inhibitory input from the other nuclei of the amygdala as well as inhibitory input from 
higher cortical areas, and is the main region of output of the amygdala response. 
More research is necessary to better understand the role of CE in the CART 
neuropeptide system, which is considered further in the main discussion.  
 The IL region of the mPFC was also unique in that this was the only region in 
the entire study where we found significant differences in the PTSD-like animals.  
While there were trends towards a reduction in CART expression in the Resilient 
individuals, this was not significant.  It appeared that, in this case, resilient animals 
were the ones that were resisting change in CART expression. However, this was 
another instance where the protein levels did not follow the mRNA expression 
trends.  As the IL region of mPFC is known to inhibit amygdala activity, and 
necessary for extinction learning (Quirk et al. 2003; McDougall et al. 2004), it is 
possible that increased CART protein is indicative of active inhibitory neurons in this 
region, a sign of proper inhibitory tone. 
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 This result introduces another important factor; although we only found 
significant expression changes in the resilient animals, there was a trend for the 
PTSD-like animals to change from baseline in the same direction (and a trend for 
Resilient animals to change from baseline, in the case of the IL region of mPFC), 
particularly in protein expression.  This supports the idea that resilience is an active 
process, and those animals that produce a sufficient molecular change in response 
to a stressor are actually the ones that retain their pre-stress behavior, while those 
that cannot mount the appropriate molecule response above a certain threshold are 
destined to become more anxious.  
 The question remains, are these changes in CART necessary for the 
resilience profile and retention of pre-stress anxiety levels, or are they just a 
secondary effect?  To answer this, better understanding of what is happening 
upstream of the CART changes is necessary.  One possible candidate molecule 
working upstream of CART would be NPY.  Increased NPY levels in both blood and 
brain appear to be anxiolytic (Thorsell et al. 1998; Heilig 2004) and positively 
influence stress resilience in both animals and humans (Morgan et al. 2000; Morgan 
et al. 2002; Yehuda et al. 2006).  NPY-positive axon terminals have been shown to 
be apposed to dendrites in CART positive neurons in the hypothalamus and medial 
nucleus of the amygdala (Broberger 1999). While NPY may be acting on CART 
expression, no differences were found in NPY mRNA expression levels between 
stressed animals with PTSD-like and resilient behavior or in unstressed controls 
with different anxiety profiles in the above studies.  Other candidate molecular 
systems are discussed and tested in the following chapter. 
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Chapter 6: Mechanisms for stress resilience and 
prevention of PTSD 
Based on the results of Chapter 5, the multimodal stressor proved to be 
effective for eliciting a long-term anxiety response in the Lewis rats.  This paradigm 
was utilized as a model of PTSD in the following experiments. The neurotransmitter 
glutamate and the NMDA family of receptors have been implicated in the encoding 
of fear memories and in the enhancement of anxiety after stress (Maren et al. 1996; 
Adamec et al. 1998; Blair et al. 2001). Here we administer the NMDA receptor 
antagonist CGP43487 prior to the multimodal stress exposure to test whether 
NMDA receptor blockade during stress can prevent stress-induced changes in 
behavior. The stress hormone Corticosterone (CORT) and its receptors also play a 
large role in eliciting anxiety behavior after stress (McEwen et al. 1988; Raber 1998; 
Calvo et al. 2001; Mitra et al. 2008).  However, the Lewis rat strain has been shown 
to have a blunted CORT response immediately following stress, and this has been 
implicated in the PTSD-like symptoms found in this strain (Cohen et al. 2006). As 
administration of additional CORT during the stress episode has been shown to 
eliminate the PTSD-like effects on behavior, we attempted to replicate this finding 
using a non-invasive route of CORT administration.  Neuropeptide Y (NPY) 
expression has been strongly associated with reduced anxiety and behavioral 
resilience to stress (Heilig et al. 1993; Yehuda et al. 2006; Gutman et al. 2008; 
Sajdyk et al. 2008), however, some of the NPY receptors have opposing effects on 
anxiety behavior (Thorsell et al. 2002). Here we used a drug to block the NPY Y5 
 136 
receptor during stress. As the Y5 receptor antagonist, Lu AA33810, has only been 
shown to be effective with chronic treatment (Walker et al. 2009), a chronic stressor 
was utilized to examine the ability of this drug for enhancing stress resilience.  
 
Experimental Paradigm 
Experiment 1: NMDA-Receptor blockade during an acute multimodal 
stress exposure. Adult male Lewis rats were divided into 6 groups, run in two 
cohorts of 9 animals per group: control/no injection, control/vehicle, control/NMDAR 
Ant, stress/no injection, stress/vehicle, stress NMDAR Ant.  Animals in the injection 
groups received an s.c. injection with 5mg/kg of the NMDAR antagonist CGP43487 
or vehicle. In both studies, a five-minute open field test occurred several days prior 
injections and/or stress or control exposures.  Seven days after stress or control 
exposure, rats were placed in the elevated-plus maze for five minutes. Brains were 
collected via rapid decapitation or perfusion on the same day. 
 
Experiment 2: Noninvasive corticosterone treatment during an acute 
multimodal stress exposure.  This experiment was conducted in two cohorts 
(first cohort for plasma analysis, 6 per group; second cohort for behavior, 12 per 
group).  In both studies, a five-minute open field test occurred several days prior to 
CORT treatment and stress exposure in order to divide the animals evenly into 
groups based on anxiety measures; control/vehicle, control/CORT, stress/vehicle, 
stress/CORT. CORT treatment consisted of changing the regular water bottles for 
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water containing 400μg/ml corticosterone and 2.4% ethanol, while controls receive 
bottles with 2.4% ethanol, for 12 hours prior to stress/control exposure.  
In the first cohort, animals were sacrificed by rapid decapitation immediately 
after the stress or control exposure (40 minutes after onset of exposure). Blood was 
collected and processed for hormone analysis and the brains flash frozen. For the 
second cohort, seven days after stress exposure, rats were placed in the elevated-
plus maze for five minutes. Brains were collected via rapid decapitation less than 
two hours after maze exposure, flash frozen on dry ice, and processed for in situ 
hybridization.  
 
Experiment 3: Y5 receptor antagonist treatment during chronic stress: 
Adult male SD rats were divided into four groups: control/normal chow, control/ Y5 
Ant, stress/normal chow, stress/ Y5 Ant (12 animals per group, 48 total).  Prior to 
the start of the experiment all animals were run in the open field and divided evenly 
across groups based on anxiety behavior. Administration of chow containing Y5 
Receptor Antagonist Lu AA33810 (30 mg/kg/day) or normal chow began four days 
before the start of the stress experiment. A sucrose preference was performed 
immediately after the first and last day of stress for all groups. In cage behavior was 
monitored for 2 hours after stress day 2 and day 20 for all groups.  Animals were 
weighed once a week. Twenty-four hours after the last stress episode, all animals 
were placed in the EPM for five minutes.   
Animals were sacrificed by rapid decapitation five minutes after removal from the 
maze, and blood collected for plasma hormone analysis.  Brains were removed and 
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flash frozen for in situ hybridization processing.  In situ hybridization using 
radiolabeled oligonucleotide probes for NPY and Y5 receptor were conducted on 
prepared hippocampal and mPFC sections.  Matched sections on the resulting 




Behavior in the EPM was examined seven days after NMDA receptor 
antagonist treatment and stress exposure.  A two-way analysis of variance found no 
differences in the percent time spent in the open arms (Figure 23A, p > 0.1) nor in 
the number of open arm entries (Figure 23B).  As the pre-stress open field test 
showed a wide range of anxiety levels prior to dividing the animals into experimental 
groups, a comparison of anxiety behavior was accomplished by calculating z-scores 
(calculated as percent of the population) for pre-experiment and post-experiment 
behavior. The pre-experiment z-score was obtained by taking the individual data for 
time spent in the center of the open field, and subtracting the mean of the entire 
population.  This number was then divided by the standard deviation of the entire 
population, and adjusted to a z-score calculated percentile.  The post-experiment z-
score was obtained by taking the individual data for time spent in the open arms of 
the EPM, and subtracting the mean for the Control/No Injection group, which should 
represent an unchanged population.  This was then divided by the standard 
deviation of the same control group, and adjusted to a z-score percentile. In order to 
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emphasize whether changes from pre-experiment behavior were in the positive 
(less anxiety) or negative (more anxiety) direction, z-score percentiles for post-
experiment behavior were subtracted from pre-experiment behavior to acquire a 
difference score (Figure 23C).  A two-way ANOVA of difference scores by group did 
not reveal any significant effects (p > 0.10 for both analyses), however, these 






















Figure 23. Effects of NMDA receptor antagonist on acute multimodal stress 
remain unclear. There is no effect of Stress or NMDA receptor antagonist 
treatment on (A) percent time spent in the open arms of the EPM, nor (B) number of 
open arm entries (p > 0.05).  Although not significant, difference scores between 
open field measures and (C) percent time spent in the open arms in the EPM were 
obtained to show overall trends in behavior for each group. 
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Experiment 2 
Plasma corticosterone (CORT) was analyzed from the blood collected from 
the first cohort immediately after stress exposure (Figure 24).  A two-way ANOVA 
found a significant main effect of stress, F(1,19) = 9.60, p = 0.0059, a main effect of 
CORT treatment, F(1,19) = 6.75, p = 0.0177, and a stress by CORT treatment 
interaction F(1,19) = 11.2, p = 0.0034.  Post-hoc comparisons revealed that animals 
in the stress/No CORT group had a stress-related increase in plasma CORT levels 
as compared to controls(p < 0.001, Bonferroni corrected). 
 In the second cohort, behavior in the EPM was examined seven days after 
CORT treatment and stress exposure.  A two-way ANOVA found no differences in 
the percent time spent in the open arms (Figure  25A,) nor in the number of open 
arm entries (Figure 25B), however, there was a trend towards significance for the 
stress by CORT treatment interaction F(1,42) = 3.18, p = 0.0819.  As the pre-stress 
open field test showed a wide range of anxiety levels prior to dividing the animals 
into groups, a comparison of anxiety behavior was accomplished by calculating z-
scores as described above for percent time spent in the open arms of the EPM 
(Figure 25C) and open arm entries (Figure 25D).  In order to emphasize whether 
changes from pre-experiment behavior were in the positive (less anxiety) or 
negative (more anxiety) direction, z-score percentiles for EPM behavior were 
subtracted from open field behavior to acquire a difference score.  A two-way 
ANOVA of difference scores did not reveal any significant effects (p > 0.10 for both 
analyses), however, these numbers to appear to highlight the changes taking place 




Figure 24. Post-stress plasma Corticosterone (CORT) is inhibited by 12 hours 
of CORT treatment. A two-way ANOVA found a main effect of stress, CORT 
treatment and a stress by CORT treatment interactions (p < 0.05 for all analyses).  
Post-hoc comparisons showed that stress significantly increased plasma CORT 




Figure 25. Effects of CORT treatment on the acute multimodal stress appear 
unclear.  There is no effect of Stress or CORT treatment in the drinking water 12 
hours prior to stress or control exposure on (A) percent time spent in the open arms 
of the EPM, nor (B) number of open arm entries (p > 0.05).  Although not significant, 
difference scores between open field measures and (C) percent time spent in the 
open arms, or (D) number of open arm entries in the EPM were obtained to show 
overall trends in behavior for each group. 
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Experiment 3  
Individual weights were collected before stress and throughout the stress procedure 
(Figure 26). A repeated measures ANOVA demonstrated an effect of time, F(5,215) 
= 1639, p < 0.0001, demonstrating that all animals gained weight over the 6 weeks 
they remained in the facility.  There was also a time by treatment interaction, 
F(15,215) = 6.92, p > 0.0001.  Two-way ANOVAs comparing weights for each week 
revealed that there was a main effect of stress on weight during week 5 and week 6 
of the experiment (F(1,44) = 14.7, p = 0.0004, and F(1,44) = 12.2, p = 0.0011, 
respectively);  however there was no effect of drug treatment or drug by stress 
interaction (p > 0.05). 
 A two-way ANOVA for sucrose preference found no effect of stress or drug 
treatment on sucrose preference on Day 2 or Day 20 of the study (p > 0.05, Figure 
27A and B, respectively). Bonferroni corrected post-hoc analyses did not show 
significant differences between stress and control in the No Drug group, although 
there was a trend for the stressed animals to consume less sucrose water on Day 2 
(p = 0.147), which was significant when the No Drug groups were compared by a 
two-tailed student’s t-test, t(6)= 2.57, p = 0.0425.  This comparison was not 
significant by Day 20 (p > 0.1). 
 In cage behaviors were counted within the first 2 hours after restraint stress, 
controls matched for time of day. Aggressive behaviors varied widely across cages 
(3 rats/cage), from no aggression noted up to 17 aggressive acts in two hours; 
however, a two-way ANOVA found no differences in behavior either on Day 1 or 
Day 21 of stress (Figure 27C and D, p > 0.1 for all groups). This variability was 
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found both within groups as well as within cages measured over time; a two-way 
ANOVA with repeated measures comparing Day 1 and Day 21 found no effect of 
time, F(1,12) =3.15, p = 0.101. 
 A two-way ANOVA of EPM behaviors measured after chronic stress found no 
main effects on the percent time spent in the open arms (Figure 28A) nor any 
significant Bonferroni corrected post-hoc comparisons (p > 0.05 for all analyses).  
There was a main effect of stress on the total number of open arm entries (Figure 
28B), F(1,42)= 4.56, P = 0.0386.  Further, there were no significant main effects for 
the number of times the head reached the end of the open platforms (Figure 28C). 
Although the Bonferroni corrected post-hoc comparisons for these three measures 
were not significantly different between Stress and Controls in the No Drug group (p 
> 0.05), we had predicted that we would find a stress-induced increase in anxiety in 
those animals who did not receive the Y5 antagonist.  A two-tailed unpaired 
student’s t-test showed that stressed animals entered the open arms less often, 
t(20) =  2.35, p = 0.0293, and there was a trend for the stressed animals to spend 
less time in the open arms, t(20) = 1.74, p = 0.0973, and to reach the end of the 
open platforms less often, t(20) = 1.762, p = 0.0933.   
As the pre-stress open field test showed a wide range of anxiety levels prior 
to dividing the animals into experimental groups, a comparison of anxiety behavior 
was accomplished by calculating z-scores as described in the NMDA receptor 
antagonist study above for the percent time spent in the center of the open field and 
the percent time spent in the open arms of the EPM.  In order to emphasize whether 
changes from pre-experiment behavior were in the positive (less anxiety) or 
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negative (more anxiety) direction, z-score percentiles for post-experiment behavior 
were subtracted from pre-experiment behavior to acquire a difference scores 
(Figure 28D). A two-way ANOVA of difference scores by group did not reveal any 
significant effects (p > 0.10 for all analyses), however, these numbers to appear to 






















Figure 26.  Chronic restraint stress reduces weight gain regardless of Y5 
receptor antagonist treatment. Stress began at the start of week 3, as noted 
on the figure.  A two-way ANOVA with repeated measures revealed that animals in 
the stress groups weighed less than controls; drug treatment had no effect on 




Figure 27. Restraint stress and Y5 receptor antagonist treatment have no 
effect on sucrose preference or in cage aggression.  A two-way ANOVA of 
behaviors measured at the start and end of the 21-day stress period found no 
effects of stress or Y5 antagonist drug treatment on hedonic tendencies (A and B) 
nor on the number of aggressive acts (C and D, p > 0.10 for all groups). 
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Figure 28. Chronic stress and/or chronic Y5 antagonist treatment produced 
little change in anxiety behavior.  Behavior in the EPM was measured by (A) 
percent time spent in the open arms, (B) number of open arm entries, and (C) 
number of times the animal reached the end of the open platform.  A two-way 
ANOVA found a main effect of stress for the number of open arm entries (p < 
0.05).  A two-tailed student’s t-test comparing the means between the No Drug 
groups revealed a small but expected decrease in percent time spent in the open 
arms (p < 0.1), number of open arm entries (p < 0.05), and number of times to 
reach the end of the open arm platform (p < 0.1).  Although not significant, 
difference scores (D) obtained from comparing individual pre-experiment and 
post-experiment anxiety measures showed overall trends in behavior for each 




Densitometry was conducted on the autoradiographs generated from the In 
situ hybridization of oligonucleotide probes for NPY and Y5 receptor.  Regions of 
interest were chosen as described in Appendix 1.  In the hippocampus, stress 
induced changes in NPY expression were found through out the Cornu Ammonis 
region.  Analysis of NPY mRNA expression in CA1 (Figure 29A) a two-way ANOVA 
revealed a trend towards main effect of stress, F(1,27) = 3.08, p = 0.0903) and a 
stress by drug interaction, F(1,27) = 4.26, p = 0.0489).  Post-hoc comparisons of the 
No Drug group showed that stress reduced expression (p < 0.05, Bonferroni 
corrected).  Similar results were found in region CA2 and CA3a (Figure 29B and C, 
respectively); there was an significant main effect of stress on NPY mRNA 
expression, F(1,27) = 4.55, p = 0.0422 in CA2 and F(1,28) = 5.92, p = 0.0216 in 
CA3a,  although post hoc analysis found a stress-induced reduction in expression 
only for the No Drug groups (p<0.05, Bonferroni corrected).  In CA3b (Figure 29D), 
a two-way ANOVA found a trend toward a main effect of stress, F(1,28) = 3.23,p = 
0.0832, and a main effect of stress was found in CA3c (Figure 29E), F (1,28) = 
5.04, p = 0.0331, although post-hoc comparisons were not significantly different for 
any group (p > 0.05 for all groups, Bonferroni corrected).  In contrast to the effects 
found in the CA region, no differences in NPY mRNA expression were found in the 
upper or lower blade of the dentate gyrus (Figure 29F and G) of these same 
animals (p > 0.1) for all groups. Stress and controls animals in the Drug group did 
not differ from each other, nor from No  Drug controls (p > 0.05, Bonferroni 
corrected, for all analyses). 
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 The mPFC was also examined for NPY mRNA expression.  A two-way 
ANOVA of NPY expression in the prelimbic region (Figure 29H), showed a trend 
towards a main effect of stress, F(1,31) = 3.38, p = 0.0757, although post-hoc 
comparisons were not significantly different (p > 0.05 for all groups, Bonferroni 
corrected).  The infralimbic cortex was also examined, however, no differences 
were found between groups (p > 0.1, data not shown). 
 Analysis of Y5 receptor mRNA expression in the hippocampus found only 
minor stress and drug related changes.  In the upper blade of the dentate gyrus 
(Figure 30A) a two-way ANOVA found a trend towards a main effect of drug, 
F(1,31) = 3.75, p = 0.0615, with no difference between stress and controls in either 
Drug or No Drug group (p > 0.05).  In contrast, no effects were found in the lower 
blade of the dentate gyrus (Figure 30B, p > 0.01 for all comparisons). In CA1 
(Figure 30C), there was a trend towards a main effect of both stress, F(1,30) = 2.81,  
p = 0.100, and drug, F(1,30) = 2.81, p = 0.100.  No differences between stress and 
controls were found in either the Drug or No Drug groups in the post-hoc 
comparisons analysis (p > 0.05).  No alterations in Y5 mRNA expression were 
found in CA2, CA3a or CA3c (Figure 30D, E and G), p >0.10 for all groups).  
However, analysis of CA3b (Figure 30F), revealed a significant stress by drug 
interaction, F(1,26) = 5.75, p = 0.0240.  Post-hoc analysis found a significant stress-
related decrease in Y5 expression in the No Drug group (p > 0.05, Bonferroni 
corrected). In the medial prefrontal cortex, there was a trend towards a main effect 
of stress, F(1,24) = 3.02, p = 0.095.  Post-hoc analysis did not show any differences 
between stress and controls for either drug group (p > 0.05). 
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Figure 29. Chronic Restraint Stress reduces NPY mRNA expression in the 
hippocampus, Y5 antagonist treatment appears to partially reverse these 
effects. NPY mRNA expression was measured in regions of the hippocampus by 
densitometry. A significant (p < 0.05) main effect of stress was found by two-way 
ANOVA in (B) CA2, (C) CA3a, and (E) CA3c, while a trend (p < 0.1) towards a 
main effect was found in  (A) CA1, and  (D) CA3b. Post-hoc analyses were 
conducted between stress and control animals for the No Drug and Drug groups 
and a significant difference was found where noted. Significance is illustrated; *, 
where p < 0.05.  No differences were found between stress and control groups 
with Drug (p > 0.05, Bonferroni corrected).  In (H) the Prelimbic region of the 





Figure 30. Both chronic restraint stress and Y5 antagonist appear to 
influence Y5 receptor mRNA expression. Y5 mRNA expression was measured 
in regions of the hippocampus by densitometry. A trend towards a main effect of 
stress (p < 0.1) was found by two-way ANOVA in (A) the upper blade but not the 
(B) lower blade of the DG.  In the (C) CA1 region, there was a trend towards both 
a main effect of stress and drug (p = 0.1 for both analyses).  No effect of stress or 
drug was found in (D) CA2, (E) CA3a, or (G) CA3c (p > 0.1 for all analyses).  
However, a significant stress by drug interaction was present in (F) CA3b (p < 
0.05). Post-hoc analysis of CA3b revealed a significant stress-induced decrease 
in Y5 mRNA expression in the No Drug group. Significance is illustrated; *, where 
p < 0.05. In (H) the Prelimbic region of the mPFC, there was a trend towards a 







No differences in anxiety were found after pre-treatment with either CORT or 
a NMDA receptor antagonist prior to stress.  However, no significant differences 
were found between stress and control groups without drug treatment, so no 
conclusions can be made about the efficacy of the two treatments.  While there was 
an effect of chronic stress on NPY mRNA expression in the hippocampus, 
behavioral differences between stress and control groups were not robust enough 
to achieve significance.   
The lack of an effect of both NMDA receptor antagonist and CORT treatment 
brings up several issues with the design of these experiments.  In the first 
experiment, the necessity for injection of the NMDA receptor antagonist CGP43487 
requires that a third, saline injected vehicle group be added to experiment.  As the 
multimodal stressor is not strong enough to induce anxiety symptoms in all 
individuals, and a 3x2 ANOVA requires more power to achieve statistical 
significance, we were unable to find behavioral differences even with 18 animals per 
group.  A second issue that may have caused additional variability, was that 
animals in the treatment groups were given injections. Although injection 
procedures were practiced without a needle tip in order to habituate the animals to 
the extra handling, some animals appeared to have more fearful reactions to the 
injections than others.  For this reason, we chose a non-invasive approach to drug 
administration for the CORT treatment experiment. 
There is recent evidence to suggest that even a single CORT injection may 
be sufficient to cause an increase in anxiety behavior in unstressed animals.  Mitra 
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and Sapolsky (2008) have shown that twelve days after CORT treatment, animals 
showed decreased exploration into the open arms of the EPM and increased 
amygdala volume and dendritic hypertrophy in neurons of the basolateral nucleus.  
Thus, it is possible that the CORT supplementation in the drinking water mimicked 
some of these stress effects in the control CORT treated animals. Nonetheless, 
even in non drug-treated treated, non injected animals, with 12-18 animals per 
group, no behavioral difference was found between stress and control groups for 
either of these experiments.   This was in contrast to previous pilot studies and the 
results of the conditioned stimulus cued behavioral study (Chapter 5).  However, 
even in this experiment, we were only able to achieve a significant difference 
between stress and control behavior, when the groups were collapsed across song 
exposure (n = 36 per group).  
  Since the multimodal stress paradigm produces PTSD-like symptoms only 
in a fraction of the population of animals subjected to it, this makes it an ideal model 
for studying stress vulnerability and stress resilience but a poor model for studying 
the effects of manipulating a candidate neurochemical system using a behavioral 
endpoint.   A model using a more robust stressor, such as CRS has historically 
produced more consistent behavioral effects (Wood et al. 2008).  This paradigm 
was used in the third experiment, examining the effects of a Y5 receptor antagonist. 
 Three weeks of CRS significantly reduced weight gain in the stressed 
groups, regardless of drug treatment.  This effect, while consistent with the stress 
literature (Magarinos et al. 1995; Goldwater et al. 2009), was not necessarily 
predicted for the drug treatment groups.  As the drug was administered orally in the 
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chow, it was important that animals in the stress and control groups consumed 
similar amounts of chow in relation to their body weight.  As stressed animals 
continued to gain weight after week 5 of the study, this did not appear to be a factor.   
Unfortunately, no in-cage behaviors appeared to be affected by either stress 
or drug treatment.  Anhedonia or decreased sucrose water preference is a common 
result of chronic stress (Rygula et al. 2005; Kompagne et al. 2008; Tynan et al. 
2010).  We may not have been able to find this effect for several reasons. First, 
most experiments have individually housed animals.  Therefore, all sucrose 
consumption can be attributed to a single animal.  In this experiment, animals were 
housed in groups of three and were not separated in order to reduce stressful 
experiences in the control animals.  As all three animals shared a single water 
bottle, which increased competition, this may have mitigated some of the effect. 
Second, sucrose preference was tested twice, once on day 2 and again on day 20 
of stress.  What effect repeated trials may have on sucrose preference is unclear, 
however, virtually no regular water was consumed when the animals were given the 
choice of sucrose water on Day 20.  
Aggressive acts were also very minimal in the two hours immediately after 6 
hours of restraint stress, with matched controls.  The protocol used follows the one 
found in (Wood et al. 2008), which showed significant increases in aggression in the 
stressed animals after a three- week stress. The only difference was that in this 
experiment, behavior was recorded using a video camera and no experimenter was 
present in the room at the time of observation.  The majority of animals fell asleep 
quickly after the start of recording, therefore producing few aggressive acts.  It is 
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possible that having an experimenter in the room was a confounding variable that 
may have even been a stressful or arousing stimulus that kept the animals awake 
and induced aggressive behavior.  Future studies will examine in cage behavior 
during the dark cycle when the animals are more likely to be awake. 
Finally, although behavior in the EPM differed between stress and control 
animals in the No Drug group when compared using a unpaired student’s t-test, the 
addition of another variable, and the necessity to compare these groups by a two-
way ANOVA diminished this effect.  As Sprague-Dawley rats have highly variable 
pre-stress anxiety behaviors, the combined results of a second behavioral cohort 
should enhance these results. 
Of the stress and drug- induced alterations to the molecular profiles, NPY 
changed the most significantly.  Stress reduced NPY expression in the Cornu 
Ammonis region of the hippocampal formation, which confirms studies of chronic 
stress in the literature (Sweerts et al. 2001; Sergeyev et al. 2005).  It appears that 
Y5 antagonist partially blocks this effect, although there was a trend for the Y5 
antagonist to reduce the amount of NPY in the hippocampus of control animals.  As 
many types of NPY receptors can be found in the hippocampus of the rat brain 
(Parker et al. 1998), it is possible that the balance of these receptors or the amount 
of NPY protein may be disrupted by the Y5 antagonism. 
There appeared to be an interesting stress by drug interaction in the 
expression of Y5 mRNA. As Lu AA33810 works directly on the Y5 receptors as a 
competitive antagonist, it was unclear what consequence it would have on Y5 
mRNA expression. There was an effect or a trend towards an effect for the drug to 
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reduce Y5 expression in most sub-regions of the hippocampus, regardless of 
stress. Although only significant in region CA3b, there was a stress-induced 
reduction of Y5 mRNA expression. However, if we compared the expression levels 
of stress and controls in the No Drug group by unpaired two-tailed student’s t-tests, 
there was a significant stress-induced reduction of Y5 expression in all sub-regions 
of the Cornu Ammonis.  This would suggest that the drug and stress treatments 
may have interacted with each other preventing us from seeing a more robust 
effect. It is of note that Y5 mRNA decreased as a result of both stress and Y5 
receptor antagonism, as the aim of this treatment was to reduce the effects of stress 
on brain and behavior.  Although mRNA expression may be reduced with drug 
treatment, it is unclear how the protein is changing, and how much Y5 receptor is 
actually available for binding with the ligand. 
In light of the above results, and the difficulties in achieving significant 
differences between non-treatment stress and control groups when multiple 
comparisons were necessary, this has led us to conclude that the multimodal stress 
model of PTSD is not effective for use in studies where individual differences are 
not examined.  Individual differences in response to this particular stressor appear 
to induce variability to the point that we may not be able to see a result of drug 
treatment unless the drug is 100% effective a preventing anxiety after stress.  It is 
possible, although not practical, that increasing the total number of subjects run in 
each group may help add power to the analyses. While there was difficulty 
achieving a significant difference between non-drug groups in the Y5 receptor 
antagonist study, we believe that a second cohort of animals would be sufficient to 
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demonstrate stress-induced anxiety in the non-drug groups and show that drug 
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Chapter 7: General discussion and implications for stress 
research 
First and foremost, the results of this research demonstrate that molecular 
and morphological differences are already apparent in unstressed adult male rats 
and correlate with basal anxiety levels.  In particular, anxious rats have smaller 
apical dendrites in pyramidal neurons of the mPFC, and anxiety correlates with 
CART mRNA expression in many regions involved in learning and memory.    
Using this information, and, in order to better replicate the parameters of 
PTSD in humans, where only a percentage of people exposed to a traumatic 
experience develop PTSD, an animal model of PTSD was developed to produce 
both stress-vulnerable and stress resilient individuals. When animals were divided 
into groups based on whether or not there was a stress-induced change in their 
anxiety levels, differences were found between groups in expression of the 
neuropeptide CART.  Instead of finding molecular changes in the brains of the 
affected individuals, the PTSD-like group, it was actually the “Resilient” animals that 
showed differences in CART expression from unstressed controls.  These results 
suggest that stress-resilience is an active process, and that CART may play a role 






The brain encodes for different aspects of a stressor, including 
length, timing and modality 
Messenger RNA expression of the neuropeptides CART and NPY were 
differentially affected by both stress timing and modality.  Chronic stress had the 
greatest effect on CART expression, inducing increases in the hippocampus, 
amygdala and nucleus accumbens and a decrease in the mPFC.  This would 
suggest that a long-term, more severe stressor has larger effects in the brain, which 
is supported by the chronic stress literature (McEwen 2001; Mitra et al. 2005).   In 
contrast, changes in NPY mRNA expression appeared in the immediate aftermath 
of an acute stress, increasing in the dentate gyrus and CA3 region of the 
hippocampus as well as the mPFC.  There is evidence that NPY levels in plasma 
increase over several hours during or after stress (Zukowska-Grojec et al. 1988).  
As these animals were sacrificed 2 hours after stressor onset, it is possible that 
NPY has already been upregulated in the brain (Zukowska-Grojec 1995).  
Additionally, the 21-day chronic restraint stress (see Chapter 6) decreased NPY 
mRNA levels in the CA1, CA2, and CA3 region of the hippocampus, confirming 
findings of previously published chronic stress studies (Sergeyev et al. 2005; 
Zambello et al. 2010). These results suggest a time dependent mechanism for NPY 
expression. It’s possible that the immediate increase in NPY is a homeostatic 
response to normalize function while the decrease found with chronic stress reflects 
a maladaptive failure to maintain that compensatory response. 
  It is important to point out that that many of these changes in mRNA 
expression are happening 10 days after a single stressful stimulus, a stimulus that 
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lasts only 10 minutes in the case of COS + 10d.  Yet, we are still finding alterations 
to mRNA expression 10 days later, suggesting that there is a long term change in 
the protein output for these small neuropeptides even after short and mild stressful 
experience, and even without a change in behavior This may be a clue to the 
phenomenon that people who have experienced prior stress are more prone to 
develop stress disorders after a subsequent trauma (Sledjeski et al. 2008).  These 
long-term changes in mRNA expression in regions encoding and regulating 
memories, including fear memories may be involved in priming the brain to respond 
more quickly or severely to a subsequent stressor. 
Individual differences in basal levels of anxiety correlate with 
morphological differences in rat mPFC. 
We have shown that apical dendritic length in pyramidal neurons from layer 
II/III of the prelimbic (PL) region of the mPFC correlates with anxiety behavior 
regardless of stress. When unstressed controls were divided into groups that 
contained individuals from the top and bottom 15% of the anxiety behavior 
spectrum, those in the least anxious, or Calm group, had significantly longer apical 
dendrites than the individuals that had the highest anxiety levels. These findings 
reflect the effects of stress on dendritic morphology in the mPFC.  Three weeks of 
chronic restraint stress causes dendritic retraction and an anxious behavioral profile 
(Cook et al. 2004; Radley et al. 2004; Brown et al. 2005). A summary of results in 
the mPFC can be found in Table 1, below. 
 There were also differences between rat strains. Although all Lewis rats 
generally spent less time in the center of the open field than Sprague-Dawley (SD) 
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rats, a sign of anxiety, cells in the PL regions were generally larger.  This becomes 
even more apparent if the lower average body weight of the Lewis strain is taken 
into account.  While we did not account for brain weight, it would be expected to be 
proportional to body weight in age-matched animals. This phenomenon does not 
correspond to what we would predict based on strain behavior, and other 
connections, and even morphology, of the prefrontal cortex needs to be further 
explored in Lewis rats. Nonetheless, animals from both strains showed differences 
in mean total apical dendritic length about 15-20% between Calm and Anxious 
groups. 
Additionally, the Sholl analysis revealed a difference in the distribution of 
dendritic material between the Lewis and SD strains.  Calm Sprague-Dawley 
individuals showed a typical distribution of dendritic material across the dendrite, the 
largest concentration of branches was located around 90-120 μm from the cell 
body, which gradually tapered off farther away from the soma.  Anxious animals, 
had similar amounts of dendritic material in the 90-120 μm range, but this tapered 
off more quickly, resulting a larger reduction of dendritic material in the distal portion 
of the dendrites as compared to Calm controls.  Without the same proportion of 
inputs from the projections located closest to the pial surface, which tend to be 
GABAergic horizontal interneurons (Krimer et al. 2001; Cassidy et al. 2010) the 
most anxious individuals may have a difference in overall connectivity in the mPFC.  
Lewis rats in both the Calm and Anxious groups had similar Sholl profiles, 
suggesting that the increase in dendritic length found in the calm animals was 
spread across the entire dendritic arbor 
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These results bring up some methodological issues with experiments that 
measure dendritic length and morphology after experimental treatment. Based on 
the studies above, there is an approximately 20% difference in mean apical 
dendritic arbor size between Anxious and Calm controls without any kind of 
behavioral manipulation. This would suggest that a large part of the variation seen 
in studies examining dendritic structure of mPFC neurons could be due to this 
variability if basal anxiety behavior isn’t measured and counterbalanced.  Many 
stress studies that have examined mPFC dendritic morphology have assumed 
behavioral changes without measuring them (Wellman 2001; Radley et al. 2004; 
Perez-Cruz et al. 2007; Shansky et al. 2009). These results show that individual 
variability can be a large factor in studies with subject numbers as low as 4-6 per 
group with the number of neurons traced per animal less than 8, and proposes a 
strong message against making conclusions about stress-induced dendritic 
remodeling in mPFC without also measuring behavior in those animals.  However, 
the few studies that have examined post-stress behavior after chronic stress have 
been able to show enhanced anxiety and/or learning impairment coincide and even 
correlate with mPFC dendritic morphology (Cerqueira et al. 2005; Liston et al. 
2006), suggesting that it is possible to see stress effects on top of the individual 






Table 1. A summary of known anxiety and stress-induced changes 
in mPFC 




There is a wide range 
of basal anxiety 
behavior in the open 
field and elevated plus 
maze in SD and Lewis 
rats
PL (and to a lesser 
degree IL) apical 
dendrites are larger in 
Calm animals
Larger apical dendritic 









Wide range of basal 
anxiety behaviors in 
SD rats
No published studies No published studies
Infusion of NPY into 
PFC produces 
benzodiazepine like 








No Differences in 
behavior after AIS + 
10d
No changes in dendritic 
length or spine density 
after AIS + 10d











AIS + 10d  and COS 
+10d– mRNA 
expression: No 
differences after a delay
COS + 2 hrs – mRNA 
expression: increased 
2hrs after stress
No differences between 




AIS + 10d enhances 
anxiety behavior 
(Mitra, et al. 2005)
No published studies No published studies
No differences 
immediately or 1 day 
after restraint stress 
(Sweerts, et al 2001) 
Footshock decreases 
NPY protein expression 
(Krysiak, et al. 2000)
Administration of CRH 





21d CRS: Some 
evidence of increased 




(Liston, et al. 2006)
PL/IL apical dendrites 
smaller after 21d CRS, 
positive correlation with 
working memory  
(Liston, et al. 2006)
Significant 
decrease after 10d 
CIS
No Change after 10d 
CIS or 21d CRS
Published 
findings
21d CRS increases 
anxiety behavior
10d CIS increases 
anxiety behavior 
(Vyas, et al. 2002)
10 days of mild stress 
causes dendritic 
retraction (Brown, et al. 
2005)
21 days of CRS causes 
dendritic  retraction 
(Radley et al. 2004, and 
Cook et al. 2004) and a 
reduction in spine 




No changes in NPY 
protein levels after 12d 




What causes individual differences in anxiety? 
In examining a group of animals that are the same age, grew up and still live 
in the same environment, have similar life experiences and a similar genetic profile, 
particularly in the inbred Lewis rats, it is surprising that we can find such a wide 
range of anxiety behavior.  There are many factors that may influence and enhance 
anxiety behavior and alter the response to stress.  A major factor that we cannot 
control for is maternal care and behavior during development. The amount of time 
that mothers lick and groom their pups has been shown to change molecular 
profiles and connectivity in the amygdala, hippocampus and prefrontal cortex and 
alter anxiety and stress responses in adult animals (Francis et al. 1999; Meaney et 
al. 2005; Veenema 2009) For example, adult animals from low-licking mothers show 
impaired habituation of acoustical startle response and blunted connectivity in the 
mPFC (Zhang et al. 2005), and shortened dendrites and poorer hippocampal 
dependent memory (Champagne et al. 2008).  Mothers that have been also divided 
by their anxiety profiles also show differences in the amount of time spent licking 
and nursing their pups, where those that appeared less anxious actually groomed 
their pups less (Clinton et al. 2007).  This may present both an environmental 
component, in that a nervous mother may change the anxiety profile of her 
offspring, and a genetic component, where individual differences in anxiety may be 
passed on to the offspring. Abusive maternal care has also been modeled by 
shocking pups in the presence of their mother or during presentation of the mother’s 
scent which suppresses the normal stress hormone response to shock (Moriceau et 
al. 2006).  This type of stressor can cause alterations to HPA axis stress response 
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in adulthood and maladaptive stress responses (Korosi et al. 2009).  However, 
there is variability in the amount of grooming that each pup receives even from 
attentive mothers (Felissa van Hasselt, University of Amsterdam, personal 
communication), as well as differences in consistency of care (Tang et al. 2006), 
and this may allow for even more individual differences between animals from the 
same litter or litters with equal amounts of grooming but different schedules. 
Stress during development or later on in life can also cause changes to brain 
and behavior. Maternal separation during early life also has been shown to change 
the HPA axis responsivity (Anisman et al. 1998; Liu et al. 2000; Aisa et al. 2007) 
and alter connectivity of brain regions that are involved in stress and reward 
learning (Gos et al. 2008; Swinny et al. 2009) and enhance depressive-like and 
anxiety symptoms in adulthood (Huot et al. 2002; Ruedi-Bettschen et al. 2005). 
However, exposure to novelty during development appears to enhance memory, 
stress-coping strategies and synaptic plasticity in adulthood (Tang et al. 2003; 
Akers et al. 2006).     
Animal housing and social environment can have profound effects on 
behavior. Social isolation, a common husbandry practice for male rats has also 
been shown to have effects on anxiety, reward pathways, cognitive ability, and the 
response to stress (Ellison et al. 1984; McEwen 2000; Silva-Gomez et al. 2003; 
Thorsell et al. 2006).  However, social defeat, and the hierarchy created within a 
group of animals that are housed together can also have effects on the brain, 
anxiety behavior and the levels of circulating stress hormones.  Social defeat has 
shown increased anxiety and a change in sleeping patterns (Kinn et al. 2008), an 
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reduced activity in the hippocampus and increased depressive-symptoms, which 
could be reversed by anti-depressants (Rygula et al. 2005; Artola et al. 2006; 
Miczek et al. 2008). Even subordination within a home cage has effects on basal 
CORT and testosterone levels and changes in the serotonin system (Blanchard et 
al. 1993) 
Husbandry conditions and experimenter interactions can also have impact on 
anxiety behavior. Sometimes these issues are identical across all animals in an 
experiment, but often this isn’t the case.  We have recently performed an 
experiment that found that cage changes affected CORT levels and anxiety 
behavior in the EPM in mice for up to 24 hours after cleaning (Rasmussen, et al. 
submission in progress). Variability in ambient noise, husbandry staff and housing 
location can have an effect on the brain. In our facility, we have found differences in 
the size of prefrontal apical dendrites between two housing locations (Deena 
Goldwater, Mt. Sinai School of medicine, Supplementary Figure 1).  Animals 
housed in the smaller, quieter Smith Hall had overall larger apical dendrites in 
mPFC, although a chronic stress effect was found in both facilities. Additionally, 
there were some behavioral effects from differences in lighting levels based on cage 
location on a housing cage rack and on the use of sleeping shelters that confirm 
previously published studies (Balcombe et al. 2004; Van Loo et al. 2004; Izidio et al. 
2005). Husbandry practice such as changes in lighting have even been shown to 
affect nursing profiles of mothers, subsequently enhancing anxiety behavior in adult 
offspring (Toki et al. 2007); so many of these factors can interact with one another 
to produce the range of behavioral variability found in laboratory rodents. 
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It appears that genetics, maternal care, and in-cage and outside prior stressors can 
all influence the individual differences found in anxiety behavior and the response to 
stress. 
Stress resilience is an active process 
 Large post-stress differences were found in CART peptide and mRNA 
expression in the resilient individuals, although not always in the same direction in 
all brain regions. Differences in the Resilient group were found in areas of the 
mPFC, amygdala and hippocampus.  Each of these regions has been shown to 
have structural and neurochemical changes as a result of stress (Vyas et al. 2002; 
Radley et al. 2004), but the above results would suggest that resilience is an active 
process of preventing these stress-induced effects.  In the hippocampus, there is 
evidence that CART is neuroprotective, and can prevent excitotoxicity and enhance 
neurogenesis in the hippocampus (Yermolaieva et al. 2001; Wu et al. 2006); this is 
further discussed below. 
Stress resilience appears to be an active process in regards to NPY expression. 
Higher circulating levels of NPY have been found in humans that have gone through 
high-stress military survival training (Morgan et al. 2000) and in people recovering 
from PTSD compared to those with more PTSD symptoms (Yehuda et al. 2006). 
Administration of NPY into the brain reduces fear potentiated startle and enhances 
extinction learning (Gutman et al. 2008). These results would suggest that NPY 
mRNA expression would differ between the Resilient and PTSD-like groups in 
above experiment.  Surprisingly, we found no differences in NPY expression on 
basal anxiety level or stress using the multimodal model of PTSD.   
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However, we analyzed mRNA while the published studies examined protein 
levels.   It is possible that the mRNA expression profiles are not predictive of what is 
happening with the peptide, and future immunohistochemical studies will be 
performed on the stress resilient and PTSD-like brains. 
  Evidence that resilience is an active process is also provided by the field of 
extinction learning.  Stress resilience may be thought of as a form of extinction from 
trauma-induced generalized anxiety, and appears to be a process that happens 
gradually in a previously stressed animal or person (Yehuda et al. 2006).  A high 
percentage of people have PTSD-like symptoms such as enhanced startle reflex 
immediately after trauma, but diagnosis of an actual disorder must meet the criteria 
of being present for more than 3 months after trauma (Yehuda et al. 1998).  In 
PTSD, the gradual extinguishing of fear appears arrested (Milad et al. 2006; Milad 
et al. 2008).  Individual differences have also been found in the ability to extinguish 
a fear-conditioned response and in the amount of spontaneous recovery seen a 
population of SD rats (Bush et al. 2007). CART may either play a role or be 
indicative of other ongoing processes involved in stress resilience through extinction 
learning pathways. 
 
The benefits and pitfalls of the multimodal stress paradigm 
 While the multimodal stress paradigm was able to produce significant long-
term effects on anxiety behavior with a sufficient number of animals per group (at 
least 18), a large minority of the stressed individuals (about 20-40%) did not change 
in their behavior as a result of the experimental manipulations.  While this may be a 
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more applicable model of PTSD in humans, where only a percentage of people 
exposed to a traumatic experience develop PTSD, most experiments rely on 
statistical differences between groups to show that an experiment is working.  
Herein lies the difficult of using this paradigm in drug treatment studies; Individual 
differences in response to this particular stressor appear to induce variability to the 
point that we may not be able to see an effect of drug treatment unless the drug is 
100% effective a preventing anxiety after stress.  
  One method for accounting for this variability is to calculate a change over 
time from normalized anxiety measures of controls, since even controls have 
variable anxiety behavior that is predictive of differences in the brain. Another 
method is to remove some of the variability by excluding individuals who fall on the 
extreme ends of anxiety behavior, by way of behavioral pre-screening prior to 
experimental manipulations. However, selecting for “ideal” individuals (those that 
are not extremely calm or nervous prior to experimental procedures) is a costly and 
somewhat confounding process.   
 Yet, choosing to experiment only on “average” individuals could make drug 
treatment studies irrelevant to a human population.  Affected individuals seeking 
treatment for anxiety and mood disorders are a subset of the population 
[approximately 31.2% lifetime prevalence for anxiety disorders and 21.4% for mood 
disorders, as per the National Comorbidity Survey (NCS-R), Kessler et al. 2005].  
Comorbidity studies, such as the NCS-R illustrate that there are many factors that 
increase vulnerability to developing an anxiety disorder, such as childhood 
experiences (Kessler et al. 1997; Goodwin et al. 2004), previous trauma (Sledjeski 
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et al. 2008) , and social status (Kessler et al. 2005).  It is possible that many of 
these prior stressors may manifest as subclinical behavioral changes, similar to the 
range of anxiety behavior seen in laboratory animals.  Therefore, it is important to 
take individual differences into account when using animal models of anxiety and 
mood disorders, which may necessitate a different way of thinking about and 
designing experiments. 
The role of CART in fear and anxiety behavior 
 Some of the most interesting findings of this research were that CART 
neuropeptide mRNA expression correlated with basal levels of anxiety and that 
CART mRNA and protein levels were altered after stress, but almost entirely in the 
stress-resilient individuals (See Table 2 for summary).  While it is well-established 
where CART peptide can be found in the brain, little is understood about what 
CART is doing in the brain or even what CART receptors are and where they are 
located.  This presents a major obstacle when trying to determine the mechanism 
for the actions of CART pertaining to the production of fear and anxiety behaviors.  
However, the neuroanatomical circuits and actions of other neurotransmitter 
systems that lead to elicitation of fear and anxiety behavior are better understood.  
By combining what little is known about the location and function of CART peptide 
with what has already been established in these areas, we can infer some of the 
roles CART could be playing in these regions. 
 176 
Location and connectivity of CART to other neurotransmitter and 
hormone systems 
In rats, CART peptide is found in amygdala, hippocampus, many regions of 
the cortex including, the piriform, frontal, prefrontal and orbitofrontal, perirhinal, 
auditory, and motor cortex, the nucleus accumbens, olfactory processing areas, 
many hypothalamic nuclei, a few thalamic nuclei, the BNST, periaqueductal gray 
(PAG), dorsal raphe, locus coeruleus (LC), ventral tegmental area (VTA), medulla, 
the vagal nerve and spinal cord (Koylu et al. 1998; Murphy et al. 2000). Nearly all of 
these regions have something in common, they are connected directly or indirectly 
to amygdala and they have been implicated in the stress response and anxiety 
behavior (Ottersen 1980, 1981, 1982; Volz et al. 1990; Davis et al. 1993; Petrovich 
et al. 1996; Van Bockstaele et al. 1999; Adamec et al. 2001; Dong et al. 2001).  
Although localization of the peptide has not been ascertained in every region, CART 
has been shown to be a cotransmitter in GABAergic neurons in the nucleus 
accumbens (Smith et al. 1997) and with epinephrine in the medulla (Wittmann et al. 
2004), and many other hormones and peptides in the hypothalamus including 
corticotrophin releasing hormone (CRH), alpha-melanocyte-stimulating hormone 
(alpha-MSH), thyrotropin-releasing hormone-(TRH), dynorphin and neurotensin 
(Elias et al. 2001). 
The CART neuropeptide has a direct effect on anxiety behaviors and mood. 
CART injected into ventricles or CE induces anxiety behavior in the EPM and in a 
social interaction test (Chaki et al. 2003; Dandekar et al. 2008). Intraventricular 
CART administration also increased activity in neurons of the LC (Chaki et al. 
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2003), a region that is both directly and indirectly (through BNST) connected to CE 
and required for the output of anxiety behavior (Van Bockstaele et al. 1999).  
Interestingly, injections of CART into the amygdala or lateral ventricles can also 
decrease depressive-like behavior, such as time immobile during a forced swim test 
(Dandekar et al. 2009). Projections from CE to the medulla have been shown to 
control cardiovascular fear responses through the glucocorticoid CRH (Bohus et al. 
1996; Salome et al. 2001). Injection of CART into the fourth ventricle induces 
anhedonia similar to the stress-induced reduction in sucrose consumption (Zheng et 
al. 2001).  The CART positive neurons that are present in the dorsal vagal complex 
of the medulla have been shown not to be directly involved in food intake (Zheng et 
al. 2001) but stimulate CRH release (Stanley et al. 2001), which might suggest that 
they are actually involved in modulating the cardiovascular fear response. Taken 
together, this evidence points to a role for CART in increasing anxiety and fear 
behaviors through amygdala signaling.  As we found reduced CART protein 
expression in most regions of the amygdala and BNST in stress-resilient individuals, 
this would correspond with inhibition of amygdala activity, with CART expression as 
a direct or indirect result, and an active model of stress resilience. 
CART is regulated by glucocorticoids and also is able to modulate stress 
hormone levels. CART is differentially affected by adrenalectomy in the 
hippocampus and amygdala. Adrenalectomy reduces CART expression in the 
dentate gyrus but CE is not affected (Hunter et al. 2007), suggesting different 
actions of glucocorticoids in these regions.  On the other hand, systemic CART 
administration increases Adrenocorticotropic hormone (ACTH) and CORT plasma 
 178 
levels, although intraventricular injection had no effect (Smith et al. 2004). The 
functions of CART in the brain and the roles it has in modulating stress hormones 
have been best established in the hypothalamus. CART injection increases CRH 
and vasopressin in hypothalamus (Smith et al. 2004); and it would not be far leap to 
suggest that CART could be doing same thing in the amygdala, where both 
hormones play a role in the stress response. The CE to LC pathway is modulated 
by CRH, which in turn increases anxiety (Van Bockstaele et al. 1999; Yilmazer-
Hanke et al. 2004). Vasopressin has been shown to modulate freezing and 
cardiovascular stress responses through projections from CE to the LC, PAG and 
vagal complex of the medulla.  While it is not clear whether CART is a cotransmitter 
with CRH and vasopressin or in other projections that promote the release of these 
hormones, the above evidence suggests a direct role of CART to increase anxiety 
behavior through actions on stress hormones. The results from the stress-resilient 
animals would propose that stress hormones may also be modulating CART 
expression.  It has been shown that those individuals with positive adaptations to 
stress have a different corticosterone response (Cohen et al. 2006), and this may 
be influencing the reduction in CART protein found in the stress-resilient amygdala. 
 Another side of the CART story has been studied in the hippocampus. There 
is evidence that CART can inhibit voltage-gated calcium channel signaling during 
cocaine administration in the hippocampus, reducing excitotoxicity (Yermolaieva et 
al. 2001). More confirmation of the neuroprotective effects of CART can be found in 
ischemia studies, where blocking CART increased the extent of ischemic damage 
and CART treatment increased MAPK/ERK signaling (Jia et al. 2008). As we found 
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higher CART expression in hippocampus of calm and stress-resilient individuals, 
this would suggest that CART is involved in neuroprotection by reducing stress-
induced excitotoxicity.   CART has also been shown to increase cell survival in 
cultured hippocampal neurons through upregulation of BDNF (Wu et al. 2006).  In 
our studies, both calm individuals and stress-resilient animals had higher CART 
expression in dentate gyrus, which would be consistent with the idea that CART 
modulates BNDF expression in this region preventing a stress-induced decrease in 
neurogenesis. This coupled with the above evidence suggests a neurotrophic or 
neuroprotective role for CART in the hippocampus.  These relationships can form 
the basis of future studies of individual differences in neurogenesis and stress 























Table 2. A summary of CART mRNA and protein expression findings 
in the brain. 
 




























































































CART has multiple functions in the brain 
The above evidence indicates that CART neuropeptide has at least two roles 
in brain, which are summarized in Table 3. In regions of adult neurogenesis like the 
hippocampus, it appears that CART is neuroprotective, inhibits excitotoxicity, and 
that it also may modulate important trophic factors for neurogenesis.  This would 
support our findings of higher CART expression in both calm unstressed and stress-
resilient animals. Stress has been shown to reduce hippocampal neurogenesis, and 
treatments that increase neurogenesis prevent stress-induced changes in anxiety 
behavior and memory (Pham et al. 2003; McEwen et al. 2004; Kasper et al. 2008).    
In the amygdala, CART appears to have a direct effect on behavior. It is 
anxiogenic, which also is supported by the lower protein expression found 
throughout amygdala and BNST in the stress-resilient animals.  There is one major 
caveat to this result, variable effects on CART expression were found in the CE 
(and to a lesser degree ME) with anxiety behavior of unstressed controls and in 
stress-resilient individuals.  In unstressed controls, higher CART mRNA expression 
correlated with increased anxiety in CE.  This result appears to correspond with the 
general anxiogenic effects of CART expression.  However, after stress, animals that 
were resilient had higher CART mRNA expression in CE but no differences were 
found in protein expression. Like the rest of the amygdala nuclei, there was lower 
protein expression in ME in the resilient animals, however, calm individuals also had 
higher CART mRNA expression in ME. There is some evidence that these 
amygdala nuclei are responsible for encoding different aspects of stress. ME is 
involved in integrating odor information and may be necessary to produce 
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appropriate social and sexual responses (Newman 1999), and CART has been 
found in ME neurons that also respond to odors from conspecifics (Donato et al. 
2010). In fact, ME may be more responsible for predator odor conditioning and 
defensive behaviors than BLA or CE (Blanchard et al. 2005; Takahashi et al. 2005).  
In addition, chronic  immobilization stress induces dendritic hypertrophy in BLA and 
BNST, without affecting neurons in CE (Vyas et al. 2003); this is similar to where we 
find changes in CART expression.  Further description of the multiple pathways 
through CE can be found below. 
 The medial prefrontal cortex also shows differential effects on CART 
expression between basal anxiety levels and stress-induced anxiety.  In unstressed 
animals, higher CART expression also correlated with increased anxiety.  This 
corresponded with the decrease in PL CART mRNA expression found in the stress-
resilient group, however, a decrease in CART protein expression was found in the 
IL region in all stressed animals, although this was only significant in the PTSD-like 
group. CART mRNA expression in the mPFC was generally very low. In the protein 
analysis, although there were many CART immunolabeled fiber tracts, few 
immunolabeled cell bodies were found.  This would suggest that the population of 
cells analyzed by mRNA expression is different than the population of CART-
positive fibers analyzed for the protein expression.  Although it is not clear whether 
CART activity in this region is excitatory or inhibitory, these results appear to go in 
the same direction; CART mRNA is higher with increased anxiety, and lower in 
stress-resilient animals. CART protein is reduced in the mPFC of PTSD-like 
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individuals, but these are projections that are coming from somewhere else, 
perhaps the amygdala. 
The central amygdala and the mPFC are key regions responsible for the 
production of fear conditioning and fear extinction behaviors (Nader et al. 2001; 
Quirk et al. 2003), and may have two systems modulating them; one basal system 
that mediates general anxiety levels under normal circumstances, and a secondary 
system that is only responsive during stressful situations, or during the recall of 
these situations. Evidence for this can be found in the central amygdala, where 
there are connections from CE to PAG that are involved in fear conditioned freezing 
and fear-potentiated startle (LeDoux et al. 1988) and  two pathways have identified 
between CE and the LC, a region necessary for elicitation of fear-conditioned 
freezing and general anxiety (Van Bockstaele et al. 1999). The direct connection 
from CE to LC is regulated by the glucocorticoid CRH and well as dynorphin and 
norepinephrine.  This pathway is responsible for fear-conditioned freezing.  In the 
second pathway, neurons from CE project first to BNST, which then projects to LC.  
This pathway has been shown to be more responsible for anxiety behavior, such as 
the amount of time spent in the open arms of the EPM. Since this was the measure 
that was used to differentiate PTSD-like and resilient individuals, we would expect 
that this pathway would be the one affected, and that seems to be the case; CART 
expression is reduced in BNST.  However, we do not know whether direct fear 
behavior has been altered in our animals.  In CE, CART mRNA expression was 
higher in the Resilient group, but protein levels were unchanged.  It is possible that 
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the expression patterns we found are not related to the anxiety pathway and that 
the ability to respond to an unconditioned stimulus is similar in all animals. 
In the mPFC, there is evidence that PL and IL may have different functions 
and connections.  The IL mainly connects to CE while PL connects to several other 
amygdalar regions including LA and CE (McDonald et al. 1996).  This may be 
indicative of a different role for each of these regions in the inhibition of the 
amygdala. A summary of the regions with conflicting CART evidence can be found 

































Table 3. The functional implications of CART peptide expression in 
regions with consistent expression profiles 
 
The functional implications of CART peptide expression
CART has anxiogenic 
properties in some nuclei of 
the amygdala, and must be 
actively reduced to prevent 
anxiety after stress
CART is anxiogenic when injected 
into the amygdala
CART is anxiogenic when injected 
into the locus coeruleus, which 
receives direct and indirect input 
from amygdala
Higher CART mRNA correlates 
with anxiety in unstressed 
animals
CART protein lower in resilient 
animals in ME, BLA, LA and 
BNST
Amygdala
CART militates against the 
deleterious effects of stress 
in the hippocampus -
possibly neuroprotective
CART shown to prevent 
hippocampal excitotoxicity after 
ischemia
CART necessary for cell 
maturation of newly born neurons 
in hippocampal cultures
CART mRNA higher in calm 
unstressed animals
CART mRNA and protein higher 




ImplicationsFindings in the literatureFindingRegion
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Table 4.  Possible implications of CART expression in regions with 
conflicting expression. 
 
Regions with conflicting evidence
Basal: CART may have roles 
other than anxiety in this 
region 
Stress: ME may be very 
responsive to predators 
stress
ME responsive to predator odor 
stress and mating odor cues
CART found in ME neurons that 
also respond to conspecific odors 
and may be involved in sexual 
behaviors
CART mRNA higher in Calm 
animals
No difference in CART mRNA in 
stressed animals




Basal: CART activity in 
mPFC may increase anxiety
Stress: Decreases in CART 
protein may be from 
projections from other 
regions of the brain
CART is most commonly co-
localized in GABA positive 
neurons
Mostly CART positive fiber tracts 
in mPFC
mPFC exerts inhibitory control on 
amygdala during fear extinction
Higher CART mRNA  correlates 
with anxiety in unstressed 
animals
CART mRNA lower in Resilient 
animals
CART protein is decreased in all 
stress groups but only significant 
in the PTSD-like group
Medial Prefrontal 
Cortex
Basal: CE (and CART 
activity in CE) increase 
anxiety
Stress: CE activity maybe 
resistant to change in CE 
even in resilient group or 
predator stress may not 
involve CE
CART is anxiogenic when injected 
into CE
CART is anxiogenic when injected 
into the locus coeruleus, which 
receives direct and indirect input 
from CE
CE may not be as responsive to 
predator odor stress 
Higher CART mRNA correlates 
with anxiety in unstressed 
animals
CART mRNA higher in Resilient 
animals











Future directions and conclusions 
This research with the neuropeptide CART presents a novel mechanism 
involved in both PTSD and anxiety disorders. There may be immediate translational 
relevance, in that plasma CART screening in humans may be telling of resilience 
after trauma or indicative of anxiety problems. The fact that different brain regions 
may have different roles for CART makes this peptide a difficult target for drug 
studies, but extremely compelling.  It appears that CART is beneficial for the 
hippocampus, so any systemic drug that reduces CART in the amygdala may have 
unwanted side effects that are related to learning and memory or even depression.    
It is still unknown whether CART is directly affecting behavior or if it is 
consequently responding to another signal that causes both behavioral change and 
a change in CART expression. Evidence from the literature and the ability of CART 
injections to alter anxiety would point to CART having a direct effect on behavior.  
Future studies will manipulate CART levels, either by increasing them with injection 
of peptide or using siRNA to block CART peptide translation.  This will have to be 
done in a region specific manner; in the hippocampus and mPFC, and later in CE to 
see first what effects it has on basal anxiety, and then what effect it has on stress.  
An interesting study would be to compare CART effects in BNST and CE, to better 
understand what role CART is playing in each region.  This may help to pull apart 
the basal anxiety effects from the stress-induced changes. 
 The most import message of these studies is that individual differences need 
to be taken into account when doing any behavioral experiment, but particularly in 
stress research.  The apparent structural and molecular differences between the top 
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and bottom 20% of control individuals are very similar to what results are found in a 
stress study.  The mPFC, in particular, is very labile and quick to respond to 
environment influences. Using small groups of animals in morphological 
experiments could unintentionally produce incorrect or biased results based on 
individual differences and not on the actual experimental manipulations. 
Another theme of this research has been that a better understanding of 
stress resilience may be the key to understanding PTSD and how to treat it.  Animal 
models of PTSD that cause behavioral changes or anxiety in the vast majority of the 
experimental group may be missing the chance to look at the changes that are 
occurring in the brain in a well-adapted animal.  It appears that for anxiety behavior 
to remain unchanged in the stress-challenged individual, many active processes 
must occur. These findings provide support for the direction of medicine towards 
individualized treatments based on genetic profile and current brain chemistry for 











Supplementary Figure 1. Effects of husbandry on weight gain, anxiety and 
dendritic morphology in the mPFC. Identical chronic restraint stress 
experiments were performed in two facilities on campus. (A) Control animals 
showed a larger weight gain in the smaller, quieter Smith Hall facility compared 
to the larger LARC facility.  (B)  A two-way ANOVA showed a trend towards a 
main effect of facility on anxiety behavior in the EPM. (C) A Sholl analysis of total 
apical dendritic material of pyramidal neurons in the mPFC revealed large 







Appendix 1: Regions of interest used for densitometry 
When analyzing autoradiographs of the dentate gyrus of the hippocampus 
(Supplementary Figure 2A), only the granule cell layer was clearly defined.  
Densitometry measurements for this region were examined at Bregma -2.8mm and 
Bregma -3.3mm. When no difference between these areas was found, a mean was 
calculated for further analysis.  In slides processed for NiDAB 
immunohistochemistry, the layers of the hippocampal formation were able to be 
defined with more detail (See Figure 19 for all NiDAB immunohistochemical 
regions).   The dentate gyrus of NiDAB stained sections was further divided into the 
molecular layer, granule cell layer, granule cell/hilar border, and hilus.  Each region 
was analyzed separately.  
The Cornu Ammonis region of the hippocampus was divided into five 
subregions based on atlas landmarks (Paxinos et al. 1998); CA1, CA2, and CA3, 
which was further divided into 3 parts (see Figure 19A).  CA3a comprised the lateral 
curved edge of the CA region, as seen in coronal sections.  This area was further 
divided into the pyramidal layer and the stratum lucidum, a region know to have a 
high concentration of mossy fiber terminals. CA3b comprised the region of CA3 
between the curved lateral edge and the lateral edge of the dentate gyrus. CA3c 
contained the pyramidal cell layer of CA that is found in between the top and bottom 
blades of the dentate gyrus, and is adjacent to the hilus.  In autoradiographs, only 
the pyramidal layer of CA is visible.  In the NiDAB immunolabeled sections, both the 
pyramidal layer and the stratum lucidum could be analyzed. 
 
 192 
The amygdala was divided into several nuclei based on atlas land marks.  
For both autoradiographs and NiDAB immunolabeled sections, the central nucleus 
of the amygdala (Supplementary Figure 2B) was analyzed at both an anterior 
(Bregma -2.6mm) and posterior (Bregma -3.1mm) level.  Where there was no 
difference between anterior and posterior, the mean of these areas was calculated 
and used for further analysis.  The medial nucleus of the amygdala (Supplementary 
Figure 2C) was divided into three regions based on shape and location; anterior 
(Bregma -2.6mm), middle (Bregma -3.1mm) and posterior (Bregma -3.6mm).  As an 
anterior to posterior expression gradient was found for CART peptide and mRNA 
expression, these regions were both analyzed separately and averaged together.  
At the same level as measured in the medical nucleus, densitometry measurements 
for the basolateral and lateral nucleus of the amygdala were also collected. 
In the prefrontal cortex, layer II/III of the orbitofrontal cortex was analyzed at 
Bregma +3.8mm (Supplementary Figure 2D), as the highest expression levels of 
CART appeared around this region.  In the medial region of the prefrontal cortex, 
layer II/III was further divided into prelimbic and infralimbic regions based on 
landmarks (Supplementary Figure 2E).  When available, three regions for each 
brain were sampled throughout the mPFC, an anterior (Bregma = +3.3mm), middle 
(Bregma = +3.0mm) and posterior (Bregma = 2.7mm).  As there were generally no 
differences in densitometry measurements for these regions, they were averaged 
together, except as noted. 
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The nucleus accumbens was sampled at Bregma = +1.6mm based on 
previous research (Hunter et al. 2005), and divided into a shell and core region 






















Supplementary Figure 2.  Autoradiograph examples of regions sampled by 
densitometry for mRNA expression.  Regions were sampled as defined by the red 
outlines for (A) upper and lower blades of the dentate gyrus of the hippocampal 
formation; (B) central nucleus of the amygdala; (C) medial nucleus of the 
amygdala; (D) orbitofrontal cortex; (E) Prelimbic and Infralimbic regions of the 
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